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ABSTRACT 
Human ageing is associated with a progressive decline in the function of the immune 
system, commonly referred as immunosenescence. This is characterized by the 
shrinkage of the naïve T-cell repertoire and a concomitant accumulation of highly 
differentiated effector-memory cells and dysfunctional senescent T-cells. These 
systemic immune alterations have clinical implications and have been associated with 
increased morbidity and mortality in the elderly. However chronological ageing may not 
be the only factor influencing immunosenescence and certain lifestyle factors may 
moderate or potentiate the rate at which immune alterations occur. The studies 
comprised within this thesis investigated the effects of lifestyle factors such as physical 
activity or obesity, along with latent viral infections on the proportions of highly 
differentiated and senescent T-cells. 
 
Data were gathered from individuals of various age, physical activity, body composition 
and latent viral infection status to assess the effects of a wide range of lifestyle factors 
on T-cell proportions. The different levels of T-cell differentiation were assessed by 
four-colour flow cytometry using monoclonal antibodies specific to cell surface markers 
associated with T-cell phenotypes. The role played by leptin on T-cell activation was 
assessed by in vitro stimulation assays followed by cell surface phenotype and gene 
expression analysis. The effects of acute bouts of exercise on T-cells subsets were 
characterized using a submaximal cycling protocol. 
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Aerobic fitness was associated with lower proportions of senescent and higher 
proportions of naïve T-cells, particularly within the CD8+ T-cell compartment in 
healthy adult men. The beneficial impact of aerobic fitness, and consequently of regular 
physical activity, on the ageing immune system was independent of age, latent viral 
infection status and body composition. Furthermore, the moderating effect of higher 
estimated  ̇      on the proportions of senescent T-cells suggested that a transition 
from low physical activity, characterized as having an estimated  ̇      below average, 
to regular physical activity, characterized as having a  ̇      above average, could 
prevent the age-associated accumulation of senescent T-cells during decades. Obesity 
and excess serum leptin in adolescents were shown to be associated with changes in T-
cell subsets associated with immunosenescence, such as reduced proportions of naïve 
and early T-cell and increased proportions of effector-memory and senescent T-cells. In 
addition, high physiological concentrations of leptin enhanced the mitogen-induced T-
cell activation in vitro suggesting a potential role in the accumulation of senescent T-
cells observed in obese individuals. Latent CMV infection was also associated with 
similar reductions in naïve T-cell proportions and increased proportions of highly 
differentiated and senescent T-cells in young adults. Although CMV infection appeared 
to be associated with an amplified exercise-induced preferential mobilization of highly 
differentiated and senescent T-cells in blood, those cells may not have been specific for 
CMV.   
It is concluded from this work, therefore, that chronological ageing is not the only factor 
associated with the accumulation of senescent T-cells in the elderly. By preventing 
obesity, and by potentially inducing senescent T-cells frequent mobilization and 
subsequent deletion via apoptosis, regular physical activity may prevent the 
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accumulation of highly differentiated and senescent T-cells in the elderly, and 
consequently reduce morbidity and mortality in later life.  
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CHAPTER 1 
GENERAL INTRODUCTION 
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The immune system is a complex network of specialized cells, proteins, tissues and 
organs which primarily function to maintain host integrity and eliminate or neutralize 
any element recognized as non-self and potentially pathogenic. The immune system 
relies on two distinct but overlapping responses to fight pathogens efficiently, the innate 
and adaptive immune responses. Innate immunity is the primary response to injury and 
infectious agents, and consists of non-specific epithelial barriers and antimicrobial 
substances, effector cells such as macrophages, natural killer cells, eosinophils and 
neutrophils, and soluble proteins such as the complement system and cytokines secreted 
to co-ordinate the activities of both the innate and adaptive immune cells. Adaptive 
immunity is a slower, but more specific response against infective agents, relying on the 
creation of long-term immunological memory to create efficient and durable defenses 
against pathogens. 
 
Along with B-cells, T-cells are one of the main cell types involved in adaptive immune 
responses, and their clonal expansion in response to an antigenic stimulus is a 
fundamental process of adaptive immunity. After recognizing an infectious agent, T-
cells rapidly divide and initiate effector cell functions to combat the infection and 
prevent pathogenic dissemination in the host. Unfortunately, however, clonal expansion 
is not unending, and after repeated and excessive rounds of cell division, T-cells 
undergo replicative senescence. In this instance, T-cells fail to clonally expand in 
response to growth stimuli, compromising immune system integrity and increasing the 
opportunity for pathogens to spread and persist in the host. As most components of the 
immune system are subjected to senescence, the generic term immunosenescence has 
been used to describe the age-associated decline in the functionality of the immune 
system. Senescent T-cells are known to accumulate with increasing age, contributing to 
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poor vaccine efficacy, immunodepression and have also been linked with increased 
morbidity and mortality in the elderly.  
Replicative senescence was initially observed in vitro in human diploid fibroblasts 
(HDF) cultures (Hayflick & Moorhead 1961) as a consequence of telomeric DNA 
attrition. These highly conserved non-coding hexameric repeats of the nucleotide 
sequence TTAGGG are located at the end of each chromosome (Moyzis et al. 1988), 
associated with the protein complex shelterin (de Lange 2005) that permit cells to make 
the distinction between DNA breaks from the natural ends of chromosomes and thus 
represses abnormal chromosomic fusions to be induced by DNA repair systems. 
Telomeres are progressively shortened with each round of cell division until they reach 
a critical size, known as the Hayflick limit, where the cell enters a state of replicative 
senescence. Senescent cells differ from quiescent cells by the permanent nature of the 
cell cycle arrest and by marked morphological, functional and phenotypical 
modifications (Bird et al. 2003). In comparison to cells retaining their proliferative 
capacities, senescent cells appears to be larger, flattened with a vacuolised, more 
granular cytosol and an increased nuclear volume (Bayreuther et al. 1988; Faragher et 
al. 1998). They also exhibit altered chromatin architecture and gene expression (Gire 
2005) leading to molecular differences such as the expression of the altered senescence-
associated β-galactosidase (van der Loo et al. 1998) or the decreased expression of heat 
shock proteins (Choi et al. 1990; Blake et al. 1991). Interestingly, while replicative 
senescence has been observed in a great variety of cell types, large scale microarray 
analysis has shown that the senescence-associated changes vary from one cell type to 
another (Shelton et al. 1999). Cellular senescence and senescence-associated changes 
have also been seen in immune cells, such as CD4+ and CD8+ T-cells (Grubeck-
Loebenstein et al. 1994; Adibzadeh et al. 1995; Adibzadeh et al. 1996), suggesting 
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potential health-threatening consequences due to compromised adaptive immune 
responses. In addition to having impaired proliferative capacities, senescent T-cells 
appear to have a reduced sensitivity to apoptosis (Spaulding et al. 1999; Hsu et al. 
2001) while exhibiting an increased pro-inflammatory cytokines production (Effros 
2003; Effros et al. 2003). Consequently, in addition to the natural age-associated 
accumulation of dysfunctional senescent T-cells, their limited clearance from the so-
called “immunological space”, a fixed homeostasis-regulated space occupied by the 
cellular components of the adaptive immunity,  leads to a restricted T-cell repertoire, 
which in turns results in poor responsiveness to previously unseen or evolved pathogens 
and eventually to a higher rate of morbidity and mortality in the elderly (Koch et al. 
2007). Certain lifestyle factors, such as smoking, physical inactivity or social-
economical status (Valdes et al. 2005), and persistent viral challenges (Wikby et al. 
2002) have been shown to influence the rate of immune ageing. Indeed, as a function of 
the normal ageing process, the accumulation rate of these dysfunctional cells can 
increase dramatically due to persistent viral challenges. Latent infections with the β-
herpesvirus cytomegalovirus (CMV) and/or the γ-herpesvirus Epstein-Barr virus (EBV), 
although often clinically asymptomatic in the immunocompetent host, have been 
correlated to immunosenescence and the associated “Immune Risk Profile” (IRP), 
which has in turn been shown to predict mortality and morbidity in seniors (Wikby et 
al. 1998). The exact mechanisms underpinning immunosenesence are, however, yet to 
be discovered to allow the establishment of potential therapeutic interventions. 
 
The beneficial effects of regular physical activity on immunity, particularly in older 
adults, are well-documented. Although many studies have shown increases in Natural 
Killer (NK) cell activity and T-cell functions in active compared to inactive elderly, the 
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mechanisms for enhanced immunity by regular exercise are not well understood. It has 
been shown that acute bouts of exercise preferentially mobilize senescent T-cells in the 
peripheral blood compartment (Simpson et al. 2007a) and also that acute exercise 
impacts aged individuals differently than younger individuals. If the exercise-induced 
leukocytosis observed in young adults is also seen in the elderly, fewer cells are 
entering the blood compartment after acute bouts of exercise in the elderly (Ceddia et 
al. 1999). Bruunsgaard et al. (1999) showed a greater mobilization of memory T-cells in 
younger subjects compared to older individuals following acute bouts of exercise. 
Interestingly, the same study showed that T-cells mobilized by acute bouts of exercise 
in the elderly population had a shorter telomere restriction fragment (TRF) mean length 
than the T-cells from their younger counterparts. As TRF mean length is a marker of 
terminal differentiation, or immunosenescence it can be advocated that acute bouts of 
exercise preferentially mobilize memory, or highly differentiated T-cells in young 
individuals, but mobilize senescent, or terminally differentiated T-cells in the elderly 
(Bruunsgaard et al. 1999).  
 
Since latent herpesvirus infections, obesity and physical inactivity have been proposed 
to precipitate the onset of immune ageing in older individuals; it is legitimate to 
question the exact impact of age on immunosenescence. Indeed, although ageing is 
considered to be the major factor involved in immunosenescence, this could merely be 
an association, where the accumulation of senescent cells occurs due to infection history 
or/and lifestyle factors that are insidiously exacerbated with chronological ageing.  
Furthermore, if lifestyle factors do play a role in the accumulation of senescent T-cells 
and the concomitant shrinkage in naïve T-cell repertoire, engaging in regular physical 
activity and reducing obesity could have important clinical ramifications as a simple, 
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cheap and safe intervention with which to delay the onset of immunosenescence and 
considerably reduce the mortality rate in the elderly. 
 
The studies comprised within this thesis aimed to examine some of the potential factors 
considered to influencing the onset of immunosenescence, such as latent viral 
infections, physical exercise, and obesity. These studies were completed in order to 
enhance understanding of the factors responsible for the increased proportions of 
senescent T-cells in peripheral blood, which is a major feature of immunosenescence 
and the associated IRP. This thesis is presented in seven subsequent chapters, detailed 
as follows: 
 Chapter 2: This chapter provides a review of the current literature on 
immunosenescence and provides the necessary information relevant to the 
subsequent chapters of this thesis. 
 Chapter 3: This chapter details the general materials and methods used to collect 
the data presented in the subsequent studies.  
 Chapter 4: This chapter presents a study that investigated the effect of aerobic 
fitness on the proportions of senescent T-cells in men. 
 Chapter 5: This chapter presents a study that investigated the effects of 
adiposity, latent viral infections, gender and quality of life on T-cell 
differentiation associated with immunosenescence in adolescent children.  
 Chapter 6: This chapter presents a study examining the effects of physiological 
concentrations of leptin on T-cell activation in vitro, along with its effect on the 
constitutive and inducible expression of the leptin receptor in peripheral blood 
T-cells. 
7 
 
 Chapter 7: This chapter present a study aimed at examining the impact of latent 
CMV and EBV infections on the exercise-induced mobilization of senescent and 
viral-specific T-cells. 
 Chapter 8: This chapter discusses the general findings of the studies comprised 
within this thesis. Conclusions from the work are drawn and research questions 
for future studies are proposed. 
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CHAPTER 2 
LITERATURE REVIEW 
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2.1. The immune response 
 
The term Immunity comes from the Latin Immunis, meaning relieved of the burden, 
where the word burden meant a tax or the subjection to a law and by extension a 
disease. During the 19th century the word immunity was first  used in the context of 
human health, where it describes the properties of an organism to be resistant to some 
pathogens (Littre & Robin 1865). The primary function of the immune system is to 
maintain self integrity and to eliminate or neutralize any element recognized as non-self 
and potentially pathogenic. It is believed that the immune system development of higher 
vertebrates was induced for the defence against micro-organisms in their environment 
and maintenance of tissue integrity, i.e. surveillance against tumour, senescent or 
damaged cells (Manning 1979). 
The immune system can be divided in two distinct but overlapping responses, the innate 
and the adaptive immune responses.  
 
2.1.1. The Innate Immune System 
 
The innate immune response is the first arm of the immune response and plays an 
essential role in the defence against pathogens. This innate response has been developed 
to be very aggressive and localised to avoid being detrimental for the host (Beutler et al. 
2006). It allows the recognition of "non-self" intrusive agents using a system of soluble 
proteins and cell receptors. The recognition of microbial invasion by interactions among 
common pathogenic features, known as pathogen-associated molecular patterns 
(PAMPs), and toll-like receptors, acute-phase proteins or other cell-surface receptors, 
trigger a cascade of biological events that can lead to a rapid control of the infection. 
10 
 
Among these non-specific mechanisms, inflammation plays a predominant role by 
recruiting phagocytes, increasing vasodilation, capillary permeability and nociception. 
Immune effector cells such as NK cells, basophils, macrophages, eosinophils and 
neutrophils also play extensive roles in this non-specific response (Lehrer et al. 1988; 
Ouellette 1999; Krisanaprakornkit et al. 2000). The intra-tissue and intra-vascular 
coagulation is also activated during systemic infections. Soluble, constitutive and 
inducible proteins, such as the complement system and certain cytokines (common to 
both the innate and adaptive immune responses), are also critical factors in the primary 
response, enhancing antigen opsonisation and presentation of microbial antigenic 
determinants to the innate immune system. The engagement of the innate immune 
response is ultimately essential to help prevent the establishment of an infection and to 
induce an efficient specific adaptive and memory immune response.  
 
2.1.2. The Adaptive Immune System 
 
While innate immunity is principally orchestrated by non-specific effector cells, , the 
adaptive immune response relies on two principal cell types, the T and B cells. The 
relative persistence of T and B cells, allow the establishment of immunological 
memory, increasing the host capacity to respond to specific antigens during future 
encounters. While B-cells and T-cells are morphologically similar, they mediate two 
different responses of the adaptive immune system, the humoral and cell-mediated 
immunity. The humoral response requires activated B-cells to differentiate into plasma 
cells and produce antigen-specific antibodies, leading to micro-organism phagocytosis, 
complement activation, pathogen neutralization, and destruction. Activated B-cells are 
also known to activate the cell-mediated immunity either by acting as antigen presenting 
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cells (APCs) or by secreting certain cytokines, such as IL-6 or TNF-α (Duddy et al. 
2004). The cell-mediated branch of the adaptive immune response relies on the property 
of activated T-cells to kill virally infected, dysfunctional, abnormal or cancerous cells, 
and phagocytosed pathogens.  
 
2.2. T-cells 
 
There are two distinct sub-populations of T-cells: the T helper cells and the cytotoxic T-
cells which express a common heterodimer called the T-cell receptor (TCR). This 
receptor consists of an alpha and beta chain in 95% of T-cells, whereas 5% of T-cells 
have TCRs formed by gamma and delta chains (Janeway 2011). After production in the 
bone marrow, pluripotent haemapoietic stem cells differentiate in lymphoid progenitor 
cells and migrate to a primary lymphoid organ, the thymus. In the thymus, the newly 
migrated thymocytes will undergo maturation and receptor gene rearrangement 
whereupon diverse surface glycoproteins will be expressed, such as CD2, CD25 and 
CD44, followed by antigen receptors (TCR). The ligation of CD2 to cell function-
associated 3 (LFA-3) expressed by non-lymphoid thymic cells is essential for the 
extensive proliferation of the thymocytes (Denning et al. 1988). The T-cell receptor 
(TCR) is a heterodimer composed of either α/β chains or γ/δ chains divided in constant 
and variable regions. The constant region is attached in the cell membrane, whereas the 
variable region is available for interactions with a specific antigen presented by MHC 
molecules. Antigen recognition depends on the interaction between the TCR and a 
specific antigen-MHC complex. Thymocytes survival will depend on the functionality 
of their TCRs, and those expressing dysfunctional TCRs will be cleared by apoptosis. 
While the random nature of the TCRs gene rearrangement allows the highly specific 
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recognition of an enormous amount of antigens by the T-cells, it also increases the 
number of anergic and auto-reactive T-cells, requiring immature T-cells to be positively 
and negatively selected. During positive selection, only the immature T-cells with a 
high avidity with self-MHC molecules will survive, whereas those with a low-avidity 
with self-MHC molecules will die by apoptosis. The surviving immature T-cells that 
have strong self-antigen recognition will be cleared by apoptosis during the negative 
selection, to limit the number of circulating auto-reactive T-cells. Complete thymic 
maturation of the thymocytes is regulated by cytokines such as IL-15 or IL-7, which are 
known for their ability to induce immature and mature thymocyte proliferation (Suda & 
Zlotnik 1991; Herbelin et al. 1992). Once mature, T-cells emigrate from the thymus to 
join the T-cell repertoire, formed by the variety of T-cells with antigen-specific TCR. 
Two types of mature T-cells are found circulating in the periphery, and can be 
distinguished by the presence at the surface of the glycoprotein CD4 or CD8.The T 
helper cell generally expresses on its surface the CD4 co-receptor (CD4+ T-cell), whilst 
the cytotoxic T-cell expresses the CD8 co-receptor (CD8 + T-cell). Both types of 
mature naïve T-cells circulate in the bloodstream and through the secondary lymphoid 
organs until they are presented to their specific antigen coated in MHC molecules. The 
CD4 and CD8 co-receptors are essential for the development of an efficient immune 
response, by allowing the T helper cells and the T cytotoxic cells to recognize a MHC-
peptide complex in the context of MHC class II or MHC class I respectively. While 
MHC class II molecules are found  on the surface of APCs, MHC class I molecules are 
found on the surface of all nucleated cells.The CD4+ T-cell coordinates the immune 
response, and secretes cytokines that will play an important role in the activation of 
other immune system cells such as CD8+ T-cells, B cells and macrophages. The CD8+ 
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T-cell has, once activated, a cytotoxic activity. Its function is to specifically eliminate 
altered self-cells, such as tumour cells and virus-infected cells (Goldsby et al. 2003). 
  
2.2.1. T-cell activation 
 
Naïve T-cells have never encountered the antigen for which they will be specific and 
cannot have effectors’ activity until they have been activated by an APC or a virally 
infected or cancerous cell. These two cell types meet in secondary lymphoid organs 
such as the spleen and the lymph nodes. Naïve cells circulate steadily through the 
secondary lymphoid organs, passing from the peripheral blood compartment to the 
spleen or lymph nodes before returning into the bloodstream. The migration of T-cells 
through vascular endothelial cells, known as diapedesis, is initiated by the binding of 
the chemokine receptor CCR7 (CD197), present on T-cells, to its cognate ligand 
CCL21, present on vascular endothelial cells. This is rapidly followed by the ligation of 
the T-cell adhesion molecule L-selectin (CD62L) to two vascular addressins present on 
the vascular endothelial cells, GlyCAM-1 and CD34 (Janeway 2011). The relatively 
weak strength of these cellular bonds are however not sufficient to stop the T-cells from 
rolling on the surface of the endothelium and complete immobilisation of the naïve T-
cells will require the action of integrins. All T-cells are characterised by the expression 
on their surface of the integrin αLβ2, also called lymphocyte function-associated antigen-
1 (LFA-1) which bind to endothelial cells membrane glycoprotein belonging to the 
immunoglobulin superfamily, ICAM-1 (CD54). This family contains intercellular 
adhesion molecules (ICAM), ICAM-1, ICAM-2 and ICAM-3, which all bind the T-
cell’s LFA-1 integrin. ICAM-1 and ICAM-2 are found on endothelial cells and on 
APCs. Once bound their function is to prevent cells passing through the lining of blood 
vessels. ICAM-3 is expressed on all cells and can bind, in addition to LFA-1, the lectin 
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DC-SIGN expressed on dendritic cells. This feature makes ICAM-3 an important actor 
in cellular adhesion between T-cells and dendritic cells (Janeway 2011). Finally the 
immobilised naïve T-cell will pass through the endothelial intercellular junction by 
CD31 ligation. T-cells can travel this circuit once or twice a day. This constant cell 
movement increases the probabilities of meetings between an APC which presents a 
specific MHC-peptide complex and its specific T-cell. About one in 10
5
 cell has a 
specific receptor complex for a specific MHC-peptide (Goldsby et al. 2003). In 
addition, this perpetual circulation of T-cells into the blood stream is believed to be 
necessary for their survival. Indeed, naïve T-cells need a regular signal provided by 
their contact to a MHC-self-peptide complex found on the surface of dendritic cells in 
order to survive in the peripheral blood (Janeway 2011).  
 
T-cells encounter an APC, by the specific binding of the TCR molecule and its co-
receptor (CD4 or CD8) to the MHC-peptide complex. The number of MHC-peptide 
complexes required for the T-cell activation varies with the MHC class involved and the 
T-cell maturity. For the MHC class I, this number can vary from less than a dozen to 
several thousand depending on the combination of MHC-peptide complex and clones of 
effector T-cells involved (Kageyama et al. 1995). A study however, has shown that a 
single MHC-peptide complex would be sufficient to activate an effector T-cell (Sykulev 
et al. 1996). Concerning the MHC class II, 200 to 400 complexes would be needed to 
induce cell stimulation. Nevertheless, for a full activation, 5000 MHC-peptide would be 
required (Reay et al. 2000), and a complete activation would result in the production of 
interleukin 2 (IL-2) and the proliferation of activated T-cells. The production of IL-2 
begins to be detected when 1500 complexes are used to activate a naïve T-cell, while an 
effector cell only requires a hundred. Regarding the clonal expansion, a naïve T-cell 
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needs to be stimulated by 400 MHC-peptide to obtain a detectable proliferation, while 
an effector cell only needs 40 (Kimachi et al. 1997).  
It was believed that the only function of integrins, such as LFA-1, was to allow the 
adhesion and the cessation of T-cells during their process of extravasation or migration 
to the tissues. However recent studies also highlighted the capacity of LFA-1 to deliver 
functional signals, including the activation of sphingomyelinase and c-jun amino-
terminal kinase (JNK) when LFA-1 engagement by ICAM-1 synergise with TCR 
stimulation, reaching a level of activation comparable to the activation induced by the 
TCR/CD28 costimulation. This study has also described the induction of  inositol-1,4,5-
triphosphate (IP3) and Ca2+ flux when LFA-1 is costimulating the TCR (Gatta et al. 
2002), suggesting that LFA-1 plays a crucial role in the T-cell activation process. 
 
2.2.2. T-cell differentiation 
 
The activation of T-cells in thymo-dependent areas lead to cytokines synthesis and 
clonal expansion of activated T-cells through three series of intracellular signals. The 
signal transduction cascade is initiated after ligation of the TCR-CD3 complex and an 
MHC-antigen complex, expressed on an APC. In order to mount adequate immune 
responses against every potential pathogens, both exogenous (such as bacteria) and 
endogenous (such as viruses) antigens are processed and bound to MHC class II or 
MHC class I molecules respectively. Following cellular uptake, peptides resulting from 
the enzymatic degradation of the exogenous antigen, are bound to MHC class II 
molecules and expressed on the cell surface. Endogenous antigens are processed 
through a different pathway due to their inherent presence in the infected cell. 
Ubiquinated endogenous antigens are degraded by the proteasome and bound to MHC 
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class I molecules before being expressed on the cell surface. Naïve CD4+ T-cells bind 
specifically to MHC class II molecules, specific to APCs, whereas Naïve CD8+ T-cells 
bind to MHC class I molecules, expressed on all nucleated cells. As a consequence of 
this difference in affinity, the two CD4+ and CD8+ T-cell subsets are designed to 
eliminate respectively extracellular pathogens, such as bacteria, or intracellular 
pathogens, such as viruses.  In addition, activated CD4+ T-cell will secrete cytokines 
such as IL-2, IFN-γ and TNF-α, enhancing CD8+ T-cell activation and effector 
functions or cytokines such as IL-4 and IL-10, modulating the CD8+ T-cell response. 
After ligation of the TCR complex to a specific MHC-antigen, Src family kinases such 
as Lck or Fyn are phosphorylating the immunoreceptor tyrosine-based activation motif 
(ITAM) of the CD3 complex (Kane et al. 2000) in order to allow the attachment of two 
other kinases, Syk and ZAP70. These two kinases have a specific role to phosphorylate 
adaptor proteins such as LAT, TRIM, SIT or PAG. If these molecules have been shown 
to lack enzymatic properties, they help to recruit cytosolic proteins (Leo et al. 2002), in 
particular the phospholipase Cγ1 which will hydrolyse the phosphoinositides membrane 
(PIP2) and release inositol triphosphate (IP3) and diacylglycerol (DAG) (Montixi & He 
1999). The binding of IP3 on its receptor regulates the rate of intracellular calcium and 
mainly activates a calcium-dependent enzyme, the calcineurin. Once activated, the 
calcineurin will induce the dephosphorylation of a transcription factor: the NFAT 
(nuclear factor of activated T-cells). They will both then migrate from the cytoplasm to 
the nucleus to bind regulatory sequences of genes and induce cytokine synthesis such as 
IL-2. This calcineurin-dependent signal induces the G0 to G1 transition of mitotic cell 
cycle (Figure 2.1).  
The second signal of costimulation is induced in the immunological synapse, by the 
binding of constitutive or inducible costimulatory receptors to their ligands, such as 
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CD40, CD80 and CD86, B7-H expressed on dendritic cells and CD40L, CD28, ICOS 
expressed on T-cells. The CD28 activation induces the phosphorylation of cytoplasmic 
SRC-homology 2 (SH2) tyrosine residues such as Vav1, leading to a protein kinase 
cascade and to the regulation of c-Fos and c-Jun expression. In addition, the DAG 
formed during the first TCR signal, activates the protein kinase C (PKC), which 
dissociates the cyoplasmic complex NF-κB from its inhibitor Iκ-B. The coordinated 
action of the TCR signal and the costimulatory signal, leads to the synthesis of the T-
cells activation proteins IL-2 and α-chain of the IL-2 receptor (CD25). 
The third signal of the cell cycle progression from phase G1 to phase S is influenced by 
the IL-2 binding on its high affinity receptor. This attachment causes the 
phosphorylation of the Janus kinase-1 (Jak-1) and Jak-3 and triggers a protein kinase 
cascade resulting in mTOR (mammalian target of rapamycin) production. Once released 
mTOR will initiate the mRNA translation and the synthesis of proteins regulating the 
cell cycle progression necessary for the phase M to take place. Because of its similarity 
to the IL-2, the macrophage's IL-15 can also provide this last signal. Consecutive T-cell 
differentiation will depend on the IL-2R signal strength and the amount of IL-12 as 
shown in Figure 2.1.  
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Figure 2.1. Activation signals required for complete T-cell activation and proliferation. The first 
activation signal occurs when the TCR/CD3 complex binds to the specific MHC-antigen complex, 
leading to an intracellular cascade and to the T-cell initial activation. The second signal of 
costimulation is generated by cognate interactions through costimulatory (or adhesion) molecules of 
the APC and the T-cell. The third signal is produced by IL-2 binding to its receptor, promoting the 
cell cycle progression to M phase, and starting cell proliferation. The cytokine-induced signal 
strength is believed to play a role on T-cell differentiation (Belz & Kallies 2010). 
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2.2.3. T-cell phenotype 
 
Over the course of their maturation and differentiation, T-cells acquire and also lose the 
expression of different glycoproteins. As described above, all functional T-cells express 
a TCR-CD3 complex, allowing antigen recognition (Abbas et al. 2000) and a great 
majority of T-cells express either CD4 or CD8. Naïve T-cells also express CCR7 and 
CD62L, receptors allowing them to migrate to secondary lymph nodes and encounter 
antigens. When naïve T-cells encounter MHC-antigen peptide complex on an APC, they 
require the presence on their surface of the protein tyrosine phosphatase CD45, also 
known as the common leukocyte antigen. CD45, located on all nucleated 
haematopoietic cells, regulates the Src kinases during T-cell activation and is vital for 
T-cell functioning (Kung et al. 2000). This transmembrane receptor has the particularity 
to exist in three different forms on the T-cell surface, CD45RA, CD45RB and CD45RO 
(Okumura et al. 1996). The differential expression of CD45 molecules on T-cells have 
been wildly used to identify their differentiation stage. Indeed naïve T-cells have been 
shown to constitutively express CD45RA while memory antigen-experienced T-cells 
were characterised by their acquired expression of CD45RO and the loss of CD45RA 
(Akbar et al. 1988; Sanders et al. 1988). However, recent studies have highlighted the 
potential of some CD8+ memory T-cells to re-express CD45RA, with or without 
CD45RO expression, but whilst keeping their effector and replicating capacities 
(Hamann et al. 1997; Sallusto et al. 1999; Dunne et al. 2002). Sallusto et al. (1999), 
proposed the analysis of CD45RA and CCR7 concomitant expression on T-cells as a 
more accurate representation of their true level of differentiation. Indeed they showed 
that naïve T-cells co-expressed CD45RA and CCR7 on their surface 
(CD45RA+/CCR7+) whereas central-memory T-cells only expressed CCR7 (CD45RA-
/CCR7+) and effector-memory T-cells had lost the expression of both markers 
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(CD45RA-/CCR7-). Finally they showed that some effector-memory T-cells had re-
acquired CD45RA while still lacking CCR7 (CD45RA+/CCR7-). CD45RA+/CCR7- T-
cells, also called effector-memory T-cells re-expressing RA (TEMRA) are known to be 
very highly differentiated and to have undergone a great rounds of cell divisions. They 
have however been shown to keep replicative capacities and thus TEMRA T-cells can 
be considered as terminally differentiated T-cells but differ functionally from senescent 
T-cells (Dunne et al. 2002; Carrasco et al. 2006). A summary of the different T-cell 
phenotypes depending on their level of differentiation is shown in Figure 2.2.       
 
 
Figure 2.2. Phenotypic changes on T-cells during linear differentiation. Four distinct T-cell 
populations are defined according to the expression of CD27, CD28, CD45RA, CD45RO and 
CCR7. Relative telomere lengths indicating the cellular clonal expansion history are illustrated 
below each cell type according to current literature. Although the different T-cell subsets 
phenotypes are well defined, effector-memory T-cells are capable of expressing either CD27 or 
CD28 (Appay et al. 2008). 
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2.3. Immunosenescence 
 
The term replicative senescence was first used by Hayflick and Moorhead (1961) to 
characterise the limited replication capacity of HDF in vitro. Indeed while trying to 
develop an immortal non-tumorigenic cell line in order to culture viruses and produce 
vaccines, they showed that after undergoing a number of replications, HDFs would 
enter into a state of permanent cell cycle arrest. The number of cell divisions necessary 
for a cell to enter a senescent state, varying between 40 to 50 generations, was described 
as a replication-threshold and coined the “Hayflick limit” (Hayflick & Moorhead 1961). 
In an attempt to link replicative senescence and its mechanisms to organism ageing, 
numerous researchers have studied the in vitro lifespan of multiple cell types (Cristofalo 
et al. 1994; Gardner & Mangel 1997; Pelicci 2004). Some of these studies have shown 
that immune cells, such as CD4+ and CD8+ T-cells, would also undergo cell cycle 
arrest after sustained and excessive rounds of replication when stimulated by specific 
mitogens or antigens in vitro (Grubeck-Loebenstein et al. 1994; Adibzadeh et al. 1995; 
Weng et al. 1995; Adibzadeh et al. 1996; Spaulding et al. 1999). Furthermore, Vaziri et 
al. (1998) have linked replicative senescence to telomeric DNA and telomerase activity, 
by showing that reconstitution of telomeric activity in vivo increased telomere length 
and more importantly cellular lifespan (Vaziri et al. 1997; Bodnar et al. 1998; Vaziri & 
Benchimol 1998).       
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2.3.1. Telomere-dependent senescence 
 
2.3.1.1. Telomeres 
 
Telomeres are non-coding nucleoprotein complexes composed of the highly conserved 
sequence TTAGGG and associated telomere binding proteins (Meyne et al. 1989). They 
are located at the chromosome ends and have an important secondary and tertiary 
structure which is believed to be as potent with regard to senescence as the telomere 
length itself (van Steensel et al. 1998). Their role is to protect the chromosome DNA 
from degradations potentially occurring at their extremities and facilitate chromosome 
replication by enhancing the chromosome binding to the nuclear envelope (Sharpless et 
al. 2004). They are shortened at each cell division and lose between 15 and 200 
nucleotides, until they reach the Hayflick limit at an average length of 4 to 7 kb. A 
signal to the p53 and/or Rb proto-oncogenes is then produced, which stops mitoses by 
expressing cyclin-dependent kinases inhibitors (CKis) such as p21
waf1
,
 
p16
INK4a
 and 
p14/19
ARF 
(Collado & Serrano 2005). These CKIs are playing an anti-tumorigenic role 
by maintaining the retinoblastoma protein (pRb) hypophosphorylated, and thus inducing 
pRb binding to E2F to form the more stable complex pRb-E2F (Cao et al. 1992; 
Hagemeier et al. 1993; Lees et al. 1993). The members of the E2F family are 
transcription factors targeting the principal genes involved in cell replication, such as 
cyclins, cyclin-dependent kinases, replication proteins etc. (He & Cress 2002; Bracken 
et al. 2004; Timmers et al. 2007), and their inactivation by pRb leads to a cell cycle 
arrest in G1 (Spaulding et al. 1999; Karlseder et al. 2002; Campisi 2005).   
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2.3.1.2. Oxidative stress 
 
Telomeres are also shortened by direct physical telomeric single strand DNA damages 
caused by oxidative stress (Petersen et al. 1998). These alterations are independent to 
the telomeres size (von Zglinicki et al. 2000a; von Zglinicki 2002). Studies on 
telomeres have shown a possible structural cause of their premature shortening. Indeed, 
telomeric ends are composed of G-rich overhangs, the most oxidable nucleobase 
(Burney et al. 1999) produced by C-strand specific exonuclease which could contribute 
to telomere shortening (Makarov et al. 1997; McElligott & Wellinger 1997). 
Furthermore telomeric oxidative damages appears to be poorly repaired in comparison 
to similar chromosomal damages (von Zglinicki 2002) and researchers have managed to 
delay the onset of HDFs replicative senescence in vitro by reducing oxidative stress, 
using either oxygen depleted medium (Saito et al. 1995) or free radicals (von Zglinicki 
et al. 2000b). Interestingly increased levels of oxidative stress can also cause double 
strand breaks in chromosomal DNA, and thus triggering telomere-independent 
senescence (Chen et al. 2001; von Zglinicki et al. 2001).      
 
2.3.1.3. Saturated fatty acid metabolism 
 
When telomeres reach a critical size, a signal is transmitted to p53 and Rb, leading to 
cell cycle arrest as described above. It is however important to note that p53 also targets 
fasn-1 and consequently inhibits the production of two crucial enzymes in the fatty acid 
metabolism, the fatty acid synthase and the stearoyl-coenzyme A-desaturase 1 (D'Erchia 
et al. 2006). These two enzymes ensure the conversion of the saturated fatty acids 
palmitic and stearic acids to palmitoleic and oleic acid respectively (Nakamura & Nara 
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2004), limiting the accumulation of palmitic acid. High concentrations of palmitic acid, 
such as the one seen in obese patients, induce important mitochondrial and endoplasmic 
reticulum damages (Hickson-Bick et al. 2002) that can lead to cell cycle arrest and 
senescence (Chen et al. 2000). The important role played by stearoyl-coenzyme A-
desaturase 1 in cell proliferation has been well documented, as reviewed by Igal (Igal 
2010), and its inhibition could also help to trigger replicative senescence.      
 
2.3.2. Telomere-independent senescence 
 
Although T-cell senescence is believed to be primarily induced by telomere-dependent 
mechanisms, some studies suggest that some telomere independent-mechanisms may 
play an important role in immunosenescence. Indeed whereas telomere shortening 
occurs gradually with successive population doublings, some acute and chronic cell 
stressors may lead to premature senescence by up-regulating tumor-suppressor proteins 
with a 1-2 days kinetic, such as p16 and p21 constituting a rapid tumor-defence 
mechanism (Serrano 1997; Drayton et al. 2003).   
 
2.3.2.1. Stress-induced senescence 
 
Elegant in vitro studies have shown that diverse stressors such as intracellular oxygen 
species and oxidative stress (Chen & Ames 1994), exposure to high-doses of radiations 
(principally γ-ray) (Di Leonardo et al. 1994), inadequate cell culture conditions 
(Mathon et al. 2001; Shay & Wright 2001; Shay & Wright 2007) and dysregulated 
oncogenes (Herbig & Sedivy 2006) can lead to premature senescence before cells reach 
a critical telomere size. This state of premature senescence has been coined stress or 
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aberrant signalling-induced senescence (STASIS) or stress-induced premature 
senescence (SIPS) (Drayton & Peters 2002). Mechanistically, it has been shown that 
overexpression of the oncogenes ras (Hanahan & Weinberg 2000), with the 
concomitant reduction in c-Myc signalling (Guney et al. 2006), repeated exposure to 
H2O2 (Chen et al. 2001) and radiations (Suzuki et al. 2001) leads to the inhibition of the 
cyclin-dependent kinases 4 and 6 and the subsequent cell cycle arrest by the up-
regulation of the CKI p16
INK4a
 (Serrano et al. 1997).   
 
2.3.2.2 Bim1 
 
T-cell mitogen and antigen-induced over-proliferation has also been proposed to be one 
cell stressor leading to premature senescence (Drayton et al. 2003). Heffner et al. 
(2007), has recently shown that the p53- and retinoblastoma-dependent pathway of cell 
cycle arrest may be activated by the telomere-independent down-regulation of Bmi1. 
Bmi1 is a transcription repressor, member of the Polycomb group, inhibiting the 
production of the p16
INK4a
 and p19
ARF
 tumour suppressor proteins, by repressing the 
transcription of the Ink4a/Arf locus. During T-cell activation, TCR ligation with the 
antigen induces Bim1 expression in naïve or non-senescent antigen-experienced cells; 
however Bim1 fails to be expressed in senescent T-cells. Heffner et al. (2007) advocate 
that this loss of the TCR-dependent expression of Bim1 could explain the elevated 
levels of p16
INK4a
 and p19
ARF
 observed in senescent cells.   
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2.3.3. Characteristics of senescent cells 
 
Replicative senescence differs from other non-proliferative states like anergy or 
quiescence (Beverly et al. 1992) by irreversibly stopping their cell cycle between the 
non-division state (G0) and the phase preparing the DNA replication (G1) (Grubeck-
Loebenstein et al. 1994; Weng et al. 1995; Adibzadeh et al. 1996; Levine et al. 1997). 
These senescent cells will stay in the G0/G1 phase disregarding stimulations with 
specific-antigens, pro-inflammatory cytokines or mitogens (Perillo et al. 1993). Weng et 
al. (1995) confirmed that the in vitro senescence model was an accurate representation 
of T-cells biological ageing, by measuring telomere length and proliferative capacities 
in an heterogeneous CD4+ T-cell population. This elegant study showed that naïve 
CD4+ T-cells had longer telomeres than the memory CD4+ T-cells. Furthermore the 
more differentiated T-cells had a reduced proliferative capacity compared to the naïve 
T-cells, when stimulated with antibodies anti-CD3 and anti-CD28 (Weng et al. 1995). 
Spaulding et al. (1999) suggested that senescent cells accumulate with age, after 
reporting senescent CD8+ T-cells with an increased resistance to apoptosis in 
comparison to cells with normal replicative capacities and a decreased activity of the 
enzyme caspase 3, an essential link in the extrinsic and intrinsic apoptosis pathways. 
Hsu et al. (2001) also reported a decreased expression on CD8+ T-cells of the upstream 
mediators Fas and Fas-ligand (FasL) of the extrinsic apoptotic pathway with ageing in 
mice. In elderly and nonagenarians, the same group reported an impaired apoptotic 
response in PHA-stimulated CD45RO+ memory T-cells and an increased proportion of 
CD28- CD95+ CD8+ T-cells, unable to up-regulate CD95L via CD28 stimulation, and 
consequently undergo Activation-Induced Cell Death (AICD) (Herndon et al. 1997). 
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Other mechanisms could also be responsible for the ability of senescent T-cell to escape 
apoptosis. Akbar et al. (1993) proposed that the senescent T-cell pool maintenance 
could be regulated by type-1 interferon (IFN), such as IFN-α, IFN-β or IFN-ω. Type-1 
IFN have been shown to prevent apoptosis in activated T-cells while keeping them in a 
non-proliferative senescent state (Marrack et al. 1999), and although more research 
needs to be done to assess the impact of chronological and biological ageing on type-1 
IFN concentrations, some encouraging results tend to support this hypothesis. Indeed 
cells from older mice have been shown to be more responsive to these interferons than 
cells isolated from younger mice (Bray 2001), and human dendritic cells isolated from 
the elderly appear to elicit an increased secretion of type-1 IFN in comparison to those 
isolated from younger donors (Agrawal et al. 2010). Furthermore IFN-β has been 
shown to down-regulate c-myc expression in fibroblasts, leading to growth inhibition 
and senescence (Jonak & Knight 1984; Dani et al. 1985; Jonak et al. 1987).     
While this observation was made by several researchers (Spaulding et al. 1997; Posnett 
et al. 1999; Bryl et al. 2001a; Bryl et al. 2001b), some studies have also challenged it, 
by showing a higher propensity of senescent T-cells to undergo programmed cell death 
(Phelouzat et al. 1996; Phelouzat et al. 1997; Aggarwal et al. 1999; Dennett et al. 2002; 
Gupta 2002). When stimulated with TNF-α, CD4+ and CD8+ T-cells isolated from aged 
subjects appear to be more susceptible to undergo apoptosis than T-cells from younger 
donors (Aggarwal et al. 1999), and T-cells from aged subjects have a decreased 
expression of the anti-apoptotic gene Bcl-2 correlated with an increased expression of 
the pro-apoptotic gene Bax, compared to those from younger subjects (Aggarwal & 
Gupta 1998). Phelouzat et al. (1996) have made the same conclusion towards a higher 
sensitivity to apoptosis of senescent T-cells by demonstrating that high concentrations 
of PMA and ionomycin would lead to greater amounts of apoptotic cells in the elderly 
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than in young individuals. Consequently the disparities seen in senescent T-cells 
susceptibility to undergo apoptosis could be due to methodological differences, such as 
the use of different stimuli, experimental conditions or even phenotypes used to identify 
the different cell subsets. 
  
Despite having an apparent increased resistance to apoptosis and an impaired capacity 
to divide, senescent T-cells maintain immediate effector-cell functions such as the 
recognition and killing of infected cells and the production of pro-inflammatory 
cytokines and other mediators. Indeed, Effros et al. (2003), by creating senescent T-
cells in vitro, observed an increased production of the pro-inflammatory cytokines TNF-
α, IFN-γ and IL-6. Moreover, the same features of senescent cells have been described 
in vivo, in older individuals (Effros 2003; Effros et al. 2003) and in centenarians (Vaziri 
et al. 1993). Recently, researchers have challenged the effector properties of some 
highly differentiated T-cells, classifying them as exhausted (Akbar & Henson 2011). 
They suggest that T-cell exhaustion occurs during high antigenic load and appears to 
primarily affect CD8+ T-cells. While exhausted T-cells share their phenotypic and 
proliferative characteristics with senescent T-cells, they lack T-cell effector functions 
and cytotoxic capacities (Akbar & Henson 2011). 
Other interesting cellular characteristics of senescent T-cells include the accumulation 
of the protein p16
INK4a
 (Liu et al. 2009), the reduced production of stress proteins such 
as Hsp70 (Effros et al. 1994b), the presence of an unusual form of heterochromatin in 
discrete nuclear foci, called senescence-associated heterochromatic foci (SAHF) that 
appears to reinforce the development of immunosenescence (Narita et al. 2003) and the 
loss of telomerase (Plunkett et al. 2001; Valenzuela & Effros 2002). Activated T-cells 
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with intact proliferative capacities up-regulate telomerase to synthesise new telomere 
sequences (Broccoli et al. 1995; Hiyama et al. 1995) allowing them to clonally expand 
and establish an efficient immune response. Telomerase regulation has been shown to 
be linked to the co-stimulatory molecule CD28 (Shimizu et al. 1992; Weng et al. 1996; 
Valenzuela & Effros 2002; Akbar et al. 2004; Vallejo 2005), CD28 that has in turn been 
shown to be down-regulated on senescent T-cells following excessive rounds of 
replication both in vitro (Effros et al. 1994a) and in vivo (Ligthart et al. 1986; Azuma et 
al. 1993; Fiorentino et al. 1996; Weekes et al. 1999; Ouyang et al. 2003b; Klatt et al. 
2005). Interestingly telomerase activity has been shown to differ between CD4+ and 
CD8+ T-cells. Indeed, CD8+ T-cells down-regulate telomerase much more rapidly than 
CD4+ T-cells, and when activated with identical stimuli CD4+ T-cells retain telomerase 
activity after 1.5 times more round of stimulations than CD8+ T-cells (Valenzuela & 
Effros 2002).    
 
2.3.4. Senescent T-cell phenotype 
 
The surface protein expression profile of senescent cells differs from phenotypic 
characteristics of normal cells. Effros et al. (1994; 1997) highlighted a significant 
decrease in the proportion of T-cells expressing the co-stimulatory glycoprotein CD28 
in centenarians compared to younger donors. Thus, they have shown that, in senescent 
cultures, over 95% of T-cells lack CD28 expression (Effros et al. 1994a), due to the 
transcriptional silencing of the CD28 gene (Brzezinska et al. 2004). As a consequence 
of the important role in telomerase activity (Weng et al. 1996; Valenzuela & Effros 
2002) and T-cell clonal expansion (June et al. 1990) played by CD28, CD28- T-cells 
have impaired proliferative capacities (Azuma et al. 1993; Effros & Pawelec 1997; 
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Hamann et al. 1997) coupled with shortened telomeres (Effros et al. 1996; Monteiro et 
al. 1996). These characteristics have placed the lack of CD28 expression on T-cells as a 
useful senescent marker. 
In correlation, Weekes et al. (1999) showed that another glycoprotein, CD57, which is 
not expressed on T-cells at birth, is up-regulated with repeated rounds of antigen-
induced replications, while CD28 expression decreases (Wikby et al. 2002). The cell 
surface glycoprotein CD57, also known as Human Natural Killer-1 (HNK-1) or Leu-7 is 
expressed on NK cells and serves several functions such as cell recognition and 
adhesion by binding to laminin-1, -2 (Kizuka et al. 2008), L-selectin and P-selectin 
(Needham & Schnaar 1993). It has also been showed to be expressed on T-cells with 
shortened telomeres with an inability to proliferate (Brenchley et al. 2003). Furthermore 
CD57+ CD8+ T-cells have been shown to accumulate in the peripheral blood 
compartment with chronological ageing (Tarazona et al. 2000; Wikby et al. 2002; 
Brzezinska 2005). These observations made CD57 a marker of T-cell senescence, 
however a recent study from Chong et al. (2008), advocated the inaccuracy in senescent 
T-cell phenotyping when using CD57 alone as a marker, by showing that some 
CD8+/CD57+ T-cells were able to replicate and produce cytokines under the optimal 
conditions and stimulations. While some cases of T-cells expressing CD57 and lacking 
CD28 have been shown to proliferate in response to IL-2 and IL-15 stimulations 
(Yamada et al. 2007), they are generally believed to be irresponsive to cytokine 
simulations (Brenchley et al. 2003).  
 
Voehringer et al. (2001, 2002) demonstrated that a member of the Killer cell lectin-like 
receptors (KLRs) family, KLRG1, is expressed on CD8+ T-cells after repeated rounds 
31 
 
of stimulations and replications. Further research has also shown that KLRG1 is also 
expressed on mature and recently activated NK cells as well as CD4+ T-cells (Robbins 
et al. 2004). KLRG1 is a highly conserved trans-membrane C-type lectin inhibitory 
receptor with an extra-cellular part binding to conserved domains on N-, E- and R-
cadherins in human and mice (Grundemann et al. 2006; Ito et al. 2006; Banh et al. 
2009; Li et al. 2009c) and a cytoplasmic domain containing an immunoreceptor 
tyrosine-based inhibitory motif (ITIM) responsible for the transmission of an inhibitory 
signal after ligation (Robbins et al. 2002). More specifically, KLRG1 ligation to the 
different ubiquitously expressed cadherins, leads to the recruitment of the phosphatase 
SHIP-1 and SHIP-2 that in turn will degrade the phosphatidylinositol (3,4,5)-
trisphosphate (PIP3) in phosphatidylinositol (4,5)-bisphosphate (PIP2) and regulate 
phosphoinositide 3 kinase (PI3K) activity (Tessmer et al. 2007). PI3K plays an essential 
role in T-cell proliferation and survival, indeed by PIP3 phophorylation, it regulates the 
recruitment of the phosphoinositide-dependent kinase 1 (PDK-1) and the mammalian 
target of rapamycin complex 2 (mTORC2) (or PDK-2) (Fresno Vara et al. 2004). These 
two enzyme will regulate the protein kinase b (Akt) activation by phosphorylating two 
specific sites, the Threonin 308 (Thr
308
) and Serine 473 (Ser
473
) respectively (Manning 
& Cantley 2007).  Finally, the phophorylated Akt will trigger cell division by inducing 
cyclin D1 expression (Ouyang et al. 2008) and p21/p27 phosphorylation (Liang et al. 
2002; Zhou & Hung 2002).  
As a consequence of KLRG1 specificity to the three forms of cadherins (Ito et al. 2006), 
it was hypothesised that KLRG1+ NK cells were playing a primordial role in immune 
surveillance and more specifically in the prevention of tumour development 
(Schwartzkopff et al. 2007). Indeed N-, E- and R-cadherins are respectively expressed 
on wild neurons, epithelial and retinal cells, but appears to be down-regulated or 
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mutated on tumour cells (Schwartzkopff et al. 2007). Consequently KLRG1 ligation to 
cadherins would inhibit NK cells cytotoxicity and protect healthy tissues while allowing 
clearance of cancer cells. Interestingly, KLRG1+ T-cells present alterations in their 
proliferative capacities, while keeping their ability to eliminate the antigen and produce 
cytokines such as IFN-γ (Voehringer et al. 2002). Repeated T-cells activation and clonal 
expansion induced by exposure to antigen or latent viruses (Thimme et al. 2005) lead to 
an accumulation of KLRG1+ dysfunctional T-cells in the elderly (Ouyang et al. 2003b). 
An elegant study conducted by Henson et al. (2009) on senescent CD8+ T-cells shed 
lights on the mechanistical role of KLRG1 in T-cell senescence, by showing that 
KLRG1 blocked Akt phosphorylation at the Ser
473
 level, inhibiting cell proliferation. 
Furthermore, Akt (ser
473
) phopshorylation being involved in hTERT phophorylation and 
the consequent telomerase up-regulation (Kang et al. 1999), KLRG1 prevents Akt 
(ser
473
) phopshorylation (Henson et al. 2009) may be a mechanism by which telomerase 
activity is greatly decreased in senescent T-cells (Plunkett et al. 2007). However some 
studies showing that KLRG1 blockade induced Akt (ser
473
) phosphorylation without 
inducing telomerase up-regulation (Henson et al. 2009), suggest that other pathways, 
such as the ERK pathway can play a role in hTERT phosphorylation and enhanced 
telomerase activity (Fauce et al. 2008). 
Until recently, KLRG1 was thought to be the ideal senescent T-cell marker, however 
studies conducted by Beyersdorf et al. (2007) identified CD4+/KLRG1+ cells as 
regulatory T-cells able to proliferate. These primordial cells are insuring the immune 
system integrity by down-regulating the immune response, to avoid the development of 
autoimmune diseases. Furthermore some antigenic stimuli have been shown to up-
regulate nuclear markers of proliferative ability, such as Ki67, in CD8+ T-cells 
expressing KLRG1 (Ibegbu et al. 2005), challenging their nature as senescent T-cells. 
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Consequently KLRG1 on its own cannot be considered as a marker of immune 
senescence on its own, but needs to be correlated with the down-regulation of CD28 
and/or the up-regulation of CD57 (Ibegbu et al. 2005; Cosgrove C. 2007; Simpson et al. 
2007a). It is also interesting to observe that CD57 appears to be up-regulated prior to 
CD28 down-regulation (Brenchley et al. 2003). Due to the lack of mitogenic-
stimulation induced proliferation of some CD28+ T-cells, the combination of KLRG1 
and CD57 coexpression is regarded as accurate phenotypic markers of senescent T-cells 
(Voehringer et al. 2002; Brenchley et al. 2003; Ibegbu et al. 2005).    
Expressions of other cell surface glycoproteins have also been shown to be dysregulated 
in senescent T-cells. In addition to CD28 and CCR7 down-regulation, studies have 
highlighted the loss of the constitutive CD27 (Akbar et al. 1988; Hendriks et al. 2000) 
and the inducible T-cell co-stimulator ICOS (Larbi et al. 2008) in senescent T-cells. 
Furthermore other cell surface proteins such as the inhibitory killer immunoglobulin-
like receptor KIR (Li et al. 2009a), the NK cell receptors KLRD1, KLRF1 and CD244 
(Phillips et al. 1995), CDw60 (Larbi et al. 2008), CD85j (Czesnikiewicz-Guzik et al. 
2008), NKG2D (Alonso-Arias et al. 2011), PD-1 (Appay et al. 2008) and the integrin 
alpha-subunit CD49d (Peres et al. 2003) are also up-regulated during T-cell senescence. 
Finally many researchers have identified an enzyme, the senescence-associated β-
galactosidase (SA-β-galactosidase), to be found exclusively in human senescent cells 
(Reznikoff et al. 1996; Serrano 1997; van der Loo et al. 1998; Mishima et al. 1999) 
making its presence in the cells cytoplasm an indicator of replicative capacity. However 
a recent study form Kurz et al. (2000), have shown that an increase in SA-β-
galactosidase in T-cells was due to an increase in lysosomal content, which although has 
been correlated to replicative senescence (Robbins et al. 1970), it cannot be considered 
as a good marker on its own. 
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2.4. The Immune Risk Profile 
 
2.4.1. Immunosenescence and the IRP 
 
Immunosenescence is the term used to describe the biological ageing of the immune 
system and has been linked with cardiovascular disease, myocardial infarction, obesity, 
various autoimmune disorders and cancer and is believed to directly or indirectly 
contribute to mortality in later life (Cawthon et al. 2003; Valdes et al. 2005; Starr et al. 
2007). Although immunosenescence has an effect on almost all the components of the 
immune system, the adaptive immunity dysfunction (i.e. T-cells and B-cells) is thought 
to create the greatest health problems in the elderly (Pawelec et al. 2006). To predict 
morbidity and mortality in older adults, immunosenescence and several other 
immunological characteristics have been grouped under the IRP (Koch et al. 2006). The 
IRP emerged as a concept in the late 1990’s. By following over 200 Swedish patients 
for more than a decade, the OCTO and NONA longitudinal studies identified the IRP as 
a collection of immune parameters which were strongly correlated to morbidity and 
mortality (Wikby et al. 1998; Wikby A. 2003). Strindhall et al. (2007) also showed that 
if the IRP is a good predictor of mortality, the rate of survival of centenarians is 
increased when in the normal immune profile (NIP).  
The immune characteristics regarded as being part of the IRP are an inverted 
CD4+/CD8+ blood T-cell ratio, a reduced naïve T-cell repertoire and a poor blood T-
cell response to mitogens and cognate antigens (Pawelec et al. 2006). These changes are 
linked to changes in T-cell surface protein expression such as the co-expression of 
CD57 and KLRG1 and the loss of the co-stimulatory molecules CD27 and CD28. The 
IRP also includes the presence of antibodies against the latent herpesvirus CMV and 
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EBV in the serum (Pawelec et al. 2006). A comprehensive overview of the IRP 
biomarkers is shown in the Table 2.1. 
 
Table 2.1. Biomarkers associated with a Normal Immune Profile and with the IRP category in the 
elderly (Simpson 2011).  
 
 
2.4.2. Latent herpesvirus infection and IRP 
 
Although the frequency of senescent T-cells increases with age, the accumulation rate 
of senescent cells is dramatically amplified due to viral challenges, such as frequent 
reactivations of latent CMV and EBV infection. Indeed persistent stimulation by the 
chronic viruses CMV and EBV have been shown to lead to enhanced expression of 
KLRG1 on the cell surface of virus specific CD8+ T-cells in mice and humans 
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(Thimme et al. 2005). CMV and EBV seropositivity is strongly correlated to 
immunosenescence and the associated "Immune Risk Profile" (Koch et al. 2006; Koch 
et al. 2007), which has, in turn, been shown to predict mortality in later life (Pawelec & 
Gouttefangeas 2006).  
The IRP, amongst other immunological parameters, includes the presence of antibodies 
against the latent herpesvirus CMV and EBV in the serum (Pawelec et al. 2006). 
Although CMV infection is clinically asymptomatic in the immunocompetent host, the 
virus persists in cells of the myeloid lineage (Koch et al. 2006) and prevents them to 
undergo apoptosis by modifying the PI(3)K-Akt pathway (Johnson et al. 2001; Cooray 
2004). As complete clearance of the virus is never achieved, CMV and EBV will be 
periodically reactivated in response to physical or psychological stress (Almanzar et al. 
2005; Senchina & Kohut 2007) inducing the clonal expansion of virus-specific CD8+ 
T-cell clone and thus contributing to immune exhaustion (Koch et al. 2006). Numerous 
studies have supported this hypothesis by analyzing T-cells from older adults. It has 
been shown that CMV-specific CD8+ T-cells are mostly expressing KLRG1 while 
lacking CD28 expression (Ouyang et al. 2004; Thimme et al. 2005), whereas CMV-
specific CD8+T-cells from younger individuals presented the opposite phenotype 
(Jackson et al. 1995). These results and the direct correlation between the proportion of 
CMV-specific CD8+ T-cells and the survival rate in elderly subjects (Koch et al. 2006) 
make CMV and EBV infections potential antecedents in early commencement of the 
IRP. While the IRP is an interesting collection of immune characteristics allowing an 
accurate assessment of the immune system in elderly, it appears even more interesting 
to understand all the mechanism responsible for entering this IRP. In addition to latent 
viral infections, markers of biological ageing (i.e. telomere length and p16
INK4a
 
expression) have been linked to low socioeconomic status (Cherkas et al. 2006) and 
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increased proportions of effector-memory and senescent T-cells have been found in 
blood due to psychological stress, adverse working conditions (Bosch et al. 2009). 
Interestingly recent studies have linked certain lifestyle and occupational factors, such 
as cigarette smoking, positive energy balance, adverse working conditions, and low 
exercise levels with classic biomarkers of ageing such as blood leukocyte telomere 
shortening and p16
INK4a
 expression (Valdes et al. 2005; Cherkas et al. 2008; Song et al. 
2010). These recent studies indicate that a sedentary lifestyle, in particular, promotes 
biological ageing and telomere shortening (Cherkas et al. 2008; Ludlow et al. 2008; 
LaRocca et al. 2010; Song et al. 2010), which is likely to result in early transition to the 
IRP category and premature mortality with advancing age.     
  
38 
 
2.5. Physical activity 
             
2.5.1. Benefits of physical activity 
 
Scientific studies on the relationship between physical activity and health conditions 
have been conducted for over fifty years. In the early 1950s, a study comparing 30,000 
bus drivers (with a low level of physical activity) to 20,000 controllers (potentially tive) 
revealed that the controllers were less likely to develop cardiovascular diseases than 
their colleagues, drivers (Morris et al. 1953; Morris 1956). Since the late 1980s, 
researche has been conducted on the benefits of regular physical activity, reinforcing the 
relationship between physical activities and the reduction of premature mortality 
irrespective of cause (Siscovick et al. 1984a; Siscovick et al. 1984b; Barengo et al. 
2004; Schnohr 2006; Schnohr et al. 2006). 
Bouchard proposed in 1997 a mechanism highlighting the beneficial effects of moderate 
regular physical activity on cardiovascular disease (CVD) risks (Bouchard 1997). 
According to this study, regular sessions of moderate exercise induce a decrease in the 
total body fat mass and in the abdominal adipose tissue. This has a direct effect on the 
increase of insulin sensitivity and the expression of muscle lipoprotein lipase (LPL) 
decreasing the release of hepatic triglyceride lipase (TGL). This action on the enzymatic 
system will trigger lipoprotein catabolism and lipid oxidation and consequently decrease 
the plasma level of triglycerides and cholesterol.  
Another mechanism by which physical activity reduces CVD risk is mediated by the 
reduction of blood pressure by weakening the adrenergic sympathetic activity and the 
peripheral resistance and inducing changes in the rennin-angiotensin-aldosterone system 
(Whelton et al. 2002). 
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By increasing insulin sensitivity, physical activity has also been shown to lower the risk 
of developing non-insulin-dependent diabetes mellitus (NIDDM) by 20-60% (Helmrich 
et al. 1991; Helmrich et al. 1994), with its maximum effect in populations presenting 
high risks of NIDDM (Manson et al. 1992). The need for insulin is being reduced by an 
augmentation in glucose-transportation protein (GLUT4), and an up-regulation of 
glycogen synthase leading to reinforcement of glucose storage (Hu et al. 1999; Booth et 
al. 2000). If these changes help to prevent the development of NIDDM in healthy 
subjects, they also reduce the symptoms of patients with NIDDM (Wallberg-Henriksson 
et al. 1998). 
A strong correlation between physical activity and lower risk of colon cancer has been 
highlighted by numerous researchers (Thune & Lund 1996; Martinez et al. 1997; 
Slattery et al. 1997; Warburton et al. 2006). This can be explained by characteristics of 
exercise in altering prostaglandin synthesis and increasing intestinal mobility which 
reduces exposure time between the colon mucosa and potential carcinogens. 
 
2.5.2. Role of regular exercise in weight regulation  
 
Physical activity plays an essential role in weight regulation, as it consumes the excess 
of energy coming from food intake. Exercise on its own is not responsible for weight 
loss (Booth et al. 2000), however weight control is dependent to regular physical 
activity, and consequently, cannot be achieved without it (Byers 1995). Physical activity 
can regulate weight by creating and maintaining lean body mass, in particular in seniors, 
to avoid muscle loss or atrophy. It also regulates body weight by increasing total energy 
expenditure, eventually leading to the utilization of stored lipids contained in fat mass. 
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Lack of physical activity can create an unbalanced state of energy excess leading to 
obesity.  
 
2.5.3. Obesity 
 
Obesity can be defined as an excessive accumulation of adipose tissue with harmful 
consequences on health. The weight of an individual can be considered as a 
physiological regulated variable. An imbalance in this regulation with a reduction of the 
energetic expenditure, leads to an accumulation of energetic reserves and to obesity. 
The global measure of obesity which is the most commonly used is the body mass index 
(BMI) defined as: BMI = weight (kg)/height
2
 (m) (Garrow 1985; World Health 
Organization 1995). This index, which is size-independent in human populations, is 
well correlated with fat mass. 
The international definition of obesity recommended by the World Health organisation 
in 1997 and adopted in the United Kingdom is based on the relation between this index 
and mortality (Allison et al. 1997). In Caucasian populations, this relationship follows a 
U-shaped curve. The lowest risks are recorded for BMI between 18.5 and 25 kg/m
2
. For 
high values, the risk starts to rise above 25 kg/m
2
 and compared with the subjects 
between 18.5 and 25 kg/m
2
, the relative risk exceeds 1.5 beyond 30 kg/m
2
. The BMI, 
simple index which only needs the measurements of weight and size, is none-the-less an 
imperfect approximation of the body fat percentage in the body. While, when the index 
exceeds 30 kg/m
2
, it generally indicates a significant increase in adipose tissue, in more 
normal values, this same index is dependent on lean mass. A simple illustration of this 
is the difference between men and women (Micozzi et al. 1986). Indeed Ley et al. 
(1992) showed that for a same BMI of 23 kg/m
2
, the percentages of body fat through 20 
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year old women are doubled compared to 20 year old men, with respectively 26% and 
13%. This tends to indicate that the more developed lean mass in men plays a great role 
in the BMI. However, the use of a common definition of obesity among men and 
women remains a requirement as the health-related consequences of excess body fat are 
less dramatic in women than men. Indeed, a second important parameter to take into 
consideration is the relationship between adiposity and mortality is body fat 
distribution. Since the first publications in the 1980s, many epidemiological studies 
have confirmed that various measures reflecting an overload abdominal fat (waist/hips 
ratio, waist, anterior-posterior diameter of the abdomen or sagittal diameter) were high 
risk factors of mortality from any cause and especially CVD (Ohlson et al. 1985). These 
indexes have a linear effect on mortality (Lapidus et al. 1984; Larsson et al. 1984; 
Welborn et al. 2003). In men, the excess of body fat is preferentially localised in the 
abdominal level, which probably explains why it is not well tolerated, on the metabolic 
and cardiovascular view, compared to the excess of adipose tissue in women. There is 
no consensual definition of the excess of abdominal adipose tissue, or agreement on its 
measure. However, from a Scottish adult population, thresholds of 94 waist/hips ratio 
(WHR1) and 102 (WHR2) cm for men and 80 (WHR1) and 88 (WHR2) cm for women 
were proposed to identify patients requiring the prevention of weight gain (WHR1) or 
weight loss (WHR2) (Lean et al. 1995). The waist/hips ratio which was first used tends 
to be replaced only by the waist measurement. 
Obesity is now described as a worldwide epidemic by the World Health Organisation 
(World Health Organization 2000). In the USA, the number of adults with a BMI over 
30 kg/m
2 
rose from 14.25% in 1971 to over 31% in 2000 and in the UK, adult obesity 
rates rose from 6% of men and 8% of women in 1980, to 21% of men and 23.5% of 
women in 2000 (Mokdad et al. 2001; Deitel 2003). Furthermore, childhood obesity has 
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been a growing sanitary issue for the past 25 years, with the proportions of obese 
adolescents rising from an average of 5% of the 12-19 years old who were obese in 
1980 to 18% in 2008 (Skelton et al. 2009). The frequency of 12-19 years old with an 
excess body mass reaches a third of the adolescent populations in the United States 
(Ogden et al. 2010). Developing countries are also affected by obesity as a result of 
changes in traditions, alimentation and physical activity. The increases in overweight 
and obesity have been linked to increases in chronic conditions including diabetes, 
hypertension, hypercholesterolemia, stroke, heart disease, certain cancers, and arthritis 
(Johnson et al. 1993; Burt et al. 1995; Allison et al. 1997; World Health Organization 
1997; Harris et al. 1998). Although some of those conditions are only affecting the adult 
overweight and obese population, the emergence of some obese-related illness such as 
type 2 diabetes mellitus (American Diabetes Association 2000) and metabolic syndrome 
(Cook et al. 2003) in obese teenagers is considered as very alarming. Physical activity 
has been shown to reduce the risks of developing these chronic conditions in obese 
patients (Wei et al. 1999; Barengo et al. 2004). Consequently it is believed that obesity-
related diseases may also be caused by a lack of physical activity. 
 
2.5.3.1. Leptin: Linking feeding behaviour and the immune system 
 
As a consequence of their pleiotropy, cytokines are known to affect more systems than 
the immune system alone, such as the reproductive system (Simon & Polan 1994) or 
even the digestive system. Indeed various cytokines are involved in the control of 
feeding behaviour by regulating the frequency, magnitude and duration of each food 
intake episode. IL-1 α, IL-1 β, IL-6 subfamily, IL-8, TNF-α, IFN-α and the adipokine 
leptin are believed to restrict food intake by directly acting on neuronal ion channels of 
various hypothalamic regions (Plata-Salaman 1991a; Plata-Salaman 1991b; Plata-
43 
 
Salaman & Borkoski 1994; Plata-Salaman & ffrench-Mullen 1994; Plata-Salaman 1996; 
Plata-Salaman 1998). 
 
Hypotheses about weight and appetite regulation have been emitted for over 50 years. 
Ingalls et al. (1950) while looking for obesity treatment, created the first animal model 
allowing accurate studies of obesity by isolating a C57BL/6J obese mouse with an 
ob/ob phenotype. However, it is only in 1953 that Kennedy proposed the existence of a 
factor produced in the adipose tissue and targeting the brain to induce satiety (Kennedy 
1953). This theory called lipostatic theory has been supported by a study where normal 
rats became hyperphagic and obese after electrically-inducing hypothalamic lesions 
(Hervey 1959). Another study, using genetically obese mice, highlighted the existence 
of a blood-borne factor in normal mice which induces a reduction of food intake 
(Hausberger 1959). It was only in 1994 that this blood-borne circulating factor was 
identified after isolation of the ob gene (Zhang et al. 1994). Ob/ob mice significantly 
lost weight after injection with the protein coded by the ob gene (Halaas et al. 1995; 
Pelleymounter et al. 1995; Rentsch et al. 1995). 
The soluble protein, named Leptin, after the Greek leptos meaning lean, is a 16 kDa 
protein composed of 146 amino acids transcripted from the ob gene in 3.5 kb mRNA in 
the adipocytes. Leptin’s three-dimensional structure is composed by four α-helix bundle 
motif, also found in the IL-6 superfamily (Zhang et al. 1997). Leptin is released in the 
bloodstream on a circadian rhythm, with a peak observed between 20 minutes and 4 
hours, and reaches physiological concentrations ranging from 1 to 5 ng.mL
-1 
in healthy 
lean subjects, but can attain 50 ng.mL
-1 in subjects with class IV obesity (“super-
obesity”) (Prolo et al. 1998), well above the blood-brain barrier threshold for the 
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adipokine (15ng.mL
-1
) (Wang et al. 1999). Various factors influence leptin secretion 
and serum concentration such as food intake and insulin concentration. An increase in 
those factors will induce an increase in leptin secretion, and thus in serum leptin 
concentration. This effect will be reversed as soon as there is a reduction in food intake 
or insulin concentration (Kolaczynski et al. 1996). Leptin concentration is also known 
to increase in response to pro-inflammatory molecules such as TNF-α (Gualillo et al. 
2000). Interestingly sexual hormones have an opposite action on leptin secretion as 
testosterone inhibits leptin production while estrogens stimulate its release in the 
bloodstream (Blum et al. 1997; Castracane et al. 1998). Once in the bloodstream, leptin 
crosses the blood-brain barrier to bind to its receptor on the hypothalamic nuclei where 
it regulates food intake by inducing the expression of anorexigenic factors, inhibiting 
neuropeptide Y (NPY), orexin and agouti-related peptide (AGRP) neuronal activity 
(Stephens et al. 1995; Korner et al. 2001; Breen et al. 2005). It has also been shown that 
leptin will down-regulate level of NPY mRNA (Tartaglia 1997). When NPY is being 
released in the hypothalamus, it stimulates food intake, decrease thermogenogenesis, 
enhance insuline and cortisol production via the β3 adrenergic receptors of the 
sympathetic nervous system (Morley et al. 1987). Consequently when leptin binds to its 
receptor on the hypothalamus, it induces a decrease in food intake, coupled with a 
reduction in insulin and cortisol production.  
 
As described above, the leptin molecule presents structural similarities with the type I 
cytokine family (Matarese et al. 2002). Furthermore, leptin receptor (ObR) also belongs 
to the type I cytokines family receptors (Baumann et al. 1996; Tartaglia 1997) due to its 
similarities with the gp130 signal transduction arm of class I cytokine receptor family 
member, including interleukins (IL-6), granulocyte colony stimulating factor (G-CSF) 
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and leukaemia inhibitory factor (LIF) (Tartaglia 1997). These structural relative 
conformities, conjugated with studies showing that subjects with a leptin deficiency due 
to malnutrition or genetic disorders were more susceptible to infections and had an 
altered immune system (Chandra 1980; Ozata et al. 1999), suggested an important role 
for leptin in immunity. This altered immune response during long term fasting could be 
explained by the need for the body to store energy for more important functions, such as 
cardiovascular and cerebral functions, but it could also be explained by the potential 
role played by leptin in lymphopoiesis (Bennett et al. 1996).  
Many studies have highlighted the impact of leptin on both the innate and adaptive arm 
of the immune response. Indeed serum leptin activates and induce macrophage and 
monocyte proliferation by triggering leukotriene B4, phospholipase A2 (Mancuso et al. 
2004) and pro-inflammatory cytokines production (Gainsford et al. 1996; Loffreda et al. 
1998) which will enhance phagocytic function (Mancuso et al. 2002). Leptin also up-
regulates CD38, the transferrin receptor (CD71), the α-chain of the IL-2 receptor 
(CD25) and adhesion molecules, such as the integrins CD18, CD11b and CD11c on 
monocytes and macrophages (Santos-Alvarez et al. 1999; Lord 2006). Finally, leptin 
prevents monocyte undergoing apoptosis, via MAPK activations (Lin et al. 2002) and 
enhances the differentiation, activation, proliferation and cytotoxicity of NK cells (Zhao 
et al. 2003). Contrasting with these results, many studies have shown leptin to have 
anti-inflammatory properties by reducing pro-inflammatory cytokines during sepsis in 
primates (Xiao et al. 2003) and increasing anti-inflammatory cytokines production, such 
as IL-4 (Jaworek et al. 2002) and IL-1 receptor antagonist (IL1RA) (Gabay et al. 2001). 
Consequently leptin should be regarded as an immunomodulatory adipokine.    
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As stated above, leptin also effects the adaptive immune system. Similarly to its effect 
on monocytes and macrophages, leptin up-regulates the expression of CD71, CD25, 
CD69 on CD4+ and CD8+ T-cells (Martin-Romero et al. 2000) and adhesion molecules 
such as ICAM-1, and very late antigen 2 (VLA-2) on CD4+ T-cells (Park et al. 2001). It 
also appears to induce CD45RA+ (‘naïve’) T-cell proliferation via STAT3 activation 
(Akaishi et al. 1998; De Rosa et al. 2007) when cultured in presence of a mitogen, but it 
tends to inhibit CD45RO+ (‘memory’) T-cell proliferation (Lord et al. 2002) while 
eliciting them to shift to a more Th1 cytokine-profile response (Lord et al. 1998; Mito et 
al. 2004; Goldberg et al. 2005; Lord 2006). This shift to a Th1 profile has multiple 
consequences, such as a reduction of anti-inflammatory cytokine secretion, such as IL-
4, while increasing TNF-α and IFN-γ production, but it also promotes IgG2a production 
by B-cells while inhibiting IgG1 formation (Faggioni et al. 2001). Furthermore, 
observations on thymic atrophy in ob/ob mice and on diminished thymic function 
during acute caloric restriction are suggesting an action of leptin in thymic output and 
naïve T-cells formation (Lord et al. 1998). This is supported by studies showing that 
thymic output can be restored in cases of malnutrition by leptin administration (Howard 
et al. 1999; Lord et al. 2001). Finally leptin increases anti-apoptotic proteins such as 
Bcl-2, Bcl-XL (Fujita et al. 2002) and T-bet (Lord et al. 2002), protecting thymocytes 
and mature T-cells from undergoing apoptosis.   
 
Interestingly Valdes et al. (2005) has shown an inverse correlation between telomere 
length, BMI and serum leptin concentration. This could be explained by an increased 
proliferation rate of naïve T-cells in the presence of leptin, coupled with a Th-1 
cytokine-profile response and a reduced clearance of redundant memory cells via 
apoptosis, potentially highlighting leptin as the central actor of premature senescent in 
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obesity. This however remains hypothetical and as very few in vivo studies have been 
conducted and most of the in vitro studies founding an effect of leptin on immune cells 
have used supra-physiological doses of leptin (Martin-Romero et al. 2000), chronic 
exposure of this adipokine in cases of obesity and severe obesity remains to be tested. 
High serum leptin concentrations alone cannot however explain the state of immune 
depression seen in obese patients.  
 
2.5.3.2. Impact of obesity on the immune system 
 
The highly deleterious effect of excess weight and obesity on the cardiovascular system 
has been of interest for many years. However the potential link between obesity and 
immunosuppression has only been proposed recently. Obesity increases the risk for 
cardiovascular disease (Larsson et al. 1984), that are in turn correlated with shortened 
leukocyte mean telomere length. Indeed Brouilette et al. have repeatedly demonstrated 
that healthy subjects retain longer leukocytes mean telomere length than subjects with 
premature myocardial infarction (Brouilette et al. 2003; Brouilette et al. 2007; 
Brouilette et al. 2008). This observation was supported by a study conducted on the 
Scottish elderly, where participants who suffered chronic heart diseases had shorter 
leukocyte mean telomere length than healthy age-matched subjects (Starr et al. 2007; 
Starr et al. 2008). The hypothesis that obesity has a direct or indirect link with 
immunosuppression was further advocated by researchers when an increased BMI was 
shown to be combined with a reduced leukocyte mean telomere length in women 
(Valdes et al. 2005), with reduced response to tetanus vaccination in children (Eliakim 
et al. 2006) and with an increased risk of bacteremia infections following surgery 
(Munoz et al. 2004).  
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The mechanisms linking obesity and immunosuppression are still unclear and require to 
be investigated thoroughly. It is reasonable to believe that the high levels of oxidative 
stress (Furukawa et al. 2004) and the elevated pro-inflammatory cytokines secreted by 
the excess of adipocytes (Dandona et al. 2004) observed in obese individuals increases 
the risk of single strand breaks in telomeric DNA and thus accelerate telomere 
shortening and the onset of replicative senescence (von Zglinicki et al. 2000a; von 
Zglinicki 2002). Finally as described previously, fatty acid metabolism can also play a 
role in the onset of replicative senescence and calorie restriction is known for restoring a 
robust cellular proliferative response that was reduced during obesity (Apte et al. 2002). 
More research on the impact of fatty acid metabolism on immunosenescence are 
required before proposing that a diet-related elevated serum concentration of fatty acid 
coupled with chronological ageing could accelerate immunosenescence.  
 
2.5.4. Exercise immunology 
 
Regular physical activity has been shown to prevent numerous health complications in 
the elderly, such as cardiovascular events (Goldstein 2010), certain cancers (Shepard 
1990), bone loss (Cousins et al. 2010), muscle atrophy (Kuh et al. 2005) and depression 
(Ruuskanen & Ruoppila 1995; Hassmen et al. 2000). Furthermore, the beneficial impact 
of regular physical activity on body weight is widely accepted. Indeed, regular physical 
activity and a higher fitness level are associated with both reduced obesity and obesity-
related diseases (Martinez-Gonzalez et al. 1999; Mortensen et al. 2006; Chaput & 
Tremblay 2009). Although  relatively few studies have examined the link between 
regular exercise and the immune system as a function of age (Nieman et al. 1994; 
Nieman et al. 1995; Nieman 1997; Bruunsgaard et al. 1999; Buyukyazi 2004; 
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Buyukyazi et al. 2004; Drela et al. 2004; Simpson & Guy 2010), regular physical 
activity helps to maintain a healthy lifestyle in the elderly by reducing risks of 
depression (Strawbridge et al. 2002) and by reducing both infection risks and infection 
severity among older adults (Leveille et al. 2000).  
 
2.5.4.1 T-cell Responses to Moderate Exercise 
 
As mentioned above, the beneficial effect of regular moderate physical activity, such as 
bi-weekly recreational and non-exhaustive exercise, has been shown to be especially 
marked in older adults (Bruunsgaard et al. 1999; Buyukyazi 2004). Kohut et al. (2002) 
recently highlighted the favorable effect of vigorous exercise on the immune response 
of seniors to the influenza vaccine. Moderate physical activity will have a different 
effect on the immune system compared to vigorous exercise. Indeed, in healthy young 
adults, moderate physical activity will direct the immune response into a Th1-type 
cytokine response (IL-2, IL-12) and an intense physical activity will lead to an indirect 
Th2-type cytokine response, by down-regulating the Th1-type cytokine response. 
(Ostrowski et al. 1999; Suzuki et al. 2002; Suzuki et al. 2003). However, animal and 
human studies have shown that the elderly will respond differently to exercise than 
younger individuals. Older adults preferentially elicit a Th2-type cytokine response when 
subjected to moderate exercise (Shearer 1997; Kohut et al. 2001) and should 
consequently have a more efficient humoral immune response than their younger 
counterparts. The beneficial effects of moderate physical activity on health was further 
suggested by Nieman et al. (1993), who reported a negative correlation between high 
levels of physical activity and self-reported scores on symptoms of upper-respiratory 
tract infections. More recently, Ludlow et al. (2008) proposed another mechanism 
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explaining the positive effect of moderate regular exercise on infection in older adults, 
by finding that leukocyte telomere lengths were longer in physically active seniors 
compared to inactive seniors, indicating a lower frequency of senescent T-cells in 
physically active seniors compared to their inactive counterparts. These findings were 
supported by a study conducted in 2008 by Cherkas et al. where a strong correlation has 
been observed between shortened telomeres in mixed blood leukocytes and a sedentary 
lifestyle.  
 
2.5.4.2. T-cell Responses to Acute Exercise 
 
Regular or chronic physical activity is often opposed to acute exercise as a consequence 
of the apparent dissimilarities between them. Indeed while regular physical activity 
appears to have beneficial effect on the immune system, a growing number of studies 
have highlighted the potential detrimental effects of frequent bouts of acute high-
intensity exercise on the immune system (Nieman D.C. 1990; Nieman 1997). Although 
it was hypothesised that the beneficial impact of regular physical activity on the 
immune system could be due to the periodic repetition of acute bouts of exercise 
performed over an extended period of time (Simpson 2011), it remains to be tested.  
Individuals frequently exercising at high intensity such as elite athletes, present a high 
prevalence of symptoms of upper respiratory tract infections (URTIs) before and after 
competition potentially linked to the increase in training volume and intensity (Nieman 
D.C. 1990; Nieman 1997). Similar effects have been observed in animal models, where 
mice appear to be at a greater risk of infection to viruses after acute exercise, compared 
to non-exercising control (Murphy et al. 2008). The mechanisms underlying this 
apparent state of immune dysfunction after acute bouts of exercise have been widely 
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investigated and changes in T-cell numbers and functions have been highlighted. 
Buyukyazi (2004) observed a reduction in the proportion of CD4+ T-cells in athletes 
with an increasing estimated  ̇     . This is consistent with studies showing a decrease 
in the CD4/CD8 T-cells ratio during athlete’s training season (Rebelo et al. 1998). 
Furthermore, T-cell function is altered with acute bouts of exercise and significant 
reductions in activation and proliferative responses have been documented post training 
and competitive events (Nieman et al. 1994; Bury et al. 1996; Vider et al. 2001a). T-
cell activation can be modulated by hormonal changes such as those observed during 
exercise. The release of the catecholamines epinephrine, norepinephrine and dopamine 
(Bahr et al. 1991) occurs with physical exercise.  Bergquist et al. (1997) showed that 
dopamine might enhance peripheral blood mononuclear cell apoptosis by up-regulating 
Fas/FasL and pro-apoptotic molecules such as Bax. However, while high concentrations 
of dopamine inhibit T-cell proliferations (Cook-Mills et al. 1995), limited doses of 
dopamine seem to enhance T-cell division (Basu et al. 1993; Tsao et al. 1997). 
Furthermore, the circadian release of epinephrine and norepinephrine have been shown 
to regulate the preferential mobilization of highly differentiated effector and senescent 
T-cells (Dimitrov et al. 2009). As training routines include repeated and daily bouts of 
exercise, highly differentiated and senescent athlete’s T-cells would be constantly 
mobilized in the peripheral blood compartment and exposed to high concentrations of 
dopamine during training periods (Sutoo & Akiyama 2003).  
Acute exercise has also been shown to decrease T-cell responsiveness to mitogenic 
stimuli (Tharp & Preuss 1991; Nieman et al. 1994; Nieman et al. 1995; Ceddia et al. 
1999). Finally, acute bouts of exercise appear to have a great effect on cell shifts from 
and to the peripheral blood compartment. Larrabee (1902) was the first to investigate 
this effect by showing that exhaustive bouts of exercise such as marathons, induced 
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leukocytosis suggesting the development of an inflammatory response. It has been later 
shown that during and immediately after acute bouts of exercise, the observed 
lymphopenia is preceded by the entry of T-cells in the peripheral blood compartment 
(Simpson et al. 2007a; Simpson et al. 2008). Interestingly, studies have shown a 
preferential mobilization of senescent CD4+ and CD8+ T-cells.  Indeed, in both young 
and old individuals there is a large influx of KLRG1+, CD57+ and CD28- T-cells to the 
peripheral blood compartment (Bruunsgaard et al. 1999; Simpson et al. 2007a; Simpson 
et al. 2008). While the preferential mobilization of terminally differentiated T-cells 
following acute bouts of exercise have been well documented (Simpson et al. 2007a; 
Simpson et al. 2008), other studies have shown the same effect of exercise on highly 
differentiated, non-senescent T-cells. Indeed Campbell et al. (2009) showed that acute 
exercise induced a greater mobilization of effector-memory and TEMRA CD8+ T-cells 
in the peripheral blood compartment, than naïve and central-memory T-cells. Following 
these encouraging results, these researchers recently investigated the impact of exercise 
on T-cell mobilization in CMV seropositive individuals (Turner et al. 2010). In addition 
to confirming the results previously obtained by Campbell et al. (2009), they observed a 
greater mobilization of TEMRA and EM CD8+ T-cells in the blood compartment of 
CMV seropositive subjects after acute exercise compared to the mobilization of the 
same cell populations seen in CMV seronegative subjects. They advocated that infection 
history may have an effect on T-cell mobilization, which could be a protective 
mechanism of exercise against ageing immunity. While these studies are providing 
valuable information on the impact of exercise on memory T-cells in CMV seropositive 
subjects, they have failed to assess the impact of acute exercise on dysfunctional, 
senescent T-cells in these individuals. It is plausible to propose that repeated acute bouts 
of exercise would mobilize senescent T-cells in the peripheral blood compartment and 
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free some “immunological space” by promoting their elimination via mechanisms such 
as apoptosis or AICD (Simpson 2011). Figure 2.3 is presenting the hypothetical impact 
of acute bouts of exercise on the immune system.  
 
 
 
Figure 2.3. Proposed model by Simpson (2011) highlighting the potential impact of repeated bouts 
of acute exercise on the immune space. Highly differentiated and senescent T-cells are mobilized in 
the peripheral blood compartment during each bout of exercise. Mobilized T-cells are exposed to 
multiple apoptotic stimuli, eventually leading to the programmed cell death of apoptosis-susceptible 
cells during the recovery phase and creating more “immune space”. Naïve T-cell output will 
increase to maintain immune homeostasis and repeating this process will help maintaining a 
healthy the naïve T-cell repertoire (Simpson 2011).  
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2.6. Summary 
 
The effect of chronological ageing on the immune system has been well documented, 
and it is clear that the accumulation of senescent T-cells and the concomitant shrinkage 
of naïve T-cell repertoire lead to increased risks of morbidity and mortality in the 
elderly. However, immunosenescence is not affecting older adults equally, and although 
some elderly are in a state of immunodepression and at risk of infection, others are not 
immunocompromised and have mastered the art of healthy longevity.  
Lifestyle factors such as reduced physical activity and positive energy balance along 
with a lifetime of recurrent viral challenges could be the main culprits of the inter-
individual differences observed in the current literature. Indeed elevated levels of 
oxidative stress, as seen in obese individuals, can trigger premature senescence by 
accelerating telomere attrition or inducing excessive DNA damage. Furthermore, the 
correlation between obesity and increased levels of serum adipokines, such as leptin 
suggests a potential link between obesity and immune senescence. Indeed, leptin is 
known to have a stimulating effect on peripheral blood T-cells which could ultimately 
lead to the accumulation of senescent T-cells. In addition to the potential activation 
effect of high leptin concentrations in obese individuals, recurrent viral activation by 
latent herpesviruses over a prolonged period of time could explain the disparity in 
proportions of senescent T-cells seen among the elderly. Indeed CMV and EBV 
infections have been associated with a state of immunodepression in the elderly termed 
Immune Risk Profile (IRP), which in turn is associated with increased morbidity and 
mortality in older adults. 
The mechanisms underpinning the beneficial effects of regular physical exercise on 
ageing immunity are not currently known, but could be explained by a combined 
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beneficial effect on excess body weight and by its influence on CMV/EBV-induced 
immunosenescence. Frequent bouts of acute exercise might serve as a mechanism to 
remove virus-specific T-cells from the “immunological space”, thus triggering a release 
of naïve and newly functional T-cells from the thymus and subsequent expansion of the 
naïve T-cell repertoire. The different studies presented in this thesis were conducted to 
provide new insights in the factors leading to the onset of premature immunosenescence 
and to assess the effect of regular physical activity on the immune system. The data 
discussed in the subsequent chapters could introduce physical activity as a cost-effective 
and safe clinical intervention to reduce or delay the onset of immunosenescence. 
 
2.7. Specific aims of the Studies described within this Thesis 
 
The overarching aim of the studies presented in this thesis was to examine the effects of 
different factors potentially influencing the onset of immunosenescence independently 
of chronological ageing. The specific aims of the studies conducted and described 
within the data chapters of this thesis were: 
 
Chapter 4: 
(1) The aim of this study was to examine the association of physical activity and 
aerobic fitness, indicated by estimated  ̇     , and the age-related increase of 
effector-memory and senescent T-cells in a population of healthy adult men.  
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Chapter 5: 
(2) The main aim of this study was to examine the relationship between adiposity 
and excess body mass and the proportions of blood T-cell subsets in an age-
controlled population of Mexican-American adolescents.  
(3) The second aim of this study was to examine the association between serum 
leptin concentrations and the proportions of effector-memory and senescent T-
cells in an age-controlled population of Mexican-American adolescents. 
(4) The last aim of this study was to examine the effect of potential confounding 
factors such as latent CMV and EBV infections, quality of life and gender on the 
associations between excess body mass and serum leptin concentrations and the 
proportions of blood T-cell subsets. 
 
Chapter 6: 
(5) The aim of the study presented in this chapter was to examine the effect of 
physiological concentrations of plasma leptin on T-cell activation to assess the 
potential role of high serum concentrations of this adipokine on the T-cell 
repertoire of obese subjects. 
(6)  The second aim of this study was to assess both the constitutional and inducible 
expression of the functional form of the cell surface leptin receptor and mRNA 
in T-cells. 
 
Chapter 7: 
(7) The main aim of this study was to examine the impact of latent CMV and EBV 
infections on blood T-cell phenotypes in healthy young adult men. 
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(8) The second aim of this study was to examine the impact of the latent CMV and 
EBV infections on the exercise-induced changes in T-cell concentration in 
peripheral blood. 
(9) The third aim of this study was to determine the contribution of viral-specific T-
cells to the mobilization of memory and senescent T-cells with exercise. 
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CHAPTER 3 
GENERAL MATERIALS AND METHODS 
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3.1. Subjects 
 
3.1.1. Subject Selection 
 
All peripheral blood samples were taken by a qualified phlebotomist from healthy non-
smoking male subjects. Subjects with excessive alcohol intake (>14 units of alcohol per 
week), taking medication affecting the immune system, routinely using ibuprofen and/or 
aspirin, anti-depressants, medications designed to alter blood pressure or cardiovascular 
function and hormone replacement therapy were excluded from the subject pool. 
Subjects reporting major affective disorders, HIV infection, hepatitis, 
chronic/debilitating arthritis, central or peripheral nervous disorders, previous stroke or 
cardiac events, were bedridden in the past three months, suffer from known 
cardiovascular disease or autoimmune diseases were all excluded from the study.  All 
volunteers gave written informed consent (Appendix 1) and ethical approval was 
obtained from the School of Life Sciences, Edinburgh Napier University and the 
Committee for Protection of Human Services at the University of Houston. 
 
3.1.2. Anthropometric Measurements 
 
All donors completed an assessment of percentage body fat determined by a 
bioelectrical impedance method (Bodystat, Douglas, UK), unless stated otherwise. 
Electrodes were placed on the dominant ipsilateral wrist and ankle as designated by the 
subject and measurements were duplicated to obtain greater accuracy. Resistance and 
reactance were measured in the normally hydrated volunteers in the supine position. All 
subjects were weighed, measured and waist and hips circumference were obtained by 
the same researcher to limit inter-tester inaccuracies. Waist circumference was 
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measured midway between the lateral lower rib margin and the iliac crest. Hip 
circumference was measured at the level of the major trochanters, through the pubic 
symphisis.  
 
3.2. Exercise protocol and measurement of physiological variables   
 
3.2.1. Physical activity assessment 
 
Each participant from the studies described in Chapter 4 and in Chapter 7 provided his 
physical activity score using a non-exercise 7-level questionnaire (Jackson et al. 1990) 
(Appendix 2). The physical activity rating questionnaire (PA-R) was divided in 3-
categories: minimal physical activity defined by infrequent light physical activity such 
as walking or infrequent (0-1) moderate physical activity defined by 10 minutes to an 
hour of weekly regular moderate physical activity such as weight lifting or yard work 
(2-3) and vigorous physical activity such as running from 1 mile to 10 miles per week 
(4-7).  Measures of  ̇      were estimated from both the questionnaire and the 
submaximal cycling exercise protocol described below. The relationship between 
 ̇      estimated from the non-exercise questionnaire and the  ̇      estimated from 
the submaximal cycling test was r = 0.88 (p<0.001). 
 
3.2.2. Indoor cycling trainer calibration 
 
To ensure accuracy and repeatability of the exercise protocol for each individual 
subject, the computrainer was calibrated for rolling resistance prior to the exercise. The 
load generator and bike tire were mechanically warmed to an optimal temperature by 
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pedaling at a low-comfortable speed and 150 W for 10 minutes. This was done by a 
researcher while the subject remained seated, to prevent a premature start of the exercise 
protocol. Subjects were then asked to pedal and reach a speed of 25 mph before coasting 
to a stop without applying pressure on the pedals. Rolling resistance was adjusted and 
set to 2.00 lbs for each individual subject during the computrainer calibration to ensure 
homogeneity in the exercise protocol throughout the studies. 
 
3.2.3. Submaximal exercise test to estimate maximal oxygen uptake and maximum 
cycling power 
 
After providing the resting blood sample, all participants from the studies described in 
Chapter 4 and Chapter 7 had their  ̇      estimated using a submaximal cycling 
exercise protocol (Astrand 1960). Subjects completed four 3-minute heart-rate adjusted 
incremental stages on a Trek road bike mounted on a calibrated indoor cycling trainer 
(Computrainer Lab, Racermate, WA, USA). The subjects’ heart rate (HR) was 
measured continuously during the exercise protocols by short-range telemetry (Suunto 
T6, Vantaa, Finland) and the average HR during the last minute of each stage was used 
to determine the age-adjusted wattage to apply to the following increment. Maximal 
oxygen uptake and maximum power was estimated from the test using the equations 
provided by Adams et al. (1998).  
 
3.2.4. Cycling Exercise Protocol 
 
All participants from the study described in Chapter 7 completed the cycling exercise 
protocol within 1-3 weeks after the initial  ̇      estimation test. Subjects reported to 
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the laboratory after an overnight fast between 07:30 and 09:00 hours and provided a 
resting blood sample. Subjects were then fitted with a heart rate monitor and completed 
a 30-min cycling protocol at a fixed intensity corresponding to 85% of the pre-
determined estimated maximum wattage. Further blood samples were collected 
immediately on completion of the exercise test then again 1h after exercise cessation. 
Serum samples were collected and tested for CMV and EBV as described below.  
 
3.3. Peripheral blood collection and mononuclear cell isolation 
 
Blood sampling was consistent throughout the different studies comprised within this 
thesis. Intravenous blood samples were collected from an antecubital vein in 10mL 
vacutainers® tubes (BD vacutainer™, Franklin Lakes, NJ USA) spray-coated with 
lithium heparin, using ¾” BD Vacutainer Safety-Lok™ (BD Biosciences, Oxford, UK). 
Serum samples were collected in 10mL serum-separating tubes SST™ (BD 
vacutainer™, Franklin Lakes, NJ USA) coated with clotting agents and stored frozen at 
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C for further analysis, including serum viral antibody titers. Peripheral Blood 
Mononuclear Cells (PBMC) were isolated from whole blood using density gradient 
centrifugation (Lymphoprep®; Axis-Shield, Oslo, Norway or Histopaque®; Sigma-
Aldrich, Irvine, Scotland). Whole blood was diluted with an equal volume of 0.9% 
NaCl (Baxter™, Deerfield, IL USA), and 6mL of the diluted blood was layered over 3 
ml of Lymphoprep®.  Samples were then centrifuged for 25 minutes at 800g. Following 
centrifugation, the distinct band formed by the PBMC was carefully removed using a 
Pasteur pipette (Figure 3.1) and washed twice in 0.9% NaCl for 10 minutes at 250g, 
then again in either cell culture medium RPMI 1640 (Sigma-Aldrich, Irvine, Scotland) 
when cells were cultured or in Phosphate Buffer Saline + 2% bovine serum albumin + 
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0.02% Sodium Azide (Sigma-Aldrich, Irvine, Scotland) when cells were stained for 
flow cytometry analysis immediately following isolation. Finally, the cell pellet was re-
suspended in RPMI 1640 or PBS-BSA-NaN3 and quantified.  
 
 
 
 
 
 
 
 
Figure 3.1. Mononuclear cell separation by centrifugation 
 
3.3.1. PBMC Quantification 
 
The cells were counted using the Nucleocounter® automated analyzer (Sartorius, 
Edison, NJ, USA) and using optical microscopy by coupling a Malassez 
haemocytometer with the use of the cell dye trypan blue. When using the 
Nucleocounter® automated analyser, the cells’ nuclei were stained with a fluorescent 
dye, propidium iodide (PI), after lysis of the cell membrane by specific reagents. An 
equal amount of cells was directly stained with PI without lysing the cells, in order to 
quantify the non-viable or dead cells already present in the suspension. The 
fluorescence was read by a fluorescent microscope in the Nucleocounter. The 
fluorescence intensity is directly correlated to the number of cells. A percentage of 
viability was also obtained using this technique. 
800g for 25 min 
Diluted blood 
and saline 
Lymphoprep® 
or Histopaque® 
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3.3.2. Mitogen titration and PBMC stimulation 
 
The experimental procedures used for the data presented in Chapter 6 required PBMC 
in vitro stimulation. Isolated PBMC were cultured to assess the effect of leptin exposure 
on their activation state. According to the Tunable Activation Threshold (TAT) Theory 
(Grossman & Paul 1992) and to previous studies on T-cell activation (Martin-Romero et 
al. 2000), we mildly stimulated the isolated PBMC with optimal concentrations of the 
mitogen Phorbol 12-Myristate 13-Acetate (PMA). PMA is a polyfunctional diterpene 
phorbol ester mimicking diacylglycerol (DAG), a natural activator and ligand for the C1 
domain of the Protein Kinase C, thus activating T-cell independently of the TCR-
signaling pathway. As a consequence of its lack of specificity, the concentration of 
PMA required to obtain the activation of between 40-50% of a T-cell population will 
vary from batch to batch. 
Two different batches of commercially available PMA (Sigma-Aldrich, Irvine, 
Scotland) were re-suspended in 1 mL of DMSO to obtain a stock solution at 1 mg.mL
-1
. 
Freshly isolated PBMCs (1x10
6
) were cultured in 1 mL of RPMI 1640 culture medium 
with various concentrations of PMA during 4 hours at 37 
 
C with 5% of CO2. The cells 
were then taken out of culture, washed with an excess of PBS-BSA-NaN3 for 10 
minutes at 250g and labeled with anti-CD3 FITC-conjugated and anti-CD69 PE-
conjugated antibodies. The optimal concentrations of PMA from the batch 1 and batch 2 
to activate an optimal proportion of 40 to 50% of T-cells was found to be respectively 
0.25 ng.mL
-1
 and 0.125 ng.mL
-1
 (Figure 3.2).   
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Figure 3.2. The proportions of activated CD3+ T-cells after 4 hours of incubation in RPMI 1640 
and various concentrations of PMA (ng.mL
-1
) from two different batches. All values are Mean ±SD. 
 
3.4. Serological Testing for CMV and EBV IgG Antibodies 
 
Subject serostatus was required to analyse the data presented in the Chapter 4, Chapter 
5 and Chapter 7. Serum samples were analysed within 8 weeks of storage, in duplicate 
for CMV and EBV IgG antibodies using separate commercially available ELISA kits in 
accordance with the manufacturer’s instructions (GenWay Biotech, CA, USA). Diluted 
serum (1/100) was added to CMV or EBV-antigen pre-coated wells (Genway Biotech, 
CA, USA). The anti-virus IgG specific antibody, if present, bound to the antigen. 
Unbound materials were washed away from the wells with the provided washing buffer 
before allowing the horseradish peroxidase (HRP) enzyme conjugate to bind to the 
antibody-antigen complex. The substrate, 3,3’,5,5’ tetramethylbenzidine (TMB), was 
added to the wells and the plate was incubated for 10 minutes at room temperature (22 
 
C) to allow complete TMB hydrolysis. The intensity of the colour generated being 
proportional to the amount of anti-CMV or anti-EBV IgG specific antibody present in 
the serum sample, spectrophotometric analysis was performed on each well with a 96-
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wells plate reader (SpectromaxM2, Molecular Devices, CA, USA). The Antibody index 
of each sample was calculated relative to the provided calibrator. As instructed by the 
manufacturer, subjects were considered to be seronegative for CMV or EBV if the 
antibody index was below 0.9, and CMV or EBV seropositive if the antibody index was 
greater than 1.1. Subjects with an antibody index of 0.9 to 1.1 (borderline) were 
excluded from the studies. The antibody index of two resting samples were analysed per 
subject in order to exclude subjects with a recent reactivation of the latent virus (defined 
as a % increase in serum IgG).  
 
3.5. Cellular staining for flow cytometric analysis 
 
3.5.1. Direct Immunofluorescence Assays 
 
PBMCs (1 x 10
6) were labelled with 100μL of pre-diluted directly conjugated 
monoclonal antibodies (mAbs) in a three or four colour procedure. After labelling, the 
PBMCs were incubated for 45 minutes at room temperature. Commercial stock 
solutions of the mAbs were diluted in PBS + 0.5% BSA + 0.02% Sodium Azide (PBS-
BSA-NaN3) at concentrations previously identified as being optimal for analysis by 
flow cytometry. Details on the different mAbs used in the different experiments 
conducted in this thesis are presented in the Table 3.1. The excess unbound mAbs was 
washed away in PBS-BSA-NaN3 for 10 minutes at 250g and the cell pellet was 
resuspended in 400 μL of PBS-BSA-NaN3 before flow cytometric analysis. 
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Table 3.1. Monoclonal antibodies used in the detection of cell surface protein and the optimal dilutions determined after titrations.  
Specificity Isotype Clone Conjugate Optimal dilution Species reactivity Manufacturer 
CD3ε IgG2a, κ MEM-57 FITC 1/100 Human Immunotools, Friesoythe, Germany 
CD3ε IgG2a, κ HIT3a APC 1/100 Human BD Bioscience, San Jose, CA, USA 
CD3ε IgG2a, κ MEM-57 APC 1/100 Human Immunotools, Friesoythe, Germany 
CD4 IgG1, κ MEM-241 PE-Cy5 1/50 Human Immunotools, Friesoythe, Germany 
CD4 IgG2b, κ OKT-4 PerCP-Cy5.5 1/50 Human BD Bioscience, San Jose, CA, USA 
CD8α IgG2a, κ MEM-31 FITC 1/100 Human Immunotools, Friesoythe, Germany 
CD8α IgG2a, κ MEM-31 PE-Cy5 1/50 Human Immunotools, Friesoythe, Germany 
CD8α IgG1, κ RPA-T8 PerCP-Cy5.5 1/50 Human BD Bioscience, San Jose, CA, USA 
CD25 IgG1, κ MEM-181 PE 1/50 Human Immunotools, Friesoythe, Germany 
CD27 IgG1, κ LG.7F9 PE 1/50 Human BD Bioscience, San Jose, CA, USA 
CD28 IgG1, κ KOLT-2 FITC 1/100 Human Immunotools, Friesoythe, Germany 
CD28 IgG1, κ CD28.2 PE 1/100 Human BD Bioscience, San Jose, CA, USA 
CD45RA IgG2b, κ MEM-56 FITC 1/100 Human Immunotools, Friesoythe, Germany 
C45RA IgG2b, κ HI100 FITC 1/100 Human BD Bioscience, San Jose, CA, USA 
CD45RO IgG2a, κ UCHL1 PE 1/50 Human Immunotools, Friesoythe, Germany 
CD45RO IgG2a, κ UCHL1 PE 1/100 Human BD Bioscience, San Jose, CA, USA 
CD57 IgM NK-1 PE 1/300 Human Abcam, Cambridge, UK 
CD69 IgG1, κ FN50 PE 1/50 Human Immunotools, Friesoythe, Germany 
CD71 IgG1, κ MEM-75 PE 1/50 Human Immunotools, Friesoythe, Germany 
CCR7 IgG2a, κ 4B12 PE 1/100 Human BD Bioscience, San Jose, CA, USA 
KLRG1 IgG2a, κ 13A2 Alexa-488 1/400 Human Dr H. Pircher, U of F, Freiburg, Germany 
OB-Rb IgG2b, κ 52263 FITC 1/300 Human R&D systems, Minneapolis, MN, USA 
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3.5.2. Antigen-specific T-cells staining 
 
Identification and numeration of viral-specific CD8+ T-cells as presented in the Chapter 
7 was completed by flow cytometry analysis. Antigen-specific CD8+ T-cells from 
seropositive donors were labeled with 5μL of undiluted Allophycocyanin(APC)-
conjugated CMV-specific MHC class I pentamers or EBV-specific MHC class I 
pentamers (pp65: A*201 NLVPMVATV and BMLF-1: A*201 GLCTVAML 
respectively, Proimmune, Oxford, UK) for 15 minutes at room temperature in the dark.  
The labeled antigen-specific CD8+ T-cells were then labeled according to the protocol 
described above. 
  
3.5.3. Flow cytometers 
 
PBMCs phenotypes in the study presented in Chapter 4 were assessed on two different 
flow cytometer depending on the testing location site. The FACSCalibur flow cytometer 
(BD Biosciences, San Jose, CA USA) used at Edinburgh Napier University was 
equipped with a 15-mW argon ion laser emitting light at a fixed wavelength of 488 nm 
whereas the Accuri C6 flow cytometer (Accuri, Ann Arbor, MI, USA) used at the 
University of Houston was equipped with a blue laser emitting light at a fixed 
wavelength of 488nm and a red laser emitting light at a fixed wavelength of 640nm. 
Fluorescein (FITC) or Alexa488 fluorescence were detected in the FL-1 filter centred at 
533nm with a 30nm half-peak bandpass and PE fluorescence was detected in the FL-2 
filter centred at 585nm with a 42nm bandpass (FACSCalibur) or 40nm bandpass (C6). 
The FL-3 and FL-4 filter were respectively used to detect the PerCP Cy-5.5 
fluorescence centered at wavelength over 670nm longpass and Allophycocyanin (APC) 
fluorescence at 661 nm with a 16 nm bandpass (FACSCalibur) or at 675nm with a 
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25nm bandpass (C6). Data were analyzed using the BD Facscalibur cell analysis 
software or the Accuri Cflow v17. software depending on the testing site. The results 
presented in Chapter 5 and Chapter 7 were entirely obtained at the University of 
Houston using the Accuri C6 flow cytometer, whereas the study presented in Chapter 6 
was conducted at Edinburgh Napier University using the FACSCalibur flow cytometer. 
 
3.5.4. Flow cytometer comparison 
 
The study presented in Chapter 4 was conducted on two testing sites using two different 
flow cytometers. To control for potential systematic differences in the measured cell 
frequencies, two samples were collected from the same individuals at both testing sites 
and labeled with the same antibody panel. The first sample was obtained in Edinburgh 
in June 2008 (using the FACSCalibur) and the second sample was collected in Houston 
(using the Accuri C6) in September 2009.  Representative flow cytometry dotplots for 
the expression of KLRG1 and CD57 on CD8+ T-cells obtained using the FACSCalibur 
and the Accuri C6 are presented in Figure 3.3.   Although the time elapsed from one 
sample collection to the next was 15-months, the values obtained from both instruments 
on this same individual are not significantly different, confirming the lack of inter-flow 
cytometer variability.  
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Figure 3.3. Representative flow cytometry dotplots of CD8+ T-cells expressing KLRG1 and CD57 
obtained from the same individual and analysed using the FACSCalibur flow cytometer or the 
Accuri C6 flow cytometer.  
 
 
3.5.5. Flow cytometry gating procedures 
 
The cells were identified and electronically gated using the forward and side light-
scatter mode. The light emitted by the laser were either diffracted in function of the cell 
size, into a Forward scatter (Fsc) detector, or reflected/refracted in function of the cell 
granularity, into a Side scatter (Ssc) detector (Figure 3.4). For each sample, 100,000 
cells of interest were collected. The signals were collected in the logarithmic mode (4 or 
6 decade logarithmic amplifier depending on the flow cytometer).  
The Fsc was used to eliminate the debris and dead cells based on their small size. An 
electronic gate was placed around the lymphocytes (Figure 3.4 and 3.5), which is 
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critical for subsequent analysis in order to select the population, free of remaining debris 
and unrelated cells. 
 
 
 
 
 
 
 
 
 
Figure 3.4. Reduction of the background noise by increasing the Fsc threshold and gating around 
the lymphocyte population.  
 
 
      
     A                B                  
  
 
 
 
 
 
 
 
Figure 3.5. Selection of  T-cells (A) and cytotoxic T-cells (B). The T-cells were selected by 
backgating on populations highly expressing the CD3 receptor. Another gate was placed to select 
the cells expressing the CD4 co-receptor or CD8 co-receptor, in order to isolate the different 
subpopulations of T-cells. 
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The use of different fluorochromes coupled to the use of electronic gates were essential 
to separate cell populations co-expressing cell surface markers of senescence (KLRG1, 
CD28, and CD57), naïve (CD45RA) and memory (CD45RO) T-cell on each CD4+ and 
CD8+ subset (Figure 3.6).  
 
        A               C 
                               
       
                    
 
      
 
 
     B 
              
Figure 3.6. Cytotoxic CD8+ T-cells expressing KLRG1 (A), CD57 (B) or both markers (C) on their 
surface.  
 
Several filter and fluorochromes emitting at different wavelength were used to 
characterise the co-expression of cells surfaces molecules. Monoclonal antibodies 
labeled with Alexa488 or FITC molecules emit green radiations detected in FL1, 
whereas mAbs labeled with Phycoerythrin (PE) molecules emit orange-red radiations 
detected in FL2. However, the important width of the emission spectra from fluorescent 
antibody labels induces overlaps between the different fluorochromes. It results in 
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detection of fluorescence from both fluorochrome in the same filter, and consequently 
results in the apparition of false positive populations. These overlaps were corrected by 
electronic compensation, by which the excess of fluorescence originating from a 
fluorochrome other than the one specified on a specific Filter is subtracted as a 
proportion of the signal from the other detector. 
 
3.5.6. T-cell subset phenotypic identification 
 
Different monoclonal antibody combinations were used to identify and quantify the 
different T-cell populations in the different studies described within this thesis. The 
different combinations used are presented in the Table 3.2. 
Table 3.2. Phenotypic identification of the blood T-cell subsets in the studies presented in the 
subsequent chapters 
Chapter Phenotypes T-cell subsets References 
Chapter 
4 
KLRG1-/CD28+
 a
 
KLRG1-/CD57- 
Naïve T-cells (Koch et al. 2008) 
CD45RA+/CD45RO+
 d 
 Transitional T-cells 
(Akbar et al. 1988; Sanders et al. 
1988) 
CD45RA-/CD45RO+
 
 Pan memory T-cells 
KLRG1+/CD28+
 c
 
KLRG1+/CD57- 
Memory T-cells (Ibegbu et al. 2005) 
KLRG1+/CD28-
 b
 
Senescent T-cells 
(Voehringer et al. 2002; Ibegbu et 
al. 2005) 
KLRG1+/CD57+
 b
 
 
 
Chapter 
5 
CD28+/CD27+ Early Differentiated T-cells (Appay et al. 2002) 
CD45RA+/CCR7+ Naïve T-cells (Geginat et al. 2003) 
CD45RA-/CCR7+ Central-memory T-cells 
(Sallusto et al. 1999; Sallusto et al. 
2004) 
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Chapter 
5 
CD45RA-/CCR7- Effector-memory T-cells 
(Sallusto et al. 1999; Sallusto et al. 
2004) 
CD28-/CD27+ 
Intermediate Differentiated 
T-cells 
(Appay et al. 2002) 
CD28-/CD27- Late Differentiated T-cells (Appay et al. 2002) 
CD45RA+/CCR7- TEMRA cells (Geginat et al. 2003) 
CD28-/CD57+ Senescent T-cells (Bandres et al. 2000) 
Chapter 
6 
CD4+/CD69+ Activated TH-cells (Cosulich et al. 1987; Cebrian et al. 
1988) 
CD8+/CD69+ Activated TC-cells 
Chapter 
7 
KLRG1-/CD28+
 a
 
KLRG1-/CD57- Naïve T-cells 
(Koch et al. 2008) 
CD45RA+/CCR7+ (Geginat et al. 2003) 
KLRG1+/CD28+
 c
 
Memory T-cells (Ibegbu et al. 2005) 
KLRG1+/CD57- 
CD45RA-/CCR7+ Central-memory T-cells 
(Sallusto et al. 1999; Sallusto et al. 
2004) 
CD45RA-/CCR7- Effector-memory T-cells 
(Sallusto et al. 1999; Sallusto et al. 
2004) 
CD45RA+/CCR7- TEMRA cells (Geginat et al. 2003) 
KLRG1+/CD28-
 b
 
KLRG1+/CD57+
 b
 
Senescent T-cells 
(Voehringer et al. 2002; Ibegbu et 
al. 2005) 
a
 Approximately 3–7% of all CD8+ T-cells displaying this phenotype may be central-memory 
T-cells (Koch et al., 2008). 
b The term ‘‘senescent’’ has been used to describe cells with this phenotype, however, some 
KLRG1+/CD28- cells may be an a state of ‘‘exhaustion’’ and their proliferative capabilities 
may be restored under certain circumstances (Akbar and Henson, 2011). The relationship 
between the proportions of KLRG1+/CD28- and KLRG1+/CD57+ was r = 0.762 (p < 0.001) 
and r = 0.814 (p < 0.001) for CD4+ and CD8+ T-cells, respectively. 
c 
The variation in CCR7 expression (28–57%) among KLRG1+/CD28+ cells (Ibegbu et al., 
2005) indicates that this phenotype may overlap both central-memory and effector-memory T-
cells. 
d
 Identifies naïve T-cells transitioning to a memory phenotype, or an effector-memory T-cell 
transitioning to a terminal phenotype. 
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3.6. T-cell subset enrichments from whole blood 
 
The data presented in Chapter 6 were partially generated after T-cell subset isolation 
and enrichment. Following whole blood isolation, pan CD3+ T-cells, CD4+ T-cells and 
CD8+ T-cells were separated from the PBMC. To limit undesirable cell activation 
resulting from the isolation procedure, a negative selection of the cell subsets of interest 
was preferred (BD Biosciences, Oxford, UK). The PBMC were washed in IMag™ 
buffer for 10 minutes at 250g and re-suspended in the same buffer to obtain a final 
concentration of 10x10
6
 cells.mL
-1
.  Every 10
6
 cells were put in contact with 5µL of 
different commercially available biotinylated enrichment cocktails (BD Biosciences, 
Oxford, UK) depending on the cell subset of interest (see appendix 3 for the different 
enrichment cocktails compositions) for 20 minutes at room temperature. The cells were 
then washed in large excess (10x) of IMag™ buffer at 250g for 10 minutes and the 
supernatant was removed. The cells were re-suspended in 5µL of IMag™ Streptavidin 
Particles Plus (BD Biosciences, Oxford, UK) per 10
6
 cells and incubated for 30 minutes 
at room temperature to allow adequate binding of the streptavidin-conjugated magnetic 
beads to the previously added primary antibodies. 
Following incubation, the labeled cells were washed in excess of IMag™ buffer for 7 
minutes at 250g and re-suspended in the same buffer to obtain a final concentration of 
50x10
6
 cells.mL
-1. The cells were placed in the IMagnet™ for 7 minutes to 
magnetically separate the unwanted cell subsets labeled with specific antibodies present 
in the biotinylated enrichment cocktails. The supernatant composed of the unlabeled cell 
subsets of interest (negative fraction) was removed and the tube was removed from the 
magnet to re-suspend the positive fraction in IMag™ buffer before being replaced in the 
magnet. This operation was repeated twice and the remaining positive fraction was 
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discarded. The negative fraction was placed twice in the IMagnet™ for 7 minutes to 
ensure maximum purity of the isolated T-cells subsets. Enriched T-cell subsets were 
assessed for OB-Rb expression by flow cytometric analysis. 
 
3.7. Cell storage in liquid nitrogen 
 
Due to technical difficulties, RNA from the isolated PBMCs could not be extracted on 
freshly enriched samples and had to be performed on a later date. To ensure integrity of 
the genetic material, the samples were conserved in liquid nitrogen for a period inferior 
to 3 months.  
The stimulated isolated PBMCs from 4 subjects were washed in PBS-BSA-NaN3 for 10 
minutes at 250g and slowly re-suspended in 1mL of freshly made cryomedium 
composed of 90% of Foetal Calf Serum (Invitrogen, Paisley, Scotland) and 10% of 
Dimethyl Sulfoxide (Sigma-Aldrich, Irvine, Scotland) on ice. Cells were then 
transferred in cryotubes (NUNC, Roskilde, Denmark) and placed overnight at -80 
 
C  
before being stored in liquid nitrogen.   
 
3.8. Leptin receptor gene expression analysis 
 
3.8.1. Total RNA extraction 
 
The data presented in Chapter 6 were obtained after total RNA was extracted and 
amplified by either Reverse Transcription Polymerase Chain Reaction (RT-PCR) or 
Real-Time Polymerase Chain Reaction (RT-PCR’). Samples were defrosted at room 
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temperature for 1 hour prior to RNA extraction. Once completely defrosted, they were 
transferred to Eppendorf tubes (Eppendorf, Hamburg, Germany), centrifuged at 200g 
for 5 minutes and the supernatant was removed. Every 5 x 10
6
 cells were lysed in 1mL 
of TRIsure™ (Bioline, London, UK) for 5 minutes at room temperature. To ensure 
correct phase separation, 0.2mL of chloroform (Bioline, London, UK) were added for 
every milliliter of TRIsure, the tubes were vigorously agitated for 15 seconds and 
centrifugated at 12 000g for 15 minutes at 4
  
C after an incubation period of 2 minutes at 
room temperature. The upper aqueous phase of the supernatant in which the RNA was 
dissolved, was carefully pipette transferred into another eppendorf tube and precipitated 
by 0.5mL of isopropyl alcohol. After incubating the samples for 10 minutes at room 
temperature, they were centrifuged at 12 000g for 10 minutes at 4 
 
C and washed in 1mL 
of 75% ethanol. Finally the extracted RNA was centrifuged at 7 500g for 5 minutes at 4 
 
C, the pellet was air-dried and re-suspended in diethylpyrocarbonate -treated water 
(DEPC-water) (Bioline, London, UK).  
 
3.8.2. RNA quantification 
 
After isolation, RNA purity and concentration was determined in each sample, using 
UV absorption with the NanoVue™ Plus Spectrophotometer (GE Healthcare, Munich, 
Germany).  The nucleotide nitrogenous bases contained in RNA have an absorption 
maximum at λ=260nm, whereas proteins have a UV absorption maximum of λ=280nm. 
Measures of RNA absorption were made at both wavelengths to measure RNA 
concentration in the samples, an optical density of 1 at λ=260nm corresponding to 40 
µg.mL
-1
 of RNA, but also the protein contamination by measuring the ratio of the 
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absorbance at 260nm/280nm.  Samples were required to have a purity superior to 95% 
of RNA to be included in the analysis. 
 
3.8.3. Leptin Receptor gene amplification and detection  
 
The expression of the functional form of the leptin receptor (OB-Rb) mRNA in PBMCs 
was analysed in Chapter 6. Extracted total RNA was used to generate complimentary 
DNA (cDNA) prior to PCR amplification. Following brief centrifugation, 2 µg of total 
RNA was added to a sterile, nuclease-free, thin-walled PCR tube containing 2 µL of 
Random Hexamer Primer (Roche Diagnostic, Burgess Hill, UK) on ice. A sufficient 
volume of PCR-grade water was added to the tube to dilute the Hexamer primer down 
to 60 µM. The samples were placed in a thermal block cycler with heated lid (PCR 
sprint, Thermo Scientific, Waltham, MA, USA) at 65 
 
C  for 10 mins to ensure RNA 
heat denaturation before being cooled down on ice. When the sample reached 4 
 
C , 10 
units of Transcriptor high fidelity Reverse Transcriptase (Roche Diagnostic, Burgess 
Hill, UK) was added to the reaction tube, with 2 µL of Deoxynucleotide Mix® (Roche 
Diagnostic, Burgess Hill, UK) and 20 units of Protector RNase inhibitor (Roche 
Diagnostic, Burgess Hill, UK.). Samples were incubated in the PCR thermal cycler for 
30 minutes at 50 
 
C  before inactivation of the reverse transcriptase at 85 
 
C  for 5 
minutes. The cDNA samples were conserved on ice until amplification by PCR.  
PCR was carried out in 50 µL reaction mixture using PCR master (Roche Diagnostic, 
Burgess Hill, UK) to amplify a specific region of the OB-Rb gene mRNA (237 bp) with 
the forward primer Ob-Rb forward primer: 5’-GCCAACAACTGTGGTCTCTC-3’ and the 
reverse primer Ob-Rb reverse primer: 5’-AGAGAAGCACTTGGTGACTG-3’. The 
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as 
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an internal control to validate the RT-PCR reaction. The sequence of the forward primer 
used to amplify GAPDH gene was GAPDH forward primer: 5’-
GCTTGGTAAAAAGATGCTCAATG-3’ and the sequence of the reverse primer used 
was GAPDH reverse primer: 5’-GCTTGGTAAAAAGATGCTCAATG-3’. Negative control 
consisted of omitting the RT reaction, which led to a lack of band on the agarose gel 
after PCR amplification and electrophoresis. 
The samples were denatured at 95 
 
C  for 5 min and PCR was carried out for 40 cycles 
with 55 
 
C  annealing temperature. A final 10 min extension step at 72 
 
C  terminated the 
reaction. The PCR products were loaded on a 2% agarose gel electrophoresis along with 
the controls and a 100bp DNA molecular weight marker (Roche Diagnostic, Burgess 
Hill, UK) and visualised under UV light after ethidium bromide staining (Roche 
Diagnostic, Burgess Hill, UK). 
 
3.8.4. Real Time Polymerase Chain Reaction 
 
Prior to running Real-Time Polymerase Chain Reaction (RT-PCR’), complementary 
DNA (cDNA) was generated from the extracted RNA using reverse transcriptase as 
described above.   
Leptin-receptor (Ob-Rb) levels contained in the samples were quantified using 
TaqMan® Real-Time PCR (LightCycler® 2.0, Roche Diagnostic, Burgess Hill, UK). 
TaqMan® probes are double-dyed oligonucleotides with a fluorophore attached to the 
5’ end of the probe and a dark quencher to the 3’ end. When excited, the fluorophore 
transmits the energy to the quencher via Fluorescence Resonance Energy Transfer. 
While no light is emitted by the fluorophore when paired to the quencher, the 5’3’ 
exonuclease of the Taq polymerase cleaves the 5’ end of the probe, leading to 
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measurable light emission by the now free fluorophore. The probe used was labelled 
with fluorescein (FAM reporter) and Carboxytetramethylrhodamine (dark quencher 
TAMRA) (Roche Diagnostic, Burgess Hill, UK). 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) being stably expressed in T-
cells, it was used as the housekeeping gene to normalize gene expression. The sequence 
of the probe used to amplify the leptin receptor gene was Ob-Rbprobe: 5’-
AAACCACATAGAATTTCTGACACATCATCTTTC-3’, the sequence of the forward 
primer used was Ob-Rb forward primer: 5’-GCCAACAACTGTGGTCTCTC-3’ and the 
sequence of the reverse primer used was Ob-Rb reverse primer: 5’-
AGAGAAGCACTTGGTGACTG-3’. The sequence of the probe used to amplify the 
GAPDH gene was GAPDH probe: 5’-GCTTGGTAAAAAGATGCTCAATG-3’, the 
sequence of the forward primer used was GAPDH forward primer: 5’-
GCTTGGTAAAAAGATGCTCAATG-3’ and the sequence of the reverse primer used 
was GAPDH reverse primer: 5’-GCTTGGTAAAAAGATGCTCAATG-3’. The Master Mix 
was composed of 4µL of Lightcycler TaqMan MasterMix® (Roche Diagnosis, Burgess 
Hill, UK) and 2 µL of the primers and probes. Finally 5 µL of 1/10 diluted amplified 
cDNA was added to the Master Mix prior to be loading in 20 µL glass capillaries 
(Roche Diagnosis, Burgess Hill, UK). Samples were amplified using the Lightcycler® 
2.0 and data were analysed with the Lightcycler® software 4.05. Relative levels of Ob-
Rb expression was determined by normalizing the OB-Rb level to the endogenously 
expressed housekeeping gene (GAPDH) and the ΔΔCt method, based on the threshold 
cycle (CT), was used to estimate OB-Rb expression as described previously. (Livak & 
Schmittgen 2001): 
   T = (CT OB Rb CT GAPDH)stimulation   (CT OB Rb CT GAPDH)control 
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3.9. Statistical analysis 
 
Data were analysed statistically using the software “Statistical Package for the Social 
Sciences” (SPSS, Chicago, IL, USA) and appropriate statistical tests for the experiments 
used. Specific details of the different statistical methods used to analyse the data 
comprised within this thesis are presented in the subsequent chapters to which they are 
relevant. All data in the different chapters of this thesis are presented as mean ± SEM, 
unless stated otherwise. Statistical significance has been set at p < 0.05. 
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CHAPTER 4 
IMPACT OF AEROBIC FITNESS ON THE 
PROPORTIONS OF SENESCENT BLOOD T-CELLS IN 
MAN 
  
83 
 
4.1. Introduction 
 
Human ageing is associated with a progressive decline in the function of the immune 
system, which is commonly referred to as immunosenescence. This is characterised by 
poor vaccine efficacy, increased incidence of opportunistic infections, and high 
morbidity and mortality among the elderly (Koch et al. 2007). Immunosenescence is 
thought to be a consequence of an accumulation of multiple exposures to external 
pathogens and persistent viral infections throughout the lifespan, although certain 
lifestyle factors (i.e. smoking, inactivity, socio-economic status) have also been shown 
to accelerate telomere shortening and thus age-associated immune dysfunction (Valdes 
et al. 2005). This manifests as increased prevalence of infectious disease due to an 
impaired ability to recognize and respond to newly evolving pathogens (i.e. influenza, 
rhinovirus, respiratory syncytial virus). Although immunosenescence refers to a 
dysfunction in systemic immunity, it is the cellular components of the immune system, 
particularly of the adaptive arm (i.e. T-cells, B-cells and their products), that appear to 
diminish most with increasing age (Pawelec 2006; Pawelec et al. 2006). Indeed, age-
related changes within the T-cell compartment are hallmark features of the immune risk 
profile (IRP), which is an amalgam of immune biomarkers that have been used to 
predict morbidity and mortality in seniors (Pawelec & Gouttefangeas 2006).  
T-cell clonal expansion in response to an antigenic stimulus is a fundamental process of 
adaptive immunity, allowing for the formation of antigen specific effector T-cells to 
combat invading pathogens. However, this clonal expansion is not unending, and after 
repeated and excessive rounds of cell division, T-cells undergo cell cycle arrest and 
become senescent (Spaulding et al. 1999). In this state, T-cells will no longer clonally 
expand upon further antigenic stimulation, but will still retain effector cell properties 
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(i.e. recognizing and killing virally infected cells) and are still capable of producing 
large amounts of pro-inflammatory cytokines, such as TNF-α, IL-2 and TNF-γ (Effros 
et al. 2003; Vescovini et al. 2007) Senescent T-cells express a number of signature cell-
surface proteins, such as the killer cell lectin-like receptor G1 (KLRG1) and/or CD57 
(Voehringer et al. 2002; Brenchley et al. 2003) while also lacking surface expression of 
the co-stimulatory molecule CD28 (Brzezinska et al. 2004). With advancing age, there 
is a progressive reduction in the number of fully functional naïve antigen-virgin T-cells 
and a concomitant increase in the frequency of senescent T-cells within the peripheral 
blood compartment. This occurs due to the age-associated atrophy of the thymus and a 
consequential reduced output of naïve T-cells, coupled with the homeostatic 
proliferation and differentiation of activated/memory cells due to life-long exposure to 
various pathogens and persistent viral infections (Simpson 2011). In this instance, the 
accumulated senescent T-cells, which have limited antigen specificity, occupy the 
“immune space” at the expense of naïve cells leading to a severely restricted T-cell 
repertoire. This, in turn, contributes to higher rates of morbidity and mortality as a result 
of infectious disease. 
Reconstituting the immune system by increasing thymic mass and output or removing 
excess clones of antigen-specific senescent T-cells, is of interest to those working in the 
immunotherapy fields as a means to maintain a diverse T-cell repertoire and reduce the 
incidences of infectious disease in the elderly. However, many of these therapeutic 
interventions (i.e. gene, cytokine, hormone and monoclonal antibody therapy) are 
expensive, risky and bear a large number of undesired side-effects, not to mention that 
the implementation of these invasive procedures in the elderly, who are not diseased per 
se, has ethical complications. As such, there has been recent interest in the manipulation 
of certain lifestyle factors that could be used as effective countermeasures against 
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immunosenescence within the ageing population. In particular, the beneficial effects of 
regular exercise on immunity have been well-documented in older adults, although the 
mechanisms that underpin enhanced immunity with regular exercise are not well 
understood (Shinkai et al. 1995; Simpson & Guy 2010). Nevertheless, many biomarkers 
associated with the IRP are positively displayed in physically active elderly compared to 
their sedentary counterparts (Simpson & Guy 2010), which include longer leukocyte 
telomere lengths, enhanced in vitro T-cell responses to mitogens (Ferguson et al. 1995), 
elevated in vivo immune responses to vaccines and recall antigens (Targonski et al. 
2007), and increased IL-2 synthesis and expression of the IL2 receptor (Flurkey et al. 
1992; Ferguson et al. 1995).  
The maximal oxygen uptake ( ̇     ) is a “gold standard” measure of aerobic capacity 
that is known to decline with age and is associated with risk of morbidity, mortality and 
quality of life (Jackson et al. 2009). Long-term follow-up studies have shown that 
individuals with a lower  ̇      are more likely to develop hypertension, diabetes and 
metabolic syndrome as well as higher mortality rates due to cardiovascular disease and 
cancer (Blair et al. 1996; Lynch et al. 1996; Evenson et al. 2003; Barlow et al. 2006; 
Kodama et al. 2009). Increased proportions of highly differentiated effector-memory 
(TEMRA) and senescent T-cells are signature properties of an ageing immune system 
and a hallmark of the immune risk profile (IRP), which, in turn, is predictive of 
morbidity and mortality in the elderly. It is not known, however, if  ̇      is associated 
with the ageing-induced accumulation of these functionally impaired T-cells. The aim 
of the study presented in this chapter, therefore, is to examine the impact of estimated 
 ̇      on the age-associated accumulation of highly differentiated effector-memory 
and senescent T-cells in a population of healthy adult men. It is hypothesized that 
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estimated  ̇      will offset the increased proportions of highly differentiated effector-
memory and senescent T-cells that are seen with advancing age. 
 
4.2. Materials and Methods 
 
4.2.1. Subjects 
 
A total of 102 healthy non-smoker males of various ethnicities aged 18-61 years old 
(Mean  SD: age= 39 ± 6 yrs; BMI= 25.5 ± 1.8 kg/m2) volunteered for this study. All 
subjects were recruited from the higher education-based community at Edinburgh 
Napier University, Scotland UK (n = 66; Mean  SD: age: 40 ± 5.5 yrs; BMI: 25.0 ± 1.7 
kg/m
2
) or the University of Houston, Houston, TX, USA (n = 36; Mean  SD: age: 37 ± 
6.5 yrs; BMI: 26.5 ± 1.8 kg/m
2
) and consisted of either students or academic members 
of staff. The percentage age distribution of the participants was: 18-31yrs: 29%; 32-
41yrs: 20%; 42-51yrs: 31%; 52-61yrs: 20%. All subjects completed a health and 
lifestyle questionnaire prior to participating in this study. Subjects with excessive 
alcohol intake (>14 drinks per week), taking medication affecting the immune system, 
routinely using ibuprofen and/or aspirin, anti-depressants, medications designed to alter 
blood pressure or cardiovascular function and hormone replacement therapy were 
excluded from the subject pool. Subjects reporting major affective disorders, HIV 
infection, hepatitis, chronic/debilitating arthritis, central or peripheral nervous disorders, 
previous stroke or cardiac events, were bedridden in the past three months, suffer from 
known cardiovascular disease or autoimmune diseases were all excluded from the 
study.. Before their visit, subjects were instructed to refrain from any form of exercise 
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considered as “vigorous” (Jackson et al. 1990) for 24 h prior to their arrival at the 
laboratory. All volunteers gave written informed consent and ethical approval was 
obtained from the School of Life Sciences, Edinburgh Napier University and the 
Committee for Protection of Human Services at the University of Houston. The physical 
characteristics of the participants are presented in Table 4.1. 
Table 4.1. Subjects’ characteristics (mean ± SD) 
 
4.2.2. Anthropometric measurements 
 
On arrival to the laboratory between 08:00 and 10:00 local time, subjects were seated 
for 5 minutes before anthropometric measurements were taken as per the general 
materials and methods Chapter 3.1.2. Bioelectrical impedance analysis was used to 
measure percentage body fat using a single-frequency (50 kHz) electric current 
produced by a tetrapolar bodystat 1500 (Bodystat, Douglas, UK) as described 
previously. (Ghosh et al. 1997). 
  Mean Standard 
deviation 
Range 
Age (yrs) 39 ± 6 18 - 61 
Body Mass (kg) 81 ± 6 53 - 110 
BMI (kg/m
2
) 25.5 ± 1.8 20.1 - 35.1 
% Body Fat 19.9 ± 3.2 6.6 - 38 
Physical Activity Rating (PA-R) 5 ± 2 1 - 7 
 ̇       (mL.kg
-1
.min
-1
) 41.7 ± 3.7 27.8 - 58.5 
Waist (cm) 87 ± 5.8 64 - 117 
Hips (cm) 92.8 ± 4.6 77 - 111 
Waist/Hips ratio 0.94 ± 0.04 0.80 - 1.09 
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4.2.3. Blood Sampling and PBMC isolation 
 
Blood samples were drawn in 6 mL collection tubes (BD vacutainer ™, Franklin Lakes, 
NJ, USA) containing a serum gel or spray-coated with lithium heparin to prevent 
coagulation and Peripheral Blood Mononuclear Cells (PBMC) were immediately 
isolated as described in the general materials and methods Chapter 3.3.  
 
4.2.4. Serological Testing for latent viral IgG Antibodies 
 
Anti-CMV, anti-EBV and anti-HSV-1 antibody titers were determined as described in 
the general materials and methods Chapter 3.4. 
 
4.2.5. Submaximal Exercise Test to Estimate Maximal Oxygen Uptake and Physical 
Activity Rating (PA-R) 
 
The  ̇      of each subject was estimated using a submaximal cycling exercise protocol 
(Astrand 1960) as described in general materials and methods Chapter 3.2.3. Prior to 
exercise, each participant also provided his physical activity score using a 7-level 
questionnaire over the last 8 weeks, which assigns numerical value (Physical Activity 
Rating; PA-R) for infrequent (0-1), moderate (2-3) and vigorous (4-7) exercisers 
(Jackson et al. 1990). This PA-R was also used to estimate the participants’  ̇      
(Jackson et al. 1990). The relationship between  ̇      estimated from the non-exercise 
questionnaire and the  ̇      estimated from the submaximal cycling test was r = 0.88 
(p < 0.001). 
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4.2.6. Labelling of cell surface antigens 
 
Aliquots of 1 x 10
6 
isolated PBMCs were labelled with a combination of directly 
conjugated monoclonal antibodies (mAbs) against the cell surface antigens KLRG1, 
CD57, CD28, CD45RA and CD45RO as described in the general materials and methods 
Chapter 3.5.1. The monoclonal antibodies were freshly diluted in PBS-BSA to their 
optimal concentration as determined by antibody titration before a volume of 50µL was 
added to the cell suspension. The monoclonal antibody panel used and the phenotypes 
of interest are presented in Table 3.2 and Table 4.2.  
Table 4.2. Phenotypic identification of the blood T-cell subsets 
Phenotypes T-cell subsets References 
KLRG1-/CD28+ Naïve T-cells (Koch et al. 2008) 
KLRG1+/CD28- 
Senescent T-cells 
(Voehringer et al. 2002; 
Ibegbu et al. 2005) KLRG1+/CD57+ 
KLRG1+/CD28+ Memory T-cells (Ibegbu et al. 2005) 
CD45RA-/CD45RO+ Pan memory T-cells 
(Akbar et al. 1988; 
Sanders et al. 1988) 
CD45RA+/CD45RO+ Transitional T-cells 
(Akbar et al. 1988; 
Sanders et al. 1988) 
 
4.2.7. Flow cytometric analysis 
 
PBMC phenotypes were assessed on a FACSCalibur flow cytometer (BD Biosciences, 
San Jose, CA USA) at Edinburgh Napier University or on an Accuri C6 flow cytometer 
(Accuri, Ann Arbor, MI, USA) at the University of Houston as per the general materials 
and methods Chapter 3.5.5.  
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4.2.8. Statistical Analysis 
 
All data were assessed for assumptions of normality and constant error variance prior to 
formal statistical testing. Skewed cell-surface phenotypic data was then normalised by 
logarithmic transformation prior to statistical analysis. Initial analysis was performed by 
linear regression to examine the association between age and the proportion of T-cell 
subsets expressing a particular cell surface phenotype in accordance with Table 4.2. 
When significant associations were found, additional variables (i.e. Age, estimated 
 ̇     , BMI and % Body Fat) were systematically added to subsequent blocks of the 
hierarchical multiple regression models to evaluate their impact on the proportion of T-
cell subsets (Table 4.3). In all models, standardized regression coefficients (B) and R
2
 
values are reported as a measure of association (Table 4.4). Linear regression models 
were created by including the centered independent variables as suggested by Aiken and 
West (1991) to eliminate doubts of potential multicolinearity between the different 
variables.  No significant interactions were found between the independent variables 
tested so interaction effects were eliminated from the final analysis. A one-way 
ANOVA was also used to detect differences among age-adjusted  ̇      classifications 
(Whaley et al. 2006). When significant group effects were found, student t-tests with 
Bonferroni correction were performed to detect location of significance. Independent t-
tests were used to compare physical characteristics and T-cell phenotypes due to latent 
CMV, EBV or HSV-1 serostatus. All values are presented as the mean ± Standard 
Deviation (SD) and all statistical analyses were performed using “Statistical Package for 
the Social Sciences” (SPSS v17.0, Chicago, IL, USA). Statistical significance was set at 
P < 0.05. 
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4.3. Results 
 
4.3.1. The effects of age and estimated  ̇      on T-cell phenotypes 
 
The impact of age or estimated  ̇      on the T-cell subsets was initially determined by 
univariate regression analysis (Table 4.3). As expected, a positive relationship was 
found between age and the proportion of senescent (KLRG1+/CD57+) CD4+ and CD8+ 
T-cells (r = 0.264 and 0.363 respectively; p < 0.05). The proportion of senescent CD4+ 
and CD8+ T-cells defined as KLRG1+/CD28- were also positively associated with age 
(r = 0.182 and 0.377 respectively;  p < 0.05 and p < 0.001) (Table 4.3). Similarly, a 
positive relationship between age and the proportion of CD4+ (r = 0.436; p < 0.01) and 
CD8+ (r = 0.411; p < 0.01) T-cells with a transitional (CD45RA+/CD45RO+) 
phenotype were observed (Table 4.3). Similar positive relationships were seen between 
estimated  ̇      and the frequencies of naïve (KLRG1-/CD28+) CD4+ and CD8+ T-
cells (r = 0.171 and 0.224 respectively; p < 0.05), while estimated  ̇      was inversely 
associated with senescent (KLRG1+/CD57+) and transitional (CD45RA+/CD45RO+) 
CD4+ (r = -0.340 and -0.403 respectively; p < 0.01) and CD8+ T-cells (r = -0.287 and -
0.336 respectively; p < 0.01). Only transitional T-cells were positively associated with 
BMI (r = 0.255 and 0.215 for CD4+ and CD8+ T-cells respectively; p < 0.05). The 
associations with T-cell phenotype and BMI were mirrored when percentage body fat 
was used instead of BMI, but for clarity only the BMI data is shown.  
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Table 4.3. Univariate regression analysis of age, estimated ̇       and BMI on T-cell subsets. 
 
4.3.2. The impact of  ̇      on age-associated changes in T-cell phenotype 
 
T-cell phenotypes found to be associated with age and/or estimated  ̇      were 
examined by hierarchical multiple regression analysis to determine if these associations 
were modified when adjusted for the other (Table 4.4). The potential confounders BMI, 
percentage body fat or hip/waist ratio were also added to the model, although for clarity 
only the BMI results are shown. Age was no longer associated with the proportions of 
senescent CD4+ (KLRG1+/CD57+) or CD8+ (KLRG1+/CD28-) T-cells when adjusted 
for estimated  ̇      (p > 0.05). Similarly, proportions of naïve (KLRG1-/CD28+) 
CD4+ or CD8+ T-cells were not associated with age after adjusting for estimated 
 ̇      (p > 0.05). A moderating effect of estimated  ̇      was also found for pan-
T-cell subsets Pearson's R (p value) F statistic (p value) 
 Age  ̇      BMI Age  ̇      BMI 
CD4+ T-cells 
KLRG1+/CD57+ 
(Senescent) 
0.264 
(0.004) 
-0.340 
(0.000) 
0.028 
(0.388) 
7.502 
(0.007) 
13.035 
(0.000) 
0.081 
(0.776) 
KLRG1+/CD28- 
(Senescent) 
0.182 
(0.034) 
-0.221 
(0.013) 
0.073 
(0.235) 
0.745 
(0.39) 
5.091 
(0.026) 
0.528 
(0.469) 
KLRG1+/CD28+ 
(Memory) 
0.052 
(0.304) 
-0.023 
(0.410) 
-0.102 
(0.154) 
0.264 
(0.609) 
0.052 
(0.820) 
1.046 
(0.309) 
KLRG1-/CD28+ 
(Naïve) 
-0.275 
(0.003) 
0.171 
(0.044) 
0.073 
(0.235) 
8.120 
(0.005) 
2.977 
(0.088) 
0.538 
(0.469) 
CD45RA+/CD45RO+ 
(Transitional) 
0.436 
(0.000) 
-0.403 
(0.000) 
0.255 
(0.011) 
18.267 
(0.000) 
15.086 
(0.000) 
5.414 
(0.023) 
CD8+ T-cells 
KLRG1+/CD57+ 
(Senescent) 
0.363 
(0.000) 
-0.287 
(0.002) 
-0.043 
(0.334) 
15.139 
(0.000) 
8.961 
(0.003) 
0.186 
(0.667) 
KLRG1+/CD28- 
(Senescent) 
0.377 
(0.000) 
-0.350 
(0.000) 
0.024 
(0.405) 
12.974 
(0.000) 
13.852 
(0.000) 
0.058 
(0.810) 
KLRG1+/CD28+ 
(Memory) 
0.368 
(0.000) 
-0.137 
(0.086) 
-0.033 
(0.371) 
15.517 
(0.000) 
1.897 
(0.172) 
0.110 
(0.741) 
KLRG1-/CD28+ 
(Naïve) 
-0.189 
(0.029) 
0.224 
(0.012) 
0.024 
(0.405) 
3.655 
(0.059) 
5.247 
(0.024) 
0.058 
(0.810) 
CD45RA+/CD45RO+ 
(Transitional) 
0.411 
(0.000) 
-0.336 
(0.001) 
0.215 
(0.027) 
16.094 
(0.000) 
10.030 
(0.002) 
3.823 
(0.054) 
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effector-memory (defined as KLRG1+) CD4+ and CD8+ T-cells (B = -0.569 and -1.186 
respectively), although age was still significantly associated (B= 0.542; p < 0.01). The 
association between estimated  ̇      and senescent CD4+ (KLRG1+/CD57+) and 
CD8+ (KLRG1+/CD28-) T-cells withstood adjustment for age (both B= -0.953; p < 
0.05). Moreover, the association between estimated  ̇      and naïve (KLRG1-
/CD28+) CD8+ T-cells (B = 1.042; p < 0.01) but not CD4+ T-cells (p > 0.05) also 
withstood age adjustment. Similar results, albeit with smaller effect sizes, were 
observed when self-reported physical activity ratings were used in the models instead of 
estimated  ̇      (data not shown). All moderating effects of estimated  ̇      
presented in Table 4.4 withstood adjustments for BMI and percentage body fat (p < 
0.05). The associations between BMI and transitional (CD45RA+/CD45RO+) CD4+ 
and CD8+ T-cells were eliminated when adjusted for age and estimated  ̇      (p > 
0.05). Marginal but non-significant effects (i.e. p = 0.05 to p = 0.10) for BMI were 
found for senescent (KLRG1+/CD57+) CD8+ T-cells (p=0.07) and memory 
(KLRG1+/CD28+) CD4+ T-cells (p = 0.05) after adjusting for age and estimated 
 ̇     . 
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Table 4.4. Hierarchical multiple regression statistics for age, estimated  ̇      and BMI on T-cell 
subsets after adjusting for the other factors.*indicates significant relationship between 
estimated ̇      and T-cell subsets after age, BMI adjustment (p<0.05). 
T-cell subsets Factors 
CD4+ T-cells CD8+ T-cells 
R2 B SEB 
F statistic 
(p value) 
t statistic (p 
value) 
R2 B SEB 
F statistic 
(p value) 
t statistic (p 
value) 
 
KLRG1+ 
(Pan Effector-Memory) 
 
Age 
0.129 
-0.071 0.075 
3.599 
(0.009) 
-0.946 
(0.347) 
0.359 
0.542 0.173 
13.609 
(0.000) 
3.139 (0.002) 
 ̇      -0.569 0.207 
-2.747 
(0.007)* 
-1.186 0.480 
-2.473 (0.015)* 
BMI  
-0.477 0.305 
-1.566 
(0.121) 
-0.701 0.706 
-0.994 (0.323) 
KLRG1+/CD57+ 
(Senescent) 
Age 
0.147 
1.000 1.007 
4.166 
(0.004) 
0.023 
(0.982) 
0.179 
0.204 0.152 
5.282 
(0.001) 
1.345 (0.182) 
 ̇      -0.953 1.021 
-2.375 
(0.019)* 
-0.690 0.421 
-1.638 (0.105) 
BMI  
-0.964 1.030 
-1.207 
(0.230) 
-1.153 0.620 
-1.861 (0.066) 
 KLRG1+/CD28- 
(Senescent)  
Age 
0.048 
0.993 1.012 
1.205 
(0.314) 
-0.734 
(0.465) 
0.178 
1.005 1.007 
5.205 
(0.098) 
0.690 (0.492) 
 ̇      -0.955 1.030 
-1.529 
(0.130) -0.953 1.023 
-2.247 (0.027)* 
BMI  
-0.971 1.045 
-0.701 
(0.485) -0.955 1.033 
-1.456 (0.149) 
KLRG1-/CD28+ 
(Naïve) 
Age 
0.077 
-0.998 1.002 
2.015 
(0.098) 
-1.834 
(0.070) 
0.116 
-1.002 1.005 
3.135 
(0.018) 
0.576 (0.566) 
 ̇      1.000 1.005 
0.092 
(0.927) 1.042 1.016 
2.665 (0.009)* 
BMI  
1.002 1.007 
0.359 
(0.720) 1.038 1.023 
1.581 (0.117) 
CD45RA+/CD45RO+ 
(Transitional) 
Age 
0.238 
0.009 0.003 
7.916 
(0.000) 
2.752 
(0.007) 
0.200 
0.010 0.004 
6.420 
(0.001) 
2.901 (0.005) 
 ̇      -0.004 0.008 
-0.540 
(0.591) 
0.000 0.008 
-0.005 (0.996) 
BMI  0.012 0.013 
1.086 
(0.281) 
0.016 0.013 
1.188 (0.239) 
KLRG1+/CD28+ 
(Memory) 
Age 
0.045 
0.000 0.057 
1.137 
(0.344) 
-0.008 
(0.994) 
0.157 
0.410 0.452 
4.478 
(0.002) 
3.580 (0.001) 
 ̇      0.033 0.158 
0.208 
(0.836) 
0.452 0.316 
1.427 (0.157) 
BMI -0.452 0.226 
-1.998 
(0.050) 
-0.192 0.455 
-0.422 (0.674) 
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4.3.4. T-cell Phenotypes and Age-related  ̇      classifications 
 
As age and estimated  ̇      were co-related (r = -0.563; p < 0.001), the impact of age-
related estimated  ̇      classifications on the phenotype characteristics of CD4+ and 
CD8+ T-cells was investigated. All participants were divided into 3 groups using the 
age-adjusted  ̇      classifications provided by the American College of Sports 
Medicine (ACSM) (Whaley et al. 2006). Participants with an age-adjusted  ̇      
ranked from the 10
th
 to the 39
th
 percentiles were classified as “Below Average”, whereas 
participants with an age-adjusted  ̇      ranked from the 40
th
 to the 69
th
 and 70
th
 to the 
99
th
 percentiles were classified as “Average” and “Above Average” respectively. The 
physical characteristics of the participants divided into these groups are presented in 
Table 4.5. Participants among the  ̇      groups did not differ in terms of age (p > 
0.05), although individuals in the below average group had a significantly greater BMI 
and % Body fat (p ˂ 0.05) compared to the other subject groups. However, it was 
already established by linear regression that estimated  ̇      was associated with 
specific T-cell phenotypes even after BMI and % Body fat adjustment (Table 4.4) and 
were therefore not considered to be confounding factors. 
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Table 4.5. Subject’s physical characteristics classified according to their age-adjusted  ̇     . 
Values are mean ± SD. Statistically significant difference from below average indicated by * (p 
<0.05); Statistically significant difference from average indicated by # (p <0.05) 
 VO2max below 
average 
VO2max 
average 
VO2max above 
average 
n  36 25 41 
Age (yrs) 40.7 ± 2.3 40.2 ± 1.9 37.1 ± 1.9 
BMI (kg/m
2
) 28.4 ± 0.6   25.2 ± 0.5 * 23.2 ± 0.4 *# 
% Body Fat 25.5 ± 1  19.4 ± 0.6 * 15.4 ± 0.7 *# 
 ̇      34.4  ± 0.8  43  ± 0.6 * 47.3 ± 0.9 *# 
PA-R 3.6 ± 0.3 5.5 ± 0.2 6.4 ± 0.2 
 
T-cell phenotype comparisons among the three VO2max tertiles are presented in Figure 
4.1. The above average  ̇      tertile had 21.1% and 22.6% less pan-effector-memory 
(KLRG1+) CD8+ T-cells compared to the below average and average tertiles 
respectively (p < 0.05) (Figure 4.1). The proportion of senescent (KLRG1+/CD57+) 
CD4+ T-cells in the above average tertile was 56.3% and 57.8% lower than the average 
and below average tertiles respectively (p < 0.05). The above average tertile had 37% 
less senescent (KLRG1+/CD57+) CD8+ T-cells compared to the average tertile (p < 
0.05), but no differences were found between the below average and above average 
tertiles (p > 0.05). The above average tertile had a 16.4% and 17.5% higher proportion 
of naïve (KLRG1-/CD28+) CD8+ T-cells compared to the average and below average 
tertiles respectively (p < 0.05). Consistent with the regression analysis, no differences 
were found for transitional (CD45RA+/CD45RO+) or memory (KLRG1+/CD28+) T-
cells within CD4+ or CD8+ subsets among the  ̇      classifications (p > 0.05). Fitted 
line plots with individual subject data for proportions of senescent (KLRG1+/CD57+) 
CD4+ and CD8+ T-cells and naïve (KLRG1-/CD28+) CD4+ and CD8+ T-cells in 
97 
 
accordance with age-related  ̇      classification tertiles are presented in Figure. 4.2. A 
below average  ̇      is associated with an increased rate of senescent 
(KLRG1+/CD28-) CD4+ and CD8+ T-cells accumulation with ageing, when compared 
to average and above average  ̇     . Furthermore, the decline in number of naïve 
(KLRG1-/CD28+) CD8+ T-cells is reduced in subjects with above average  ̇      
when compared to subjects with lower  ̇     . 
98 
 
 
Figure 4.1. The percentage of all CD4+ (left column) and CD8+ (right column) T-cells expressing 
surface markers of naïve (KLRG1-/CD28+; CD45RA+/CD45RO-), memory (CD45RA-/CD45RO+), 
transitional (CD45RA+/CD45RO+) and senescent (KLRG1+/CD57+; KLRG1+/CD28-) T-cells 
among the different age-adjusted  ̇      classifications. Values are mean ± SD. Statistically 
significant difference from below average indicated by * (p <0.05); Statistically significant 
difference from average indicated by # (p < 0.05). 
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Figure 4.2. Changes in the percentage of all CD4+ (left column) and CD8+ (right column) T-cells 
expressing surface markers of naïve (KLRG1-/CD28+) and senescent (KLRG1+/CD28-) T-cells as a 
function of age. Changes with age in accordance with  ̇      classification are also shown. 
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4.3.5. Physical Activity Rating (PA-R) and T-cell phenotypes 
 
To determine whether scores of physical activity, as opposed to estimated  ̇     , 
influenced blood T-cell phenotypes, all participants were divided into three groups in 
accordance with their self-reported PA-R following the procedures described by Jackson 
et al. (1990). The results could not be analysed using the multiple regression model 
analysis alone due to the lack of linearity between the PA-R scores. Indeed the 
difference of physical activity level between the PA-R 6 and 7 are much greater than the 
difference of physical activity level between the PA-R 1 and 2.  Those with a score of 1-
2, 3-4 and 5-7 were considered to have a “low PA-R”, “moderate PA-R” and “high PA-
R” respectively. The physical characteristics of the participants divided into these 
groups are presented in Table 4.6. No differences were found among the groups for age, 
however while individuals with a greater PA-R had a lower BMI and % Body Fat (p < 
0.05) than the individuals in the two other groups, the regression model analysis 
established the absence of impact of these factors on the different T-cells subsets.  Those 
with a low PA-R had a 67.8% and 55.7% greater proportion of senescent 
KLRG1+/CD57+ CD4+ T-cells compared to average and high PA-R group respectively 
(p < 0.05). However, despite finding differences in senescent KLRG1+/CD57+ CD8+ T-
cells among the  ̇      groups, no significant differences were found among the three 
PA-R groups for this T-cell subset (p > 0.05). Interestingly individuals with a high PA-R 
had a 33.9% lesser proportion of KLRG1+/CD28- CD8+ T-cells, another senescent 
phenotype compared to individuals with a low PA-R (p ˂ 0.05). Similarly, the 
differences in the proportion of KLRG1-/CD28+ naïve  CD8+ T-cells that were 
associated with estimated  ̇      were not seen among the different PA-R groups (p > 
0.05), instead new statistical differences in the proportions of naïve 
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CD45RA+/CD45RO- CD4+ are being seen among the different PA-R groups (Figure. 
4.3). Individuals with an average PA-R had a 29.9% greater proportion of naïve 
CD45RA+/CD45RO- CD4+ T-cells compared to individuals with a low PA-R (p ˂ 
0.05). Similarly, individuals with an average PA-R had 16% greater proportions of naïve 
CD45RA/CD45RO- CD8+ T-cells than the individuals with a high PA-R (p ˂ 0.05). 
Table 4.6. Subject’s physical characteristics classified according to their PA-R. Values are mean ± 
SD. Statistically significant difference from low PA-R indicated by * (p <0.05); Statistically 
significant difference from medium PA-R indicated by # (p <0.05). 
 Low PA-R Medium PA-R High PA-R 
n  19 28 57 
Age (yrs) 41 ± 3.5 36.4 ± 2.7 39.8 ± 1.4 
BMI (kg/m2) 28.9 ± 0.9  26.4 ± 0.7 * 24.1 ± 0.4 *# 
% Body Fat 25.4 ± 1.5  21.1 ± 1.3 * 17.6 ± 0.7 *# 
 ̇       32.7 ± 1.1  39.4 ± 1.1 * 45.8 ± 0.8 *# 
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Figure 4.3. The percentage of all CD4+ (left column) and CD8+ (right column) T-cells expressing 
surface markers of naïve (KLRG1-/CD28+; CD45RA+/CD45RO-) and senescent (KLRG1+/CD57+; 
KLRG1+/CD28-) T-cells among the different level of physical activity (PA-R). Values are mean ± 
SD. Statistically significant difference from below average indicated by * (p < 0.05); Statistically 
significant difference from average indicated by # (p < 0.05). 
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4.3.6. The Impact of latent CMV, EBV and HSV-1 infections 
 
As the moderating effects of estimated  ̇      on age-associated changes in T-cell 
phenotype may be confounded by latent viral infections, it was important to determine 
the CMV, EBV and HSV-1 serostatus on the Houston subject cohort (n=36). Due to the 
greater prevalence of these viruses with age, subjects were age-matched in accordance 
with their serostatus and compared for physical characteristics and T-cell phenotypes. 
Neither CMV, EBV or HSV-1 serostatus was associated with estimated  ̇     , PA-R, 
BMI or percentage body fat (data not shown; p>0.05).  Latent CMV infection was 
associated with a greater proportion of senescent (KLRG1+/CD57+; 20.2 ± 1.9% versus 
10.9 ± 0.8%) and lower proportion of naïve (KLRG1-/CD28+; 51 ± 3.3% versus 61 ± 
2.2%) CD8+ T-cells compared to the non-infected. Similarly, CMV infection was 
associated with a greater proportion of senescent (KLRG1+/CD57+; 3.4 ± 0.4 % versus 
1.9 ± 0.3 %) CD4+ T-cells. However, the frequencies of naïve (KLRG1-/CD28+; 82.5 ± 
1.3% versus 82.8 ±1.2 %) CD4+ T-cells were not affected by CMV infection. T-cell 
phenotypes were not influenced by latent EBV or HSV-1 infection (data not shown; p > 
0.05). 
 
4.4. Discussion 
 
Increased proportions of effector-memory and senescent T-cells are striking features of 
an ageing immune system and a hallmark of the immune risk profile (IRP). The results 
presented in this study sought to examine for the first time the impact of estimated  
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maximal aerobic capacity ( ̇     ) as a measure of aerobic fitness on the proportions of 
naïve, memory, effector-memory and senescent blood T-cell populations that are known 
to undergo profound age-associated changes. As expected, the proportions of senescent 
CD4+ and CD8+ T-cells increased with advancing age at a respective rate of 10% and 
10.2% per decade. This was accompanied by a per decade reduction in the proportions 
of naïve CD4+ and CD8+ T-cells of 10 % and 9.9 % respectively. Supporting the main 
hypothesis of the study presented in this chapter, we found that those with above 
average  ̇      scores had less senescent CD4+ and CD8+ T-cells and more naïve 
CD8+ T-cells than those with below average  ̇      scores, even after adjusting for age, 
body mass index and percentage body fat. Strikingly, it was found that the well-
accepted association between age and senescent T-cells no longer existed when age was 
adjusted for  ̇     , indicating that aerobic fitness may be a stronger determinant of T-
cell phenotypic shifts than chronological age. This effect was limited to the senescent 
cells as estimated  ̇      was not associated with the memory (KLRG1+/CD28+) cells 
after adjusting for age. Interestingly, a similar effect of high PA-R on the proportions of 
senescent T-cells could not be observed. This can be explained by the lack of linearity 
within the PA-R rating scale, which is likely to have reduced the power of the statistical 
analysis. This is the first study to show that aerobic fitness moderates the natural age-
related accumulation of senescent T-cells in peripheral blood, highlighting the 
beneficial effects of maintaining a physically active lifestyle on the ageing immune 
system.  
 
Increased proportions of effector-memory and senescent T-cells have been found in 
blood due to ageing (Simpson et al. 2008), psychological adverse working conditions 
(Bosch et al. 2009) and persistent viral infections (Thimme et al. 2005). Although 
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recent studies indicate that a sedentary lifestyle promotes biological ageing and 
telomere shortening (Cherkas et al. 2008; Ludlow et al. 2008; LaRocca et al. 2010; 
Song et al. 2010), the study presented in this chapter is the first study to our knowledge 
to report a moderating effect of aerobic fitness on the age-related accumulation of 
senescent T-cells. The results show that, on average, a difference in estimated  ̇      of 
10mlkg-1min-1, which corresponds to a transition from the below average to the above 
average  ̇      category, was associated with a 9.5% difference in the proportion of 
senescent CD8+ T-cells independently of age. As the average proportion of senescent 
CD8+ T-cells was found to increase by 10% per decade, this indicates that aerobic 
fitness could play a major role in shaping the ageing T-cell compartment. Indeed, 
senescent T-cells are known to have critically short telomeres (Olovnikov 1973; 
Karlseder et al. 2002) and have been associated with poor vaccine efficacy, impaired 
immune vigilance and greater morbidity and mortality as a result of infectious disease 
(Wikby et al. 1998). As such, the data presented in this chapter bolsters the intuition that 
regular physical activity may exert preventative and/or rejuvenating properties on the 
ageing immune system by dampening the age-related accumulation of senescent T-cells 
and preventing early transition to the IRP category in later life (Simpson & Guy 2010).  
 
Aerobic fitness also moderated the proportions of naïve CD8+ T-cells, which were 
positively associated with estimated  ̇      scores even after adjusting for age. 
Remarkably, the associations observed between age and naïve and senescent T-cells did 
not withstand adjustment for estimated  ̇     , indicating that ageing may be secondary 
to changes in aerobic fitness at shaping T-cell phenotypic shifts.  This seems plausible 
as  ̇      is also known to decline with age, although not conspicuously so until after 
40yrs of age (Jackson et al. 2009). It is plausible to postulate that maintaining high 
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levels of aerobic fitness during the natural course of ageing may help prevent the 
accumulation of senescent T-cells that have limited antigenic specificity, whilst also 
maintaining adequate numbers of naïve T-cells capable of recognizing and responding 
to novel pathogens.  Moreover, because many of the currently available therapeutic 
interventions (i.e. gene, cytokine, hormone and monoclonal antibody therapy) that have 
been proposed to negate ageing immunity (Greenstein et al. 1987; Kendall et al. 1990; 
Phillips et al. 2004; Rosenberg et al. 2006) are risky and bear a large number of 
undesired side effects and ethical complications, physical exercise could be considered a 
safer alternative strategy to combat age-related immunosenescence. It is acknowledged, 
however, that the presently reported links between estimated  ̇      and T-cell 
phenotypes have been obtained using cross-sectional data and a longitudinal study is 
required to determine if increases in  ̇      are accompanied by changes in the 
proportions of naïve and senescent T-cells.  
 
The impact of estimated  ̇      on the T-cell subsets withstood adjustment for, BMI, 
percentage body fat and waist/hip ratio, suggesting that the moderating effects of 
estimated  ̇      were not secondary to differences in body composition. However, 
previous studies have documented negative associations linking BMI, % Body fat, and 
biological markers of adiposity such as leptin with leukocyte telomere length  (Valdes et 
al. 2005; Lee et al. 2010) and reduced thymic output (Yang et al. 2009). Although the 
measures of adiposity presented in this study were not related with immunosenescence, 
this was not surprising as very few subjects (7%) in the present cohort were classified as 
obese (BMI > 30 kg/m
2
) as the aim of the study presented in this chapter was to 
determine the association of aerobic fitness on blood T-cell phenotypes independently 
of BMI and % Body fat, which are known confounders. It remains possible, and very 
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likely, therefore, that excess adiposity will be related with increased senescent blood T-
cells when more severe classifications of obesity are examined. Indeed, BMI was 
marginally associated with the proportions of memory (KLRG1+/CD28+) CD4+ T-cells 
and senescent (KLRG1+/CD57+) CD8+ T-cells after age and estimated  ̇      
adjustment.  
  
The mechanisms by which regular exercise exerts positive effects on the ageing immune 
system remain to be established. It has been suggested that the beneficial effects of 
exercise may come from either prevention and/or rejuvenation perspectives (Simpson & 
Guy 2010). Firstly, from a prevention standpoint, exercise may elicit secondary effects 
on the immune system due to its well-known stress reducing properties (Salmon 2001), 
thus limiting the potential for stress-induced latent viral reactivation and telomere 
erosion. Secondly, from a rejuvenation standpoint, regular exercise may lead to the 
destruction of excess viral specific T-cell clones via apoptosis, freeing up “immune 
space” for naïve T-cells to occupy and expand the antigenic T-cell repertoire (Simpson 
2011). Furthermore, it was shown recently that exercise elicits Interleukin-7 release 
from active skeletal muscle (Haugen et al. 2010). This cytokine is known to play an 
important role in naïve T-cell homeostasis and the output of recent thymic emigrants 
(Schluns et al. 2000) and may therefore be involved in the aetiology of exercise-induced 
immune enhancement.  
 
As latent herpesvirus infections, particularly CMV, are associated with a greater number 
and proportion of senescent T-cells (Ouyang et al. 2004), CMV, EBV and HSV-1 
serostatus were considered as potential confounders of the moderating effects of 
estimated  ̇     . Although CMV, but not EBV or HSV-1, serpositivity was associated 
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with a greater proportion of senescent CD4+ and CD8+ T-cells, none of these latent 
viruses influenced  ̇      scores.  It is therefore possible to consider estimated  ̇      
to be associated with blood T-cell phenotypes independently of these persistent viral 
infections.   It is acknowledged, however, that the sample size used for the serostatus 
determination was relatively small and the possibility that relationships exist between 
aerobic fitness and latent viral infections cannot be ruled out if a larger cohort is 
examined. Furthermore, another limitation lies in the  ̇      determination. Indeed to 
limit the physical stress to be endured by the older volunteers, individuals’  ̇      were 
estimated from a submaximal cycling protocol. Although the protocol created by 
Astrand et al. (196) has been validated and used by the scientific community for the past 
50 years, and although a validated non-exercise questionnaire (Jackson et al. 1990) was 
also used to compare the estimated  ̇      value obtained by the cycling protocol 
(Pearson’s R = 0.88), small inaccuracies could have occurred. It is however important to 
highlight that such inaccuracies would have been more likely to happen in an athletic 
population, than in the normal population of subject used. Additional limitations of the 
present study include the non-inclusion of women and the elderly (i.e. over 65yrs), and, 
because the subject recruited to be part of the study presented in this chapter was limited 
to students and members of academic staff at institutions of higher education, 
participants of lower socioeconomic standing were less likely to be recruited and may 
explain why estimated  ̇      was not related to latent viral infections in our study.  
 
In conclusion, aerobic fitness is associated with a lower proportion of senescent and a 
higher proportion of naïve cells, particularly within the CD8+ T-cell compartment in 
healthy adult men. These findings withstood adjustment for a number of potential 
confounders (i.e. age, BMI, % body fat, latent viral infections) indicating that high 
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levels of aerobic fitness could independently exert protective effects on the ageing 
immune system. Future longitudinal studies are required to determine if changes in 
 ̇      due to exercise training will be accompanied by changes in the composition of 
naïve and senescent T-cells. It will be of particular interest to determine if exercise can 
improve immunity in those displaying biomarkers associated with the IRP, as this 
would help to establish if regular exercise has immune restorative properties. 
Furthermore, the results presented in this chapter were obtained on a relatively lean 
cohort (less than 7% of the subjects had a BMI above 30 kg/m
2
), potentially explaining 
the lack of confounding effect of BMI and % Body fat on the T-cell repertoire. The 
plausible implication of excess body mass and adiposity on the accumulation of 
senescent T-cells and the premature onset of immunosenescence is consequently 
required to be further investigated in an age-controlled obese population.  
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CHAPTER 5 
THE IMPACT OF CHILDHOOD OBESITY AND 
PERSISTENT VIRAL INFECTION ON THE T-CELL 
DIFFERENTIATION ASSOCIATED WITH 
IMMUNOSENESCENCE 
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5.1. Introduction 
Reduced physical activity and sustained excessive energy intake, amongst other obesity-
related behavior and genetic factors, have led to the fast increasing number of 
overweight and obese adults observed in both industrialized and developing countries 
(Mokdad et al. 2001; Deitel 2003; Chaput & Tremblay 2009). This is not limited to 
adults as childhood obesity has more than tripled in the past 25 years, rising from 5% of 
the 12-19 years old who were obese in 1980 to 18% in 2008 (Skelton et al. 2009). 
Alarmingly, the proportion of overweight adolescents in the United States is even 
greater, with almost a third of the 12-19 years old (31.7%) with an excess body mass 
(Ogden et al. 2010). Childhood obesity affects adolescents of various socio-economical 
status and ethnicities, with the greatest prevalence of obesity observed amongst Afro-
Americans and Mexican-Americans (Skelton et al. 2009) of low socio-economical 
status (Strauss & Pollack 2001). The wide-ranging detrimental effect of adult obesity on 
health have been well-documented (Zimmet et al. 2001; Poirier et al. 2006; Su et al. 
2011), raising concerns on the impact of childhood obesity on health. 
The development of childhood obesity has been linked with the apparition amongst 
teenagers of disease formerly affecting adults, such as type 2 diabetes mellitus 
(American Diabetes Association 2000; Daniels et al. 2005) and metabolic syndrome 
(Cook et al. 2003). Moreover, in addition to direct health effect, childhood obesity has 
long-term effects on adult health. Indeed, it has been shown to predispose to adult 
obesity (Guo & Chumlea 1999; Freedman et al. 2005), and could consequently fasten 
the onset of obesity-related disorders in later life. This is supported by evidence linking 
childhood obesity with lasting detrimental cardiac structural changes, sleep apnea, and 
thromboembolic disease in adults (Dhuper et al. 2011), but also psychological disorders 
such as depression and poor quality of life (Pine et al. 2001; Strauss & Pollack 2003). 
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Similarly to adult obesity, childhood obesity appears to promote a pro-inflammatory 
state with increased levels of circulating C-reactive protein and pro-inflammatory 
cytokines such as TNF-α and IL-6 (Giordano et al. 2011) concomitant with reduced 
levels of circulating anti-inflammatory cytokines such as IL-10 (Arslan et al. 2010).  
The persistent pro-inflammatory state and the resulting increased oxidative stress and 
reactive oxygen species formation seen in obese adolescents could potentially induce 
DNA damage and lead to replicative senescence (von Zglinicki et al. 2000a; Chen et al. 
2001; von Zglinicki et al. 2001; von Zglinicki 2002). The results detailed in Chapter 4 
suggest that a lack of physical activity precipitates the onset of immune senescence and 
the accumulation of dysfunctional senescent T-cells in adults, in addition to promoting 
obesity. Consequently, the early emergence of obesity and obese-related behaviors such 
as reduced physical activity could accelerate the development of immune senescence in 
teenagers, in turn aggravating the proportions of senescent T-cells in later life. Although 
the results presented in Chapter 4 failed to show an impact of BMI and body fat 
composition on the proportions of senescent cells in healthy non-obese adults, it is 
plausible to hypothesize that these factors would enhance immune senescence in obese 
adults and to lesser extent obese adolescents. 
Other indirect mechanisms have been proposed as potential sources for the chronic pro-
inflammatory state seen in obese patients. Although controversial results exist in the 
literature, one of these factors is believed to be the elevated serum concentration of 
adipocytes-derived hormones such as leptin (Loffreda et al. 1998; Hukshorn et al. 
2004). Indeed reductions in serum leptin concentrations as observed during weight loss 
intervention in middle-aged women, have led to the concurrent reduction in obesity-
associated pro-inflammatory cytokines concentrations (Rosenbaum et al. 1997; Ziccardi 
et al. 2002). There is however no study to our knowledge, analyzing the impact of leptin 
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concentrations on the proportions of senescent and highly differentiated T-cells in 
adolescent.  
Enhanced T-cell activation and proliferation are a consequence of repeated antigenic 
stimulation, as seen in the context of latent viral reactivations. Indeed recurring 
activations of the prevalent latent herpes viruses Cytomegalovirus (CMV) and Epstein-
Barr virus (EBV) are believed to induce immune cell division leading to the premature 
terminal differentiation of T-cells. Although CMV and EBV seropositivity are 
hallmarks of the “immune risk profile” and are known to influence the proportions of 
terminally differentiated T-cells and increase infection risk in adults (Wikby et al. 2002; 
Wikby A. 2003; Koch et al. 2007), it is not known if CMV or EBV infections impact on 
the proportions of these cells in a young subject cohort. We decided to measure latent 
viral infections as a potential cofounding variable to the impact of obesity and the 
subsequent circulating serum leptin on the T-cell subsets.  
The accumulation of effector-memory and senescent/exhausted T-cells, along with 
CMV and EBV infections, are part of the immune risk profile and have been shown to 
partially predict morbidity and mortality in the elderly (Wikby et al. 2002; Wikby A. 
2003). However the exact mechanisms and factors driving immune senescence remain 
unclear and the influence of normal chronological ageing on the accumulation of 
senescent T-cells needs to be isolated from other potential causes. No study to date has 
examined the impact of obesity on the different T-cell subsets, and although obesity is 
believed to accelerate the onset of immunosenescence, further studies are required. The 
aim of the study presented in this chapter was to examine relationships between 
adiposity and plasma leptin concentrations and the proportions of blood T-cell subsets 
in a population of Mexican-American adolescents, while adjusting for potential 
confounding factors such as latent CMV and EBV infections and quality of life.  It was 
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hypothesized that increasing age- and sex-adjusted body mass and plasma leptin 
concentration would be positively associated with the proportions of 
senescent/exhausted CD8+ T-cells in peripheral blood independently of latent viral 
status.  
 
5.2. Materials and Methods 
 
5.2.1. Subjects 
 
All subjects for this study were recruited by Dr. John P. Foreyt and Craig A. Johnston 
(Baylor College of Medicine). A total of 123 Mexican-American children (67 females) 
aged 10 to 14 (mean 12.3 ± 0.7 years) volunteered for this study. Subjects were 
recruited from an urban charter school in the city of Houston, with a 95% prevalence of 
Mexican-Americans. The physical characteristics of the participants are presented in 
Table 5.1.  Intravenous blood samples were drawn as described in the general materials 
and methods Chapter 3.3. None of the subjects were on any medication, and were free 
of any infectious illness for 6 weeks prior to the study. Prior to the inclusion of their 
child in the study, parents signed a written consent form on behalf of their child along 
with a written assent provided by the subjects. Ethical approval was granted by the 
Institutional Review Board for Human Subjects at Baylor College of Medicine. 
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Table 5.1. Physical characteristics of the participants (mean ± SD) 
 
5.2.2. Anthropometric measurements 
 
Body weight and height were obtained using a digital scale and a stadiometer 
respectively. Percentage of body fat was assessed by measuring the subcutaneous fat 
over the right triceps muscle equidistant between the acromion and the olecranon 
(Jackson et al. 1978). Measurements were made in triplicates on all subjects by an 
individual technician from Baylor College of Medicine to ensure inter-measurements 
reliability. Childhood obesity characterization diverges from the classical diagnosis of 
adult obesity as a consequence of the continuing skeletal and muscular development of 
the child or adolescent. The use of age-matched and sex-matched Body Mass Index 
(BMI) percentile along with the transformation of BMI into a standardized score 
(zBMI) are consequently preferred to the use of traditional BMI (Ogden et al. 2002). 
Weight classifications were determined using the Center for Disease Control guidelines 
growth charts (Centers for Disease Control and Prevention 2000). Subjects were 
classified as obese when their BMI was at or above the 95
th
 percentile, and at risk of 
obesity when their BMI was comprised between the 86
th
 to the 94
th
 percentile. A BMI 
  Mean Standard 
deviation 
Range 
Age (yrs) 12.3 ± 0.7 10.8 – 14.7 
Body Mass (kg) 52.5 ± 14.5 30.1 – 115.2 
BMI (kg/m
2
) 22.6 ± 5.3  14.3 – 41.9 
zBMI 0.9 ± 1.1 -2.2 – 2.7 
BMI percentile 73.0 ± 27.6 1.4 – 99.7 
% Body Fat 26.5 ± 11.1 6.2 – 63.6 
Serum Leptin (ng.mL
-1
) 27.2 ± 22.0 3.7 - 113.9 
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below the 85
th
 percentile and above the 5
th
 percentile was considered as appropriate 
weight. The use of the 85
th
 percentile as a cut-off value was supported by studies linking 
the 85
th
 percentile with adult obesity and obesity-related health disorders (Reilly 2005). 
 
5.2.3. Lifestyle Scores 
 
Socio-economical status and quality of life are known to impact chronic-health 
conditions in both adults and children (Eiser 2004; Poterico et al. 2011; Pudrovska & 
Anikputa 2011). In order to assess the impact of health-related quality of life of the 
volunteers on the proportions of the different T-cell subsets the subjects were asked to 
fill the Pediatric Quality of Life Inventory (PedsQL 4.0) (Pediatric Quality of Life 
Inventory™). Physical health scores along with Psychosocial health scores and total 
quality of life scores were obtained from the self-reported itemized questionnaire. Items 
were graded on a 5-points scale, from 0 corresponding to “never a problem” to 4 
“always almost a problem”. Finally, items were reverse-scored and lineary transformed 
to a 0-100 scale where higher scores attest of a greater health related quality of life 
(Varni et al. 2006). 
 
5.2.4. Serum Leptin and viral antibodies titration 
 
Serum leptin concentrations were measured in freshly thawed serum samples, using 
enzyme-linked immunosorbent assays (Invitrogen, Carlsbad, California, USA). 
Measures were done in duplicate, according to the manufacturer’s guidelines. Anti-
CMV and anti-EBV antibody titers were determined as described in the general 
materials and methods Chapter 3.4. 
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5.2.5. PBMC isolation 
 
Mononuclear cells were isolated from freshly drawn peripheral blood as per the general 
materials and methods Chapter 3.3. 
 
5.2.6. Flow Cytometric analysis 
 
Isolated mononuclear cells were labeled with a combination of four antibodies including 
anti-CD28 FITC, anti-CD45RA FITC, anti-CD27 PE, anti-CD57 PE, anti-CCR7 PE, 
anti-CD3 APC, and either with anti-CD4 PEcy5.5 or anti-CD8 PEcy5.5 depending on 
the cell population of interest as described in general materials and methods Chapter 
3.5.6, Table 3.2. The exact combinations used to detect the different cell types are 
presented in Table 5.2. Once labeled, flow cytometric analysis was performed using an 
Accuri C6 flow Cytometer in combination with Cflow software.   
Table 5.2. Combination of monoclonal antibodies used in the characterization of the different T-cell 
phenotypes 
 
5.2.7. Statistical analysis 
 
All data were assessed for assumptions of normality using the Shapiro-Wilk test and 
constant error variance prior to formal statistical testing. Chi Square tests were used to 
Tube FL-1 FL-2 FL-3 FL-4 T-cell phenotypes T-cell subtypes 
1 CD28 CD27 CD4 CD3 CD28+/CD27+ 
CD28-/CD27+ 
CD28-/CD27- 
Early dif.  
Intermediate dif. 
Late dif. 
2 CD28 CD27 CD8 CD3 
3 CD28 CD57 CD4 CD3 
CD28+/CD57- Senescent 
4 CD28 CD57 CD8 CD3 
5 CD45RA CCR7 CD4 CD3 CD45RA+/CCR7+ 
CD45RA-/CCR7+ 
CD45RA-/CCR7- 
CD45RA+/CCR7- 
Naïve 
Central-memory 
Effector-memory 
TEMRA 
6 CD45RA CCR7 CD8 CD3 
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determine the impact of weight classification on both gender and viral status; while its 
impact on the participant’s physical characteristics were determined using a one-way 
ANOVA. As normalization of some skewed cell-surface phenotypic data were not 
obtainable by numerical transformation, the Kruskal-Wallis non-parametric test was 
used to determine the impact of weight classification on the proportions of the different 
T-cell subsets. When a significant impact of the weight classification on the proportions 
of a T-cell subset was observed, further non-parametric post-hoc pairwise group 
comparisons were performed as suggested by Sprent and Smeeton (Sprent 2001).   
Generalized linear model were used to detect potential impacts of the different variables 
on the proportions of T-cell subsets. By creating fractional logit model, initial univariate 
associations between each individual variable and the proportions of the different T-cell 
subsets in accordance with Table 3.2 were analysed. All the variables being shown to 
have a significant effect on the T-cell repertoire were included in multivariate models to 
evaluate their independent impact on the proportion of T-cell subsets while adjusting for 
the other significant factors. The effects size of each variable on the T-cell subsets were 
reported as an average change in T-cell proportions for a single-unit change of the 
independent variable.   
Statistical significance was set at P < 0.05. All values are presented as the mean ± 
Standard Error of the mean (SEM). All statistical analyses were performed using 
“Statistical Package for the Social Sciences” (SPSS v17.0, Chicago, IL, USA).  
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5.3. Results 
 
The physical characteristics of all subjects are presented in Table 5.3. Physical 
characteristic differences were seen amongst the weight groups (p < 0.001), however no 
significant differences in age or PEDS QL scores were observed amongst the three 
categories (p > 0.05). No statistical differences in CMV or EBV seroprevalence 
amongst the different weight classifications were seen (χ2CMV (2) =1.346, p ˃ 0.05; Chi 
χ2 EBV (2) = 3.110; p ˃ 0.05).  Male and Female subjects were equally distributed within 
the different weight classifications (χ2 (1) = 1.180; p ˃ 0.05) and no statistical difference 
in CMV or EBV seroprevalence were seen between Male and Female subjects. 
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Table 5.3. Physical characteristics of the participants in relation to their weight classifications 
(mean ± SEM). Significant differences from the appropriate weight classification (* p<0.001) and 
the obese classification (# p<0.01). 
 
5.3.1. Univariate associations between the different factors and the T-cell subsets 
 
We sought to determine the associations between the different factors presented in 
Table 5.3 and the proportions of different T-cell subsets. Although we hypothesized that 
excess body mass, and consequently high circulating serum leptin, would be associated 
with increased proportions of senescent T-cells in adolescents, other factors such as 
gender, age or latent viral infection could play a role in the development of premature 
immune senescence. The independent effect of single variables on the proportions of the 
different T-cell subsets was analysed before creating multivariate models where the 
  All Subjects 
(n=123) 
Appropriate 
Weight (n=65) 
At risk of 
obesity (n=22) 
Obese (n=36) 
Age (yrs) 12.3 ± 0.7 12.4 ± 0.7 12.2 ± 0.6  12.1 ± 0.6 
Female frequency (%) 54 % 58.5 % 54.5 % 47.2 % 
Body Mass (kg) 52.5 ± 14.5 43.1 ± 7.3 
#
 54.5 ± 6.7 * 
#
 69.0 ± 12.7 
BMI (kg/m
2
) 22.6 ± 5.3 18.7 ± 1.9 
#
 23.3 ± 1.0 * 
#
   29.2 ± 4.2 
zBMI 0.9 ± 1.1 0.1 ± 0.7 
#
 1.4 ± 0.1 * 
#
 2.1 ± 0.3 
BMI percentile 73.0 ± 27.6 53.5 ± 24.6 
#
 91.3 ± 2.3 *  97.7 ± 1.4 
% Body Fat 26.5 ± 11.1 19.6 ± 6.8 
#
 27.9 ± 6.8 * 
#
 38.6 ± 10.2 
% Overweight 24.5 ± 29.7 2.7 ± 10.4 
#
 28.8 ± 4.5 * 
#
 62.4 ± 22.7 
Serum Leptin (ng.mL
-1
) 27.0 ± 22.0 15.4 ± 7.7 
#
 24.5 ± 11.5 
#
  49.5 ± 26.8 
CMV seropositivity 27.4 % 28.6 % 29.4 % 18.2 % 
EBV seropositivity 50.9 % 47.3 % 35.3 % 60.6 % 
PEDS QL Physical health score 86.7 ± 16.3 87.8 ± 16.2 88.8 ± 12.4 83.4 ± 18.1 
PEDS QL Psychosocial health score 80.6 ± 19.3 82.0 ± 23.0 79.9 ± 15.2 78.8 ± 13.9 
PEDS QL Total score 82.8 ± 20.1 83.9 ± 23.0 83.0 ± 13.2 80.5 ± 18.0 
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impact of each significant individual variable on the T-cell proportions was controlled 
for the other variables. The effects of the following variables on the T-cell subsets were 
assessed independently: Gender, CMV status, CMV titer, EBV status, EBV titer, 
Weight classification, Leptin concentration, Age, zBMI, Body composition (ie. % Body 
Fat), PEDS QL Physical health, PEDS QL Psychological health, PEDS QL Total score). 
The variables shown to have a significant effect (p ˂ 0.05) or an effect close to 
significance (p ˂ 0.10) on the proportions of early, intermediate, late and senescent 
CD4+ and CD8+ T-cell subsets are presented on Tables 5.4 and 5.5. 
 
5.3.1.1. Naïve and Early differentiated T-cells 
 
The univariate effects of the different variables on the naïve and early differentiated T-
cell subsets are presented in the Table 5.4 and 5.5 respectively. As previously discussed, 
the univariate analysis shows an effect of weight classification on the naïve or early 
differentiated T-cell proportions. Subjects at risk of obesity had less naïve CD8+ T-cells 
(-4.08 %, p = 0.05) than the subjects with an appropriate weight (Table 5.4.) Obese 
subjects have in average 4.01 % less early differentiated (p = 0.05) CD4+ T-cells than 
subjects with an appropriate weight. Furthermore, obese subjects also had less early 
differentiated CD8+ T-cells (-7.60 %, p ˂ 0.05) than subject with an appropriate weight. 
Subjects at risk of obesity had less early differentiated (-12.05 %, p = 0.001) CD8+ T-
cells than the subjects with an appropriate weight (Table 5.5).  
Latent viral infections were also associated with lower proportions of naïve or early 
differentiated T-cells. CMV seropositivity was associated with a lower proportions of 
naïve CD8+ T-cells (-6.13 %, p ˂ 0.05) (Table 5.4.) and EBV seropositivity was 
associated with a lower proportions of early differentiated CD8+ T-cells (-5.93 %, p ˂ 
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0.05) (Table 5.5). Similarly, a difference of 1-unit in anti-CMV antibody titer was 
inversely associated with the proportions of naïve (-3.63 %, p ˂ 0.05) and early 
differentiated (-5.29 %, p ˂ 0.01) CD8+ T-cells (Table 5.4. and Table 5.5).   
The univariate analysis also showed that female subjects have significantly higher 
proportions of naïve and early differentiated (CD28+/CD27+, CD28+/CD57- and 
CD45RA+/CCR7+) CD8+ T-cells than males (+6.54 %, p ˂ 0.05 and +7.78 %, p ˂ 0.01 
respectively) (Table 5.4 and Table 5.5).  
 
5.3.1.2. Central-memory, Effector-memory and intermediate differentiated T-
cells 
 
The univariate effects of the different variables on the central-memory, effector-
memory and intermediate differentiated T-cell subsets are presented in the Table 5.4 
and Table 5.5. 
Body weight also appeared to have an impact on the proportions of memory T-cells. 
Obese subjects had a significantly greater proportion of effector-memory (+3.37 %, p ˂ 
0.05) and intermediate differentiated (+4.51 %, p ˂ 0.001) CD8+ T-cells than subjects 
with an appropriate weight (Table 5.4 and 5.5 respectively). Subjects at risk of obesity 
also exhibited an increased proportions of effector-memory CD8+ T-cells (+6.04 %, p ˂ 
0.001) when compared to subjects with an appropriate weight. In addition, body 
composition, in the form of an increase in 1% of Body fat, was also associated with a 
modest but significantly greater proportion of effector-memory (+0.17%, p ˂ 0.05) 
CD4+ T-cells, along with intermediate differentiated CD8+ T-cells (+0.06 %, p ˂ 0.01). 
Finally an increase of 1-unit in zBMI was significantly associated with an increase in 
intermediate differentiated CD8+ T-cells (+ 1.66%, p ˂ 0.01) and non-significantly 
123 
 
associated with an increase in effector-memory CD4+ and CD8+ T-cells (+1.49%, p = 
0.071 and +1.15 %, p= 0.083 respectively) (Table 5.4 and 5.5). 
Similarly to the association between CMV seropositivity and naïve CD8+ T-cells, latent 
CMV infection was associated with reduced proportions of intermediate differentiated 
CD8+ T-cells. Indeed, CMV seropositive subjects had an average of 3.64% (p ˂ 0.05) 
less intermediate differentiated CD8+ T-cells than non-infected subjects (Table 5.5). 
Finally, a yearly age-increase was positively associated with the proportions of central-
memory CD8+ T-cells (+4.47 %, p ˂ 0.001) (Table 5.4). 
 
5.3.1.3. Late differentiated, TEMRA and senescent T-cells 
 
The univariate effects of the different variables on the late differentiated, TEMRA and 
senescent T-cell subsets are presented in the Table 5.4 and 5.5. Increasing body mass 
had an effect on the proportions of senescent and late differentiated T-cell subsets. 
Indeed obese subjects had in average 0.97 % and 2.00 % more senescent (p ˂ 0.05) and 
late differentiated (p ˂ 0.01) CD4+ T-cells respectively than subjects with an 
appropriate weight (Table 5.4 and 5.5). Subjects at risk of obesity also had higher 
proportions of senescent and late differentiated CD8+ T-cells (+5.42 %, p ˂ 0.05 and 
+10.10%, p ˂ 0.01 respectively). CMV seropositivity was also associated with the 
greater proportions of TEMRA and senescent T-cells. CMV seropositive subjects had in 
average 5.42 % more senescent CD8+ T-cells (p ˂ 0.05) and 5.70 % more TEMRA 
CD8+ T-cells (p ˂ 0.05) when compared to their seronegative counterpart. The 
univariate analysis highlighted sex-associated differences in TEMRA and senescent T-
cell proportions. Female subjects had in average 5.16 % (p ˂ 0.01) less senescent CD8+ 
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T-cells and 4.80 % (p ˂ 0.05) less TEMRA CD8+ T-cells than males (Table 5.4 and 
5.5).   
Table 5.4. Univariate Associations: Unadjusted direct relation between the different factors and the 
proportions of T-cell subsets. 
T-cell subtype Factors Effect 
Size* 
p value 
Naïve CD4+ 
(CD45RA+/CCR7+) 
EBV status (Positive) 
Age 
-4.09 % 
-3.54 % 
0.100 
0.050 
Naïve CD8+ 
(CD45RA+/CCR7+) 
Gender (Female) 
CMV status (Positive) 
At risk  
CMV titer 
+6.35 % 
-6.13 % 
-4.09 % 
-3.63 % 
0.024 
0.049 
0.050 
0.050 
Central-memory CD4+ 
(CD45RA-/CCR7+) 
PEDS QL Psychological 
health score 
PEDS QL Total score 
 
-0.09 % 
-0.11 % 
 
0.075 
0.061 
Central-memory CD8+ 
(CD45RA-/CCR7+) 
Age +4.47 % 0.000 
Effector-memory CD4+ 
(CD45RA-/CCR7-) 
Age 
zBMI 
% Body Fat 
+4.89 % 
+1.49 % 
+0.17 % 
0.000 
0.071 
0.029 
Effector-memory CD8+ 
(CD45RA-/CCR7-) 
At risk of obesity 
Obese 
Age 
zBMI 
+6.04 % 
+3.37 % 
-1.73 % 
+1.14 % 
0.001 
0.025 
0.090 
0.083 
TEMRA CD4+ 
(CD45RA+/CCR7-) 
None -- -- 
TEMRA CD8+ 
(CD45RA+/CCR7-) 
Gender (Female) 
CMV status (Positive) 
CMV titer 
Age 
-4.80 % 
+5.70 % 
+3.13 % 
-4.58 % 
0.041 
0.031 
0.045 
0.007 
*Effect size is the average difference (+/-) in % of the phenotype for a 1-unit difference in the respective 
factor. 
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Table 5.5. Univariate Associations: Unadjusted direct relation between the different factors and the 
proportions of T-cell subsets. 
T-cell subtype Factors Effect Size* p value 
 
Early Differentiated CD4+ 
(CD28+/CD27+) 
At risk  
Obese 
zBMI 
% Body Fat 
-4.43 % 
-4.01 % 
-1.80 % 
-0.15 % 
0.084 
0.050 
0.038 
0.083 
Early Differentiated CD8+ 
(CD28+/CD27+) 
Gender (Female) 
CMV status (Positive) 
EBV status (Positive) 
At risk of obesity 
Obese 
CMV titer 
zBMI 
+7.78 % 
-5.24 % 
-5.93 % 
-12.05 % 
-7.60 % 
-5.29 % 
-3.46 % 
0.004 
0.098 
0.031 
0.001 
0.011 
0.006 
0.008 
Intermediate Differentiated 
CD4+ 
(CD28-/CD27+) 
None -- -- 
Intermediate Differentiated 
CD8+ 
(CD28-/CD27+) 
CMV status (Positive) 
Obese 
CMV titer 
Leptin Concentration 
Age 
zBMI 
% Body Fat 
-3.64 % 
+4.51 % 
-1.76 % 
+0.05 % 
-4.16 % 
+1.66 % 
+0.06 % 
0.013 
0.001 
0.053 
0.094 
0.000 
0.006 
0.004 
Late Differentiated CD4+ 
(CD28-/CD27-) 
At risk of obesity 
Obese 
CMV titer 
zBMI 
% Body Fat 
+1.95 % 
+2.00 % 
+1.21 % 
+0.66 % 
+0.05 % 
0.020 
0.003 
0.022 
0.023 
0.068 
Late Differentiated CD8+ 
(CD28-/CD27-) 
Gender (Female) 
CMV status (Positive) 
At risk of obesity 
CMV titer 
Age 
-6.23 % 
+5.61 % 
+10.10 % 
+5.02 % 
-3.77 % 
0.012 
0.049 
0.003 
0.000 
0.040 
Senescent CD4+ 
(CD28-/CD57+) 
At risk of obesity 
Obese 
CMV titer 
+0.97 % 
+0.97 % 
+0.53 % 
0.096 
0.037 
0.073 
 
 
Senescent CD8+ 
(CD28-/C57+) 
Gender (Female) 
CMV status (Positive) 
At risk of obesity 
CMV titer 
EBV titer 
Age 
-5.16 % 
+4.41 % 
+5.42 % 
+3.75 % 
+1.56 % 
-2.96 % 
0.005 
0.037 
0.038 
0.003 
0.086 
0.030 
*Effect size is the average difference (+/-) in % of the phenotype for a 1-unit difference in the respective 
factor.  
 
When variables were shown to have a significant effect on the T-cell repertoire, they 
were included in multivariate generalized linear model analysis for proportional 
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dependent variables, creating fractional logit models and thus controlling each 
significant factor for the other variables in the model. 
 
5.3.2. Multivariate associations between the different factors and the T-cell subsets. 
 
5.3.2.1. Naïve and Early differentiated T-cells 
 
When multiple variables were shown to have a significant effect on T-cell proportions 
in the univariate analysis, they were included in multivariate models to control for 
potential confounding effects and to characterise the effect of each variable, 
independently from the other significant variables. The independent effects of the 
different variables on the proportions of naïve and early differentiated T-cells are 
presented on the Table 5.6 and 5.7. When controlled for all other significant variables, 
subjects at risk of obesity still had on average 8.81% less early differentiated CD8+ T-
cells (p ˂ 0.05) than subjects with an appropriate weight, however obese subjects and 
subjects with an appropriate weight appeared to have similar proportions of cells with 
this phenotype (p ˃ 0.05) (Table 5.7). Subjects infected with EBV also had less early 
differentiated CD8+ T-cells (-5.76 %, p ˂ 0.05) than seronegative subjects (Table 5.7) 
and similar non-significant trends were observed between EBV seropositivity and the 
proportions of naïve CD4+ T-cells (-4.03 %, p = 0.093) (Table 5.6). While CMV 
seropositivity was not associated with the proportions of early differentiated CD8+ T-
cells when controlled for the other factors, anti-CMV antibodies titer within the CMV 
seropositive subjects was negatively associated with the proportions of early 
differentiated CD8+ T-cells (-3.86 %, p ˂ 0.05) (Table 5.7). Gender was still associated 
with the proportions of naïve and early differentiated CD8+ T-cells when controlled for 
all the other variables. Female subjects had an average of 5.31 % (p ˂ 0.05) more naïve 
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CD8+ T-cells and 6.87 % (p ˂ 0.01) more early differentiated CD8+ T-cells than male 
subjects. Naïve T-cell proportions were also associated with age. Yearly increase in age 
was associated with an average decrease of 3.50 % (p ˂ 0.05) naïve CD4+ T-cells as 
expected (Table 5.6). While Weight classification, zBMI and Body composition were 
shown to have significant effect on the early differentiated CD4+ T-cell proportions in 
the univariate analysis, they did not have an effect when controlled for eachother, 
suggesting confounding effects of among those factors (Table 5.7). 
 
5.3.2.2. Central-memory, Effector-memory and intermediate differentiated T-
cells 
 
The independent effects of the different variables on the proportions of central-memory, 
effector-memory and intermediate differentiated T-cells are presented on the Table 5.6 
and 5.7. Age-adjusted body mass was associated with greater proportions of effector-
memory CD8+ T-cells as subjects at risk of obesity and obese subjects had on average 
7.53 % (p ˂ 0.001) and 5.49 % (p ˂ 0.05) more effector-memory CD8+ T-cells 
respectively than subjects with an appropriate weight (Table 5.6). When controlled for 
the other variables, body weight classification was not associated with the proportions 
of intermediate differentiated CD8+ T-cells (p ˃ 0.05) (Table 5.7). A significant 
positive effect of body composition, characterised by variable-adjusted percentage body 
fat was found for proportions of effector-memory CD4+ T-cells (+0.21 %, p ˂ 0.01 
respectively) (Table 5.6). 
 Subjects with CMV infections had an average of 3.11% (p ˂ 0.05) less intermediate 
differentiated CD8+ T-cells than their infection-free counterparts (Table 5.7). After 
controlling for the individual effects of CMV status and anti-CMV antibodies titer, age 
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was also shown to be negatively associated with the proportions of intermediate 
differentiated CD8+ T-cells (-3.81 %, p ˂ 0.001) (Table 5.7). A yearly increase was 
however associated with 5.29% more effector-memory CD4+T-cells (p ˂ 0.001) (Table 
5.6). 
5.3.2.3. Late differentiated, TEMRA and senescent T-cells 
 
The independent effects of the different variables on the proportions of late 
differentiated, TEMRA and senescent T-cell proportions are presented on the Table 5.6 
and 5.7. Subjects at risk of obesity and obese subjects had more late differentiated 
CD4+ T-cells (+2.27 %, p ˂ 0.05 and +2.60%, p ˂ 0.05 respectively) than subjects with 
an appropriate weight. The impact of weight classification was also seen on the 
proportions of late differentiated CD8+ T-cells and senescent CD4+ T-cells. Indeed 
subjects at risk of obesity had in average 8.72% more senescent cells than subjects with 
an appropriate weight (p ˂ 0.01) and obese subjects exhibited increased proportions of 
0.98 % senescent CD4+ T-cells (p ˂ 0.05) when compared to subjects with an 
appropriate weight (Table 5.7). 
Anti-CMV antibody titers within the CMV seropositive subject group were associated 
with increased proportions of senescent CD4+ (+0.52 %, p ˂ 0.05) and CD8+ T-cells 
(+4.58 %, p ˂ 0.05) along with increased proportions of late differentiated CD8+ T-cells 
(+ 7.13 %. p ˂ 0.05). Similarly, an increase in 1-unit of anti-EBV antibody titer was 
associated with an increase of 1.73 % of senescent CD8+ T-cells (p ˂ 0.05) after 
controlling for the other significant variables (Table 5.7). Female subjects had 
consistently less senescent and late differentiated CD8+ T-cells (-5.40 %, p ˂ 0.01 and -
5.13 %, p ˂ 0.05 respectively) (Table 5.7) and less TEMRA CD8+ T-cells (-4.63 %, p ˂ 
0.05) (Table 5.6.) than males.  
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Table 5.6. Multivariate Associations: all factor effects controlled for the other significant factors 
shown for the proportions of T-cell subsets. 
T-cell subtype Factors Effect Size* p value 
Naïve CD4+ 
(CD45RA+/CCR7+) 
EBV status (Positive) 
Age 
-4.03 % 
-3.50 % 
0.098 
0.050 
Naïve CD8+ 
(CD45RA+/CCR7+) 
Gender (Female) +5.31 % 0.050 
Central-memory CD4+ 
(CD45RA-/CCR7+) 
None  -- -- 
Central-memory CD8+ 
(CD45RA-/CCR7+) 
None -- -- 
Effector-memory CD4+ 
(CD45RA-/CCR7-) 
Age 
% Body Fat 
+5.29 % 
+0.21 % 
0.000 
0.003 
Effector-memory CD8+ 
(CD45RA-/CCR7-) 
At risk of obesity 
Obese 
Age 
+7.53 % 
+5.49 % 
-1.56 % 
0.001 
0.025 
0.098 
TEMRA CD4+ 
(CD45RA+/CCR7-) 
None -- -- 
TEMRA CD8+ 
(CD45RA+/CCR7-) 
Gender (Female) 
Age 
-4.63 % 
-4.78 % 
0.036 
0.003 
*Effect size is the average difference (+/-) in % of the phenotype for a 1-unit difference in the respective 
factor. 
 
Table 5.7. Multivariate Associations: all factor effects controlled for the other significant factors 
shown for the proportions of T-cell subsets.. 
T-cell subtype Factors Effect 
Size* 
p value 
Early Differentiated CD4+ 
(CD28+/CD27+) 
None -- -- 
 
Early Differentiated CD8+ 
(CD28+/CD27+) 
Gender (Female) 
EBV status (Positive) 
At risk of obesity 
CMV titer 
+6.87 % 
-5.76 % 
-8.81 % 
-3.86 % 
0.005 
0.018 
0.039 
0.029 
Intermediate Differentiated CD4+ 
(CD28-/CD27+) 
None -- -- 
Intermediate Differentiated CD8+ 
(CD28-/CD27+) 
CMV status (Positive) 
Age 
-3.11 % 
-3.81 % 
0.014 
0.000 
Late Differentiated CD4+ 
(CD28-/CD27-) 
At risk of obesity 
Obese 
+2.27 % 
+2.60 % 
0.031 
0.031 
 
Late Differentiated CD8+ 
(CD28-/CD27-) 
Gender (Female) 
At risk of obesity 
CMV titer 
Age 
-5.13 % 
+8.72 % 
+7.13 % 
-3.88 % 
0.025 
0.005 
0.020 
0.018 
Senescent CD4+ 
(CD28-/CD57+) 
Obese 
CMV titer 
+0.98 % 
+0.52 % 
0.032 
0.049 
 
Senescent CD8+ 
(CD28-/C57+) 
Gender (Female) 
CMV titer 
EBV titer 
Age 
-5.40 % 
+4.58 % 
+1.73 % 
-3.19 % 
0.002 
0.043 
0.021 
0.009 
*Effect size is the average difference (+/-) in % of the phenotype for a 1-unit difference in the respective 
factor. 
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5.3.3. Impact of body mass on the different T-cell subset proportions 
 
To further characterise the impact of obesity on the proportions of the different T-cell 
subsets, we categorized the subjects in three groups, according to their BMI percentile. 
Subjects with a BMI below the 85
th
 percentile were categorized as “Appropriate 
weight”, subjects with a BMI comprised between the 86th to the 94th percentile were 
classified as “At risk of obesity” and finally subjects with a BMI above the 95th 
percentile were classified as “Obese” (Centers for Disease Control and Prevention 
2000).  The impacts of increasing body mass on the proportions of the different T-cell 
subsets are presented in Figures 5.1. to Figures 5.3. 
The proportions of naïve and early differentiated CD4+ and CD8+ T-cells in the 
different weight groups are presented in Figure 5.1. Subjects with an appropriate weight 
had significantly higher proportions of early differentiated CD4+ T-cells than the 
subjects at risk of obesity (4.4 % more, p ˂ 0.05) and obese (+3.8 % more, p ˂ 0.05) 
(Figure. 5.1). The same difference was observed in proportions of naïve CD4+T-cells 
between the subjects with an appropriate weight and the obese subjects (+8.1 % more, p 
˂ 0.05). However no differences in the proportions of those cell types were detected 
between the subjects with an appropriate weight and those at risk for obesity (p ˃ 0.05). 
Subjects with an appropriate weight also presented higher proportions of early 
differentiated CD8+ T-cells than subjects at risk of obesity (17.6 % more, p ˂ 0.001) 
and obese subjects (8.2 % more, p ˂ 0.05). While no significant differences were 
observed between the subjects with an appropriate weight and the obese subjects in the 
proportions of naïve CD8+ T-cells, subjects at risk of obesity had less naïve CD8+ T-
cells than the subjects with an appropriate weight (17.1 % less, p ˂ 0.01) (Figure. 5.1).  
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Figure 5.1. The impact of weight classification on the proportions of naïve CD45RA+/CCR7+ and 
early differentiated CD28+/CD27+ cells in the CD3+/CD4+ (Left) and CD3+/CD8+ (Right) T-cell 
subsets (in %). Values are mean ± SEM. Statistically significant differences from the “Appropriate 
weight” group is indicated by * p ˂ 0.05; ** p ˂ 0.01 and *** p ˂ 0.001. Statistically significant 
differences from the “Obese” group is indicated by # p ˂ 0.05. 
 
 
The proportions of central-memory, effector-memory (CD45RA-/CCR7-) and 
intermediate differentiated CD4+ and CD8+ T-cells in the different weight groups are 
presented in the Figure 5.2. Obese subjects had significantly higher proportions of 
intermediate differentiated CD8+ T-cells than subjects with an appropriate weight (33.2 
% more, p ˂ 0.01). A non-significant identical trend was observed between the obese 
subjects and those at risk of obesity (p = 0.060). Subjects with an appropriate weight 
had significantly less effector-memory CD8+ T-cells than the subjects at risk of obesity 
and obese (43.7 % less and 32.1 % less respectively, p ˂ 0.001). No difference in 
proportion of central-memory CD4+ and CD8+ T-cells could be seen among the 
different weight classification (p ˃ 0.05) (Figure. 5.2). 
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Figure 5.2.  The impact of weight classification on the proportions of central-memory CD45RA-
/CCR7+, effector-memory CD45RA-/CCR7- and intermediate differentiated CD28-/CD27+ cells in 
the CD3+/CD4+ (Left) and CD3+/CD8+ (Right) T-cell subsets (in %). Values are mean ± SEM. 
Statistically significant differences from the “Appropriate weight” group is indicated by *** p ˂ 
0.001. Statistically significant differences from the “Obese” group is indicated by ## p ˂ 0.01 and 
### p ˂ 0.001. 
 
The proportions of TEMRA, late differentiated and senescent CD4+ and CD8+ T-cells 
in the different weight groups are presented in the Figure 5.3. Obese subjects had 
significantly higher proportions of late differentiated CD4+ T-cells than subjects with 
an appropriate weight (41.1 % more, p ˂ 0.01). A non-significant identical trend was 
observed between the subjects with an appropriate weight and those at risk of obesity (p 
= 0.060). Subjects with an appropriate weight had less senescent CD4+ T-cells than the 
subjects in the two other weight classification (at risk of obesity : 34.0 % less and obese 
: 41.8 % less, p ˂ 0.05). Subjects at risk of obesity also exhibited increased proportions 
of senescent and late differentiated CD8+ T-cells when compared with the subjects with 
an appropriate weight (41.7 % more and 43.9 % more respectively, p ˂ 0.01), while 
obese subjects had only a non-significant increased proportions of senescent CD8+ T-
cells compared to subjects with an appropriate weight (p = 0.070). No difference in the 
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proportion of TEMRA CD4+ and CD8+ T-cells could be seen among the different 
weight classification (p ˃ 0.05) (Figure. 5.3). 
 
Figure 5.3. The impact of weight classification on the proportions of senescent CD28-/CD57+, 
TEMRA CD45RA+/CCR7- and late differentiated CD28-/CD27- cells in the CD3+/CD4+ (Left) and 
CD3+/CD8+ (Right) T-cell subsets (in %). Values are mean ± SEM. Statistically significant 
differences from the “Appropriate weight” group is indicated by * p ˂ 0.05 and ** p ˂ 0.01. 
Statistically significant differences from the “Obese” group is indicated by # p ˂ 0.05 and ## p ˂ 
0.01. 
 
5.3.4. Effect of Body Mass and its associated factors on serum leptin concentration 
 
The direct correlation between serum leptin concentration and body mass is wildly 
accepted in the literature (Blum et al. 1997; Brannian et al. 2001; Chow & Phoon 2003), 
it was consequently important to verify that the subject cohort tested in this study did 
not differ from the general population. The relation between serum leptin concentration 
and Body mass, BMI or zBMI are represented in Figure 5.4. Serum leptin concentration 
was positively correlated with body mass and BMI. Although exponential, this 
relationship was also observed between serum leptin concentrations and age- and sex-
adjusted zBMI (Figure. 5.4). 
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Figure 5.4. The impact of Body mass (kg) (top), BMI (bottom left) and zBMI (bottom right) on the 
circulating serum leptin concentration (ng.mL
-1
) in adolescent Mexican-Americans. 
 
5.3.5. Impact of serum leptin concentration on the different T-cell subset proportions 
 
Serum leptin concentration was directly correlated with body mass (kg) and BMI 
(kg/m
2
)
 
in our subjects. All participants were subsequently grouped into tertiles for 
plasma leptin concentration and comparisons among the three groups were made for the 
different T-cell subsets. Results are presented in Figure 5.5, 5.6 and 5.7. The proportion 
of early differentiated and naïve CD4+ and CD8+ T-cells in the different leptin tertiles 
are presented in the Figure 5.5. Subjects with low circulating leptin concentrations had 
higher proportions of early differentiated CD4+ T-cells than the subjects grouped in the 
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average (5.3 % more, p ˂ 0.05) and highest leptin tertiles (4.6 % more, p ˂ 0.05) 
(Figure. 5.5). Similarly, the proportions of early differentiated CD8+ T-cells were 
higher in subjects from the lowest leptin tertile than the subjects from the highest tertile 
(8.9 % more, p ˂ 0.05) and although non-significant, a similar trend was observed 
between between subjects from the lowest leptin tertile and subjects from the average 
leptin tertile (p = 0.057) (Figure. 5.5). No impact of leptin concentrations was observed 
on the proportions of naïve T-cells. 
 
Figure 5.5. The impact of serum leptin concentration on the proportions of naïve 
CD45RA+/CCR7+ and early differentiated CD28+/CD27+ cells in the CD3+/CD4+ (Left) and 
CD3+/CD8+ (Right) T-cell subsets (in %). Values are mean ± SEM. Statistically significant 
differences from the average leptin tertile is indicated by * p ˂ 0.05. Statistically significant 
differences from the highest leptin tertile is indicated by # p ˂ 0.05. 
 
The proportions of central-memory, effector-memory and intermediate differentiated 
CD4+ and CD8+ T-cells in the different leptin tertiles are presented in the Figure 5.6.  
A greater proportion of intermediate differentiated CD4+ T-cells were present in 
subjects grouped in the average leptin tertile than in the lowest leptin tertile (38.3 % 
more, p ˂ 0.05) but not in the highest leptin tertile (p ˃ 0.05). Intermediate differentiated 
CD8+ T-cells were also found in greater proportions in subjects from the average and 
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highest leptin tertile (32.2 % more and 41.2 % more respectively, p ˂ 0.05). While no 
significant difference in central-memory CD8+ T-cell proportions amongst the three 
tertiles were seen (p ˃ 0.05), higher proportions of effector-memory CD8+ T-cells was 
observed in the highest leptin tertile when compared to  the lowest leptin tertile (21.1 % 
more, p ˂ 0.05) (Figure. 5.6). A similar trend, although non-significant, was observed in 
the proportions of effector-memory CD4+ T-cells between the lowest and highest leptin 
tertile (p=0.076).  
 
 
Figure 5.6. The impact of serum leptin concentration on the proportions of central-memory 
CD45RA-/CCR7+, effector-memory CD45RA-/CCR7- and intermediate differentiated CD28-
/CD27+ cells in the CD3+/CD4+ (Left) and CD3+/CD8+ (Right) T-cell subsets (in %). Values are 
mean ± SEM. Statistically significant differences from the average leptin tertile is indicated by * p ˂ 
0.05. Statistically significant differences from the highest leptin tertile is indicated by # p ˂ 0.05. 
 
The proportions of TEMRA, late differentiated and senescent CD4+ and CD8+ T-cells 
in the different leptin tertiles are presented in the Figure 5.7. 
Although no difference in late differentiated CD4+ T-cells proportions were seen 
between the lowest and the average leptin tertile (p ˃ 0.05), their proportions were 
greater in the highest leptin tertile when compared to the average and lowest tertiles 
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(23.9 % more, p ˂ 0.05 and 38.4 % more, p ˂ 0.01 respectively). Non-significant greater 
proportions of senescent CD4+ T-cells were seen in the highest leptin tertile compared 
to the lowest tertile (p = 0.068). No differences in TEMRA CD4+ T-cells proportions 
were observed among the different leptin tertiles. Greater proportions of late 
differentiated and senescent CD8+ T-cells proportions were found in subjects grouped 
in the average leptin tertile when compared to those grouped in the lowest tertile (35.1 
% more and 33.8 % more respectively, p ˂ 0.05) (Figure. 5.7).  
 
Figure 5.7. The impact of serum leptin concentration on the proportions of  senescent CD28-
/CD57+ TEMRA CD45RA+/CCR7- and late differentiated CD28-/CD27- cells in the CD3+/CD4+ 
(Left) and CD3+/CD8+ (Right) T-cell subsets (in %). Values are mean ± SEM. Statistically 
significant differences from the average leptin tertile is indicated by * p ˂ 0.05. Statistically 
significant differences from the highest leptin tertile is indicated by # p ˂ 0.05 and ## p ˂ 0.01. 
 
5.4. Discussion 
 
This study sought to determine the associations between childhood obesity and T-cell 
differentiation indicative of immunosenescence. Although chronological ageing is 
believed to be the main factor responsible for the accumulation of senescent T-cells and 
the concomitant reduction in the number of naïve T-cells, this study was conducted to 
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determine the impact of obesity and serum leptin concentrations, in an age-controlled 
population, while adjusting for potential confounders including latent viral status and 
quality of life scores. The major findings in this study were: (1) Increasing body mass 
had a negative impact on the proportions of naïve and early differentiated T-cells. 
Furthermore excess body mass was associated with greater proportions of CD8+ 
effector-memory T-cells and CD4+ late differentiated T-cells. (2) Serum leptin 
concentration was also associated with altered proportions of blood T-cell subsets. High 
serum leptin concentrations were associated with reduced proportions of early 
differentiated T-cells and greater proportions of effector-memory and intermediate 
differentiated CD8+ T-cells. High leptin concentrations were also associated with 
greater proportions of late differentiated CD4+ T-cells. (3) When controlled for all the 
potential factors significantly affecting the level of T-cell differentiation, age-adjusted 
body mass was still correlated with reduced early differentiated T-cell proportions, and 
a concomitant increase in effector-memory CD8+ T-cells and senescent CD4+ T-cells. 
(4) Although the deleterious effect of latent herpesviruses on the “immunological 
space” was believed to be dependent on repeated reactivation cycles, implying 
prolonged exposure to the viruses (Almanzar et al. 2005), it was found in this study that 
latent CMV and EBV infections were associated with a reduction in naïve and early 
differentiated T-cell proportions even at a very early age. Furthermore in seropositive 
subjects, anti-CMV antibody titer was associated with increased proportions of late 
differentiated and senescent T-cells and anti-EBV antibody titer was associated with 
increased proportions of senescent CD8+ T-cells. 
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5.4.1. Impact of weight classification on the different T-cell subsets 
 
Although no study to date has assessed the impact of excess body mass and obesity on 
the accumulation of senescent T-cells, a few studies have proposed mechanisms by 
which obesity could play a role in immunosenescence. Body mass index (BMI) has 
been shown to be inversely correlated with mean telomere length in leukocytes, a 
marker of biological ageing (Valdes et al. 2005). Furthermore, while both telomere 
length (Nakashima et al. 2004) and obesity (Grundy 2007; Mathieu et al. 2010) are 
known predictors of cardiovascular diseases, senescent T-cells have been shown to 
accumulate during the development of cardiovascular disease (Brouilette et al. 2003; 
Brouilette et al. 2007; Starr et al. 2008) suggesting potential links between obesity and 
immunosenescence. This is the first study to show that excess body weight is associated 
with T-cell differentiation indicative of immunosenescence, independently of age and 
persistent viral infections. 
The beneficial effects of regular physical activity and aerobic fitness on the proportions 
of naïve, memory and senescent T-cells have been discussed previously (Chapter 4). 
While a sedentary lifestyle can lead to obesity (Martinez-Gonzalez et al. 1999; 
Mortensen et al. 2006; Chaput & Tremblay 2009) and is also associated with an 
increased proportion of senescent T-cells (Chapter 4), it was found in Chapter 4 that 
increasing body mass was not associated with the proportions of senescent T-cells. 
However, the study presented in Chapter 4 only included very few obese subjects (7%) 
so the potential link between body mass and the proportions of senescent T-cells could 
not be assertively excluded. Consequently, in order to accurately assess the impact of 
excess body mass on T-cell differentiation indicative of immunosenescence, this study 
was designed to test subjects with a wider BMI (ranging from 14.3 kg/m
2 
to 41.9 kg/m
2 
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and from the 1.4
th
 to the 99.7
th
 percentile), including 36 obese adolescents. Furthermore, 
only young subjects participated to the study presented in this chapter, to limit the 
normal age-associated immune changes observed in older populations.  
The results highlighted clear differences in T-cell differentiation among the three weight 
classifications. Subjects categorized as having an appropriate weight, had greater 
proportions of early differentiated T-cells than subjects classified as obese or at risk of 
obesity. Furthermore, while no difference could be observed for the proportions of naïve 
CD4+ T-cells between subjects with an appropriate weight and subjects at risk of 
obesity, obese subjects had significantly fewer cells exhibiting a naïve phenotype. 
Similarly, obesity was associated with an accumulation of intermediate differentiated 
CD8+ T-cells and both obese and subjects at risk of obesity presented elevated 
proportions of effector-memory CD8+ T-cells when compared to lean subjects. Finally, 
weight classification was associated with differences in senescent T-cells proportions 
and an increasing age-adjusted and sex-adjusted body mass was synonym of a greater 
proportion of senescent CD4+ T-cells. Interestingly however, being at risk of obesity 
was associated with increased proportions of senescent CD8+ T-cells, but the difference 
in senescent CD8+ T-cells between obese subjects and lean subjects was not sufficiently 
ample to be significant (p=0.070). Those results are consistent with the main hypothesis 
of this stud, stating that excess body mass has a deleterious effect on T-cell 
differentiation, independently of chronological ageing.  
The deleterious impact of obesity on the T-cell level of differentiation are also 
consistent with previous work investigating the impact of high BMI on leukocyte 
telomere length in women (Valdes et al. 2005) and in physically inactive subjects 
(Cherkas et al. 2008). Although these studies did not assess the impact of body mass on 
the individual T-cell subsets, they have shown that a higher BMI was associated with 
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shortened telomeres in mixed blood leukocytes. Telomere length is believed to be a 
good marker of biological ageing, as these non-coding nucleoproteins located at the 
chromosome ends are being shortened at each cell division and will lead to cellular 
cycle arrest when reaching a critical size (Hayflick & Moorhead 1961; Hayflick 1965). 
However, cellular senescence can also be triggered by non-telomeric dependent 
pathways during a phenomenon termed stress or aberrant signaling-induced senescence 
(STASIS) (Drayton & Peters 2002). Various stressors can induce STASIS such as the 
prolonged exposure to γ-radiations (Di Leonardo et al. 1994), dysregulated oncogenes 
(Herbig & Sedivy 2006) , but the most common stressor consist in transient or chronic 
increases in oxidative stress (Chen & Ames 1994; Chen et al. 2000), as seen during 
obesity. Consequently studying mean telomere length alone as a measure of immune 
ageing in the context of obesity is likely to minimize the deleterious impact of obesity 
on immunosenescence. Therefore, analyzing the proportions of the different T-cell 
subsets characterised by their level of differentiation as described in this study yields 
more accurate representations of obesity-associated immune changes.  
Some results where however unexpected, and whereas subjects at risk of obesity had 
significantly greater proportions of late differentiated CD8+ T-cells than the subjects 
with an appropriate weight, the same difference was not observed between obese 
subjects and lean subjects. Similarly, subjects at risk of obesity had fewer naïve CD8+ 
T-cells than the subjects with an appropriate weight, while no differences in naïve 
CD8+ T-cells could be seen between the obese subjects and the subjects with an 
appropriate weight. These unforeseen results could be explained by the intermediate 
level of circulating leptin in subjects at risk of obesity. Indeed, while the very high 
concentrations of serum leptin observed in obese subjects are known for enhancing 
reactive oxygen species production,  increasing oxidative stress (La Cava et al. 2004; La 
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Cava & Matarese 2004), and directly impacting T-cell activation and proliferation 
(Fantuzzi & Faggioni 2000; Martin-Romero et al. 2000), the effects of moderate serum 
leptin concentrations observed in subjects at risk of obesity are unknown . Constant 
elevated leptin concentration such as the level seen in obese subjects have been shown 
to induce leptin resistance, or in other words to down-regulate leptin receptors on 
various cell types (Matarese et al. 2005; Ricci et al. 2006; Nascimento et al. 2011) 
limiting its effects. It is plausible that such a down-regulation would occur on T-cells if 
serum leptin concentration was excessive, reducing its activation effects on T-cells in 
obese subjects, but not in subjects at risk of obesity. If this were to be the case, T-cells 
in subjects at risk of obesity would be extensively activated, and could become more 
differentiated than T-cells in contact with very high concentrations of leptin, such as the 
one seen in obese subjects. In order to characterise the impact of serum leptin on the 
various T-cell subsets, the plasma concentrations were measured in the participants. 
 
5.4.2. Impact of leptin concentration on the different T-cell subsets 
 
The adipokine leptin has for primary function to restrict food consumption, it was 
however recently discovered to also play a role on the immune system. Leptin has been 
shown to enhance naïve T-cell activation (identified by their expression of CD45RA) 
while restricting the anti-CD3 activation of memory T-cells (identified by their 
expression of CD45RO (Lord et al. 2002; De Rosa et al. 2006). Furthermore, it has 
been shown to elicit a shift from a Th2 to a pro-inflammatory Th1 profile (Loffreda et al. 
1998; Lord et al. 1998), further establishing the obesity-associated state of chronic 
inflammation. In light of these effects on the immune system, serum leptin 
concentrations were measured in order to identify any association with the different T-
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cell subsets. The subjects were divided into tertiles, according to their serum leptin 
concentrations. The average leptin concentration of each tertile corresponded to the 
average serum leptin concentration of the different weight groups. The average leptin 
concentration of the subjects from the lowest, intermediate and highest leptin tertile 
were 9.9 ng.mL
-1
 (± 0.5 ng.mL
-1
), 20.3 ng.mL
-1
 (± 0.6 ng.mL
-1
) and 51.2 ng.mL
-1
 (± 3.6 
ng.mL
-1
) respectively, values corresponding to the representative serum leptin 
concentrations of lean, at risk of obesity and obese subjects (Prolo et al. 1998).  
Leptin appears to have a direct effect on T-cells by binding to its receptor, OB-Rb, that 
belongs to the class I cytokine receptor superfamily (Chen et al. 1996). Leptin has been 
shown to affect the CD4+ balance by inducing a shift towards a Th1 pro-inflammatory 
subset (Loffreda et al. 1998; Lord et al. 1998). Furthermore, leptin can act as an early 
acute-phase adipokine, like IL-1 or IL-6 (Landman et al. 2003) and can stimulate the 
production of TNF-α by monocytes (Zarkesh-Esfahani et al. 2004) and IFN-γ-inducible 
proteins by monocytic cells (Meier et al. 2003). Taken together, those observations 
suggest that leptin, in addition to its neuroendocrine properties, also acts as pro-
inflammatory adipokine. The chronic inflammatory status seen in obesity could be 
enhanced by the pro-inflammatory environment generated by high physicological 
concentrations of human leptin. The resulting increased oxidative stress could explain 
the accumulation of late differentiated CD8+ T-cells and senescent CD4+ T-cells (von 
Zglinicki et al. 2000a; Chen et al. 2001; von Zglinicki et al. 2001; von Zglinicki 2002). 
In turn, as late differentiated and senescent T-cells have also been shown to produce 
greater amounts of pro-inflammatory cytokines when compared to their less 
differentiated counterparts (Effros et al. 2003), their accumulation may further 
contribute to the obesity-associated inflammatory environment. This was confirmed by 
the data presented in this study showing associations between increasing leptin 
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concentrations and lowered proportions of naïve CD4+ and CD8+ T-cells. Furthermore, 
increasing leptin concentration was also associated with increased proportions of 
intermediate differentiated CD8+ T-cells and subjects with the highest leptin levels had 
increased effector-memory CD8+ T-cells compared to subjects with lower leptin 
concentrations. Finally, the greatest proportions of late differentiated CD4+ T-cells 
were observed in subjects with the highest concentration of leptin. These results tend to 
suggest that, as hypothesized, high physiological concentration of serum leptin may 
promote T-cell differentiation eventually driving them to become senescent. While the 
impact of leptin concentration on the proportions of late differentiated and senescent T-
cells appear to be relatively moderate in young subjects, a sustained exposure to high 
concentrations of leptin is likely to induce greater deleterious effects on the T-cell level 
of differentiation in adults.      
Interestingly, while differences between subjects at risk of obesity and obese subjects 
could be seen in the proportions of effector-memory CD8+ T-cells, these differences 
disappeared when the subjects were classified according to their leptin concentrations. 
Average leptin concentration was consequently not the factor leading to greater 
proportions of effector-memory CD8+ T-cells in subjects at risk of obesity than in obese 
subjects. However, when studying the senescent and TEMRA CD8+ T-cell subsets, 
only subjects with an average leptin concentrations had increased proportions of 
senescent and TEMRA CD8+ T-cells, compared to the two other groups. These 
surprising results suggest that although average serum leptin concentrations could have 
a greater impact on senescent CD8+ T-cells than high serum leptin concentrations, the 
lack of difference between average serum leptin concentrations and high serum leptin 
concentrations tend to disprove this hypothesis.  
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A great number of young subjects took part in this study, and as a consequence of their 
young age, they were at different stages of pubertal maturation, promoting high levels 
of diversity in the results. Differences in pubertal maturation will lead to hormonal 
differences between the different subjects, with greater differences between male and 
female subjects. While subjects were in a narrow age-range, the impact of biological 
ageing on the level of T-cell differentiation could not be dissociated from the impact of 
chronological ageing. The observed diversity could also be the reflection of the 
existence of a metabolically healthy but obese (MHO) group in the participants of this 
study. Individuals classified as MHO have been shown to have a metabolically healthy 
profile including high levels of insulin sensitivity and a clinically normal lipid and 
inflammation profiles (Brochu et al. 2001; Karelis et al. 2005; Stefan et al. 2008). These 
individuals are not subject to the same immunosuppression and cardiovascular risk as 
obese individuals with metabolic disorder (Meigs et al. 2006) and could explain the 
observed discrepancies in the results.    
Other factors, such as age, latent viral infections or psychosocial health, may influence 
the level of T-cell differentiation and explain the differences seen between subjects at 
risk of obesity and obese subjects. Consequently, multivariate analyses were performed 
to assess the effect of each variable on the level of T-cell differentiation, independently 
from eachother. 
 
5.4.3. Multivariate analysis on the different T-cell subsets proportions. 
 
The rate of accumulation of senescent T-cells is known to be highly influenced by many 
different factors, such as chronological ageing (Spaulding et al. 1997) , latent viral 
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infections (Thimme et al. 2005) including CMV and EBV infections (Wikby et al. 
2002),  sustained psychological stress due to  adverse work conditions (Bosch et al. 
2009) or low socioeconomic status, as suggested by studies that have used leukocyte 
telomere length as an outcome measure (Cherkas et al. 2006). It was therefore necessary 
to control for the impact of potential confounding factors in order to accurately 
characterise the effect of excess body mass and high serum leptin concentrations on the 
proportions of late differentiated and senescent T-cells. 
After controlling for all potential confounding factors, excess body mass was still 
associated with altered T-cell subsets proportions. Obese subjects had lower proportions 
of early differentiated CD4+ T-cells than subjects with an appropriate weight, and 
subjects at risk of obesity had fewer early differentiated CD8+ T-cells than their lean 
counterparts. In addition, both subjects at risk of obesity and obese subjects had a 
greater number of effector-memory CD8+ T-cells than the subjects with an appropriate 
weight (+7.53% and +5.49% respectively) after controlling for all the confounding 
factors. Finally, excess body mass was also associated with increased proportions of 
senescent T-cells, as obese subjects had more senescent and late differentiated CD4+ T-
cells than subjects with an appropriate weight and subjects at risk of obesity had greater 
amount of late differentiated CD4+ and CD8+ T-cells than lean subjects. These results 
confirm that, excess body mass has a deleterious impact on the composition of the T-
cell population, by leading to the increase in late differentiated and senescent T-cell 
numbers, while reducing the naïve CD4+ T-cell pool. Although excess body mass was 
associated with changes in the level of T-cell differentiation indicative of 
immunosenescence, after controlling for the different confounding factors, no 
associations were seen with increasing leptin concentrations. While these results may 
suggest that increasing leptin concentration has no impact on T-cell differentiation and 
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on the proportions of the different T-cell subsets, the direct correlation seen between 
body mass and serum leptin is more likely to explain the apparent lack of association. 
Furthermore, as leptin concentration is known to increase exponentially with increasing 
body mass (Mantzoros 1999), categorizing subjects in tertiles according their serum 
leptin concentration is more sensitive than analyzing the effect of leptin concentrations 
using multivariate analysis. Consequently, the potential synergistic effect of excess 
body mass and high serum leptin concentration on the accumulation of late 
differentiated and senescent T-cells cannot be rejected. 
It is interesting to observe that other factors, such as latent viral infections, were 
associated with alterations in the T-cell subsets proportions. Although studies have 
suggested that prolonged exposure to CMV and/or EBV were required to see 
modifications in T-cell differentiation level (Wikby et al. 2002; Almanzar et al. 2005; 
Thimme et al. 2005), it appears that CMV and/or EBV infections are associated with 
reductions in naïve and early differentiated T-cell proportions. In seropositive subjects, 
antiviral antibody titer was also positively associated with the proportions of late 
differentiated and senescent T-cells in young individuals. Whereas initial infections by 
the viruses were not determined, it is plausible to believe that the subjects were infected 
relatively recently due to their young age, or that they have been carrying the virus for a 
relatively shorter period, compare to adults. Consequently, latent viruses may have an 
immediate, or shortly delayed, deleterious impact on the immune system by promoting 
T-cell differentiation, thus accelerating the onset of immunosenescence. This is 
supported by studies conducted on Gambian infants, in which CMV infection was 
shown to induce T-cell differentiation and rapid shifts toward highly differentiated 
phenotypes (Miles et al. 2007; Miles et al. 2008). Those studies did not however 
characterise the impact of CMV infection on senescent T-cells and they failed to control 
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for potential confounding factors. Consequently, the study presented in this chapter is 
the first study to highlight an association between CMV and/or EBV infections and 
increased proportions of senescent T-cells in children, independently of body mass, age 
and psychosocial status. 
While some gender-related differences in immune response have been well-
documented, including greater humoral and cellular immune responses in women 
(Weinstein et al. 1984; Ansar Ahmed et al. 1985) and a greater response to mitogens 
(Santoli et al. 1976), only few studies have assessed the gender-associated differences in 
T-cell subset frequencies (Yan et al. 2010). The results presented in this study show that 
females have more naïve and early differentiated T-cells, while having less TEMRA, 
late differentiated and senescent CD8+ T-cells. The mechanisms behind the gender-
associated difference remains to be identified, however it is possible to hypothesize that 
sexual hormones play a role in this immune protection. Indeed it has been shown that 
estrogen activates the gene coding for the telomerase reverse transcriptase leading to the 
up-regulation of telomerase and subsequently delay the onset of T-cell senescence (Kyo 
et al. 1999). Considering the potential protecting effect of sexual hormones, the 
difference in senescent T-cell proportions between males and females is likely to persist 
until the menopause. This hypothesis suggesting that female may have an increased 
immuncompetence prior to the menopausal phase when compared to their male 
counterpart is supported by various studies. Indeed females appear to be more protected 
than men against various diseases, such as CVD (Vassalle et al. 2012a; Vassalle et al. 
2012b), before they reach the menopause, but are at similar risk after they entered the 
menopausal phase. 
Finally, although we hypothesized that psychosocial status would impact the level of T-
cell differentiation, no associations between physical and psychological PEDS QL and 
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the different T-cell subset proportions were observed. However, it is important to 
remember that no differences in PEDS QL scores were seen among the different groups. 
Subjects had high PEDS QL scores, suggesting that they were not psychosocially 
distressed. Further studies should investigate the difference in T-cell subsets frequencies 
among subjects emanating from opposed socioeconomic environments to potentially see 
an effect of PEDS QL scores. In addition, future studies should investigate the effect of 
body weight on the level of T-cell differentiation in children of different ethnic groups. 
In conclusion, the study presented in this chapter highlights clear associations between 
excess body mass and reduced proportions of naïve T-cells, while being associated with 
increased proportions of effector-memory, late differentiated and senescent T-cells in 
young individuals. This is the first study to show an association between obesity and 
level of T-cell differentiation associated with immunosenescence independently of 
chronological ageing, raising clinical concerns. The accumulation of effector-memory 
and late differentiated or senescent T-cells has been associated with increased rate of 
morbidity and mortality in the elderly (Wikby et al. 2002; Wikby A. 2003), suggesting a 
state of immunodepression in obese children that may accelerate the onset of premature 
immunosenescence. Furthermore, the results presented in this chapter also highlighted 
similar deleterious impacts of CMV and/or EBV viral infections on the level of T-cell 
differentiation in children to the one seen in older adults, advocating for the important 
role played by latent viral infections on the accumulation of senescent T-cells, relatively 
shortly after primary infection. Finally, the study presented in this chapter highlighted a 
potential role of high serum leptin concentration in the level of T-cell differentiation, 
however a more detailed study should be conducted to underscore the mechanisms 
linking leptin concentration and T-cell differentiation. While the biological impact of 
excess body weight on the level of T-cell differentiation appears to be relatively modest 
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due to the small proportional differences between the different weight classifications, 
the young age of the volunteers greatly increase their clinical and biological differences. 
Indeed, the differences observed in teenagers, are likely to gradually and rapidly 
increase across the lifespan. Future studies should also examine the effect of weight loss 
interventions on the level of T-cell differentiation in children, in order to potentially 
restore a competent immune system and delay the onset of immunosenescence. 
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CHAPTER 6 
THE EFFECTS OF PHYSIOLOGICAL 
CONCENTRATIONS OF LEPTIN ON T-CELL 
ACTIVATION AND OB-Rb EXPRESSION 
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6.1. Introduction 
 
Excess body mass, and more specifically excess body fat has become a clear health-
threatening condition to the general population when the World Health Organization 
classified obesity as a worldwide epidemic (World Health Organization 2000). 
Although obesity is not affecting countries equally,  with higher prevalence in 
industrialized countries such as the USA with 33.8% of its population being obese 
(Flegal et al. 2010), than in developing countries such as Cambodia with only 1.5% of 
the population having a BMI over 30 kg/m
2 
(UNICEF Cambodia 2009), it is expected to 
become increasingly prevalent. Besides having important deleterious impacts on 
psychological and mental health based on inabilities in identification with social 
standards (Martin-Lopez et al. 2011), obesity and excessive central adiposity have been 
linked to many physical chronic conditions such as heart diseases (Poirier et al. 2006), 
type 2 diabetes mellitus (Zimmet et al. 2001) and multiple cancers (Ceschi et al. 2007; 
Su et al. 2011). Recent studies have also found obesity to negatively impact the immune 
system.  
 Obesity has been shown to have deleterious effects on both the innate and adaptive 
arms of the immune system. Animal models of obesity have been used extensively to 
highlight some of these defects, such as a diminished tolerance towards bacterial and 
viral infections (Mancuso et al. 2002; Smith et al. 2007). On a cellular level, obesity is 
associated with reduced NK cells numbers (Mori et al. 2006), activation (Nave et al. 
2008) and cytotoxicity (Lautenbach et al. 2009) along with impaired macrophages 
phagocytosis (Li et al. 2009b). Obesity has also been shown to be associated with a 
concomitant reduction in dendritic cells numbers and an attenuation of their antigen 
presentation capabilities (Macia et al. 2006; Smith et al. 2009). Although fewer studies 
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have been conducted in humans, similar immune alterations have been observed in 
obese individuals. Higher BMI has been associated with reductions in circulating T-
cells (Tanaka et al. 2001) along with reductions in both naïve and memory T-cell 
functions (Nieman et al. 1999; Karlsson et al. 2010). The data presented in Chapter 5 
highlighted the deleterious impact of obesity on the “immune space” composition, by 
showing that obesity was associated with reduced naïve and early differentiated T-cells 
and a concomitant increase in late differentiated T-cells independently of chronological 
ageing. This suggests that the immunosuppression state associated with obesity may be 
resulting in the accumulation of dysfunctional senescent and late differentiated T-cells. 
The chronic pro-inflammatory state observed in obese individuals has been proposed to 
accelerate the rate of telomere attrition, and consequently promote the accumulation of 
senescent T-cells. In addition, high concentrations of serum leptin were shown in 
Chapter 5 to be associated with increased proportions of late differentiated T-cells and 
reduced proportions of naïve and early differentiated T-cells. 
Leptin is a 16 kDa protein, composed of 146 amino acids, transcripted from the ob gene 
in 3.5 kb mRNA in adipocytes. While essentially secreted by adipocytes, proportionally 
to the adipose tissue mass, leptin can also be secreted in small quantities by skeletal 
muscle cells, fundical epithelium and by the placenta (Friedman & Halaas 1998). Leptin 
is released in the bloodstream on a circadian rhythm, with a nadir at 0800-0900h 
succeeded by a progressive rise to reach a peak between midnight and 0200h (Licinio et 
al. 1997). Physiological serum leptin concentrations in healthy lean individuals range 
from 1 to 5ng.mL
-1 
 but can attain 50ng.mL
-1 
in subjects with class IV obesity (super-
obesity) (Prolo et al. 1998). This accumulation of serum leptin is likely to be a direct 
consequence of the down-regulation of leptin receptor on the hypothalamus observed in 
obese individuals (Chen et al. 2005). Leptin is primarily an energy homeostasis 
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adipokine, limiting excessive food intake (Korner et al. 2001; Konturek et al. 2002), but 
its structural similarities with certain pro-inflammatory cytokines, such as IL-6, IL-12 or 
IL-15 (Faggioni et al. 2001; La Cava et al. 2004), extends its action to immune cells. 
Thus, it has been shown to increase in vitro proliferation and functionality of innate 
immune cells, such as monocytes, macrophages and NK cells (Gainsford et al. 1996; 
Zhao et al. 2003; Mancuso et al. 2004) but also to participate in the reduction of sepsis-
induced inflammation by reducing circulating pro-inflammatory cytokines and 
increasing secretion of anti-inflammatory IL-4 and IL1RA in animals (Gabay et al. 
2001; Jaworek et al. 2002; Xiao et al. 2003). Although more research needs to be 
conducted to study the in vivo impact of high physiological concentrations of leptin in 
humans on inflammation and oxidative stress, a potential link between abnormal serum 
leptin concentration and premature immune ageing can be hypothesized. Indeed, in 
addition to the data presented in Chapter 5 showing that leptin concentration was 
associated with increased proportions of late differentiated T-cells, studies have shown 
that both BMI and leptin concentrations were inversely correlated with leukocyte 
telomere length in human, a biomarker of immunosenescence (Valdes et al. 2005; Lee 
et al. 2010). Leptin-induced oxidative stress is however unlikely to be the only culprit of 
leukocyte telomere shortening precipitation, and a more direct action of the hormone on 
immune ageing is convincing. 
As a consequence of a wide distribution of leptin receptor (Ob-R) expression amongst 
immune cells, serum leptin has a direct effect on circulating immune cells 
(Papathanassoglou et al. 2006). It has been shown to up-regulate the expression of late 
activation markers on CD4+ and CD8+ T-cells (Martin-Romero et al. 2000) and 
adhesion molecules such as ICAM-1, and very late antigen 2 (VLA-2) on CD4+ T-cells 
(Park et al. 2001). Moreover, supra-physiological doses of leptin have been shown to 
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enhance CD45RA+ CD4+ and CD8+ “naïve” T-cell activation and proliferation when 
cultured in vitro with a mitogen, while it tends to inhibit CD45RO+ “memory” T-cell 
proliferation (Martin-Romero et al. 2000; Lord et al. 2002; De Rosa et al. 2007).  
Interestingly, while physiological concentrations of leptin corresponding to those found 
in lean individuals protects from stress-induced thymic atrophy (Gruver & Sempowski 
2008) and thymic involution in mice (Hick et al. 2006; Dixit et al. 2007), elevated 
serum leptin concentrations appear to have an opposite effect by reducing thymic output 
in obese individuals (Yang et al. 2009). The stimulating effect of high doses of leptin on 
“pre-activated” T-cells is likely to result in a constant state of T-cell activation, leading 
to disregulated T-cell proliferation, and consequently promote the accumulation of late 
differentiated and senescent T-cells seen in obese individuals. However, while the 
stimulating effects of high concentrations of leptin on T-cells have been documented 
(Martin-Romero et al. 2000), the effect of physiological leptin concentrations, such as 
the one observed in lean and obese individuals, on T-cell activations remain to be 
investigated. 
The aim of the study presented in this chapter was to examine the effect of 
physiological concentrations of plasma leptin on T-cell activation. In addition this 
chapter aimed to assess both the constitutional and inducible expression of OB-Rb 
receptor and mRNA in T-cells.  
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6.2. Materials and Methods: 
 
6.2.1. Subjects 
 
Volunteers were 10 lean healthy non-smoker Caucasian males (Mean  SD: age= 24.8 ± 
2.6 yrs; BMI= 22.6 ± 2.1 kg/m
2
) Blood samples were drawn as described in the general 
materials and methods Chapter 3.3. Subjects with excessive alcohol intake (>14 drinks 
per week), with a BMI exceeding 25 kg/m
2 
and taking medications affecting the 
immune system and/or their basal serum leptin concentration were excluded from the 
study. Height and weight measurements were used to determine their BMI. 
 
6.2.2. T-cell stimulation 
 
After isolation, 1x10
6
 PBMCs were cultured in 24 wells Iwaki flasks (Barloworld 
scientific, Stone, United Kingdom), with 1 mL of RPMI-1640 culture medium 
supplemented with 100 units.mL
-1
 P/S and 2mM of L-Glutamine. As shown in the 
literature (Martin-Romero et al. 2000) leptin alone is not likely to trigger a sufficient 
activation signal on resting T-cells and the use of a mitogenic stimulation was thought 
to overcome the resting T-cells activation threshold. The optimal concentration of 
mitogen (PMA) was defined to be 0.25 ng.mL
-1
 as described in the general material and 
methods Chapter 3.3.2. 
The various physiological concentration of human recombinant leptin added to each 
well are reported in Table 6.1. These concentrations were obtained from 1mg of 
lyophilized human recombinant leptin (R&D systems, Mineapolis, MN, USA) after 
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being reconstituted in sterile 20 mM Tris-HCI (pH 8.0) and correspond to the 
physiological range of leptin found in humans (Niskanen et al. 1997). After 4 hours of 
incubation at 37
°
C with 5% of CO2, the supernatant was removed from the wells, and 
centrifuged during 10 minutes at 250 Gs. The pellet was then washed twice with 500µL 
of PBS 0.5% BSA solution (Sigma-Aldrich, Irvine, Scotland). 
 
Table 6.1 Concentrations of leptin used for the stimulation of T-cells. 
 
PMA concentration 
(ng.mL
-1
) 
Leptin Concentrations 
(ng.mL
-1
) 
Corresponding BMI 
(kg/m
2)
 
(Zimmet et al. 1996; 
Chow & Phoon 2003) 
Negative Control 0 0 NA 
No leptin 0,25 0 NA 
Well 1 0,25 0,5 BMI below 20 
Well 2 0,25 1,5 20 
Well 3 0,25 5 20-25 
Well 4 0,25 25 30 
Well 5 0,25 50 BMI above 40 
 
6.2.3. Flow Cytometric analysis 
 
After stimulation, PBMCs were labeled with diluted antibodies as described in the 
general materials and methods Chapter 3.5.1. A combination of four antibodies was 
used to assess T-cell levels of activation: CD8 FITC, CD69 PE, CD4 Pe-cy5 and CD3 
APC.  The samples were analysed by four-colour flow cytometry, as described in the 
general materials and methods Chapter 3.5.5.  
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6.2.4. T-cell enrichment 
 
T-cells, CD4+ T-cells and CD8+ T-cells populations were negatively selected from 
PBMCs using commercially available enrichment kits (BD Biosciences, Oxford, UK) as 
described in the general materials and methods Chapter 3.6 and assessed for OB-R 
expression by direct flow cytometric analysis. 
 
6.2.5. Total RNA extraction and leptin receptor gene analysis RT-PCR’ 
 
RNA samples were isolated from stimulated PBMC (containing at least 80% of CD3+ 
T-cells) and the effect of leptin stimulation on Ob-Rb gene expression was determined 
using Real time Polymerase Chain Reaction as described in the general materials and 
methods Chapter 3.8.4.  
 
 
6.2.6. Statistical analysis 
 
All values are presented as mean ± Standard Error (SE). Data were normally distributed 
and the effects of PMA and leptin on T-cell activation were respectively analysed by 
one-way ANOVA and pair samples t-tests. Mean fold changes in OB-Rb expression in 
PBMCs among the different stimulation conditions were analysed using one-way 
ANOVA. Statistical significance was set at P < 0.05. All values are presented as the 
mean ± Standard Error of the mean (SEM) unless stated otherwise. All statistical 
analyses were performed using “Statistical Package for the Social Sciences” (SPSS 
v17.0, Chicago, IL, USA).  
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6.3. Results 
 
6.3.1. Effect of leptin on T-cell activation 
  
The proportions of CD3+, CD4+ and CD8+ T-cells subsets expressing the early 
activation marker CD69, after exposition to the mitogen PMA and increasing 
concentrations of leptin are presented in the Figure 6.1. 
 
 
 
 
 
 
 
Figure 6.1 Proportions of all CD3+ (Top), CD4+ (Bottom left) and CD8+ (Bottom right) T-cells 
expressing CD69 in function of the leptin concentration with or without mitogenic stimuli. Mean 
values are represented ± SEM. Statistical differences from the control condition, 0.25ng.mL
-1
 PMA 
without leptin is indicated by # p ˂ 0.05,  ## p ˂ 0.01 and ### p ˂ 0.001. Statistical differences 
between the different leptin concentrations is indicated by * p  ˂ 0.05, ** p ˂ 0.01 and *** p ˂ 0.001. 
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The proportions of CD3+, CD3+/CD4+ and CD3+/CD8+ T-cells expressing CD69 were 
significantly greater (p ˂ 0.001), when stimulated with 0.25 ng.mL-1 of PMA. 
Proportions of T-cells expressing CD69 were further increased by the presence of 
human leptin. The amount of CD69+ CD3+ T-cells cultured with PMA and 5 ng.mL
-1
, 
25 ng.mL
-1
 or 50 ng.mL
-1
 of leptin were significantly greater than the amount of CD69+ 
cells cultured with lower concentrations or with an absence of leptin (p ˂ 0.05). A 
greater proportion of cells stimulated with 25 ng.mL
-1
 and 50 ng.mL
-1
 of leptin 
expressed CD69 when compared to cells stimulated with 0.5 ng.mL
-1
 of leptin (Figure 
6.1).   
Greater proportions of CD69+ CD4+ T-cells were observed when the cells were 
stimulated with 25 ng.mL
-1
 and 50 ng.mL
-1
 compared with lower concentrations or with 
an absence of leptin (p ˂ 0.05). The proportions of CD4+ T-cells expressing CD69 was 
also significantly higher when cells were stimulated with 50 ng.mL
-1
 than with 0.5 
ng.mL
-1
 of leptin. However no differences were seen between the amount of CD4+ cells 
T-expressing CD69 in the control condition containing no leptin and when cells were 
exposed to 0.5 ng.mL
-1
, 1.5 ng.mL
-1
 or 5 ng.mL
-1
 of leptin (p ˃ 0.05) (Figure 6.1).   
More CD8+ T-cells expressed CD69 when stimulated with PMA and 1.5 ng.mL
-1
 (p ˂ 
0.05), 5 ng.mL
-1
 (p ˂ 0.01), 25 ng.mL-1 (p ˂ 0.001) and 50 ng.mL-1 (p ˂ 0.001) leptin, in 
comparison to the control condition (p ˂ 0.05). Furthermore, cells cultured with 25 
ng.mL
-1
 and 50 ng.mL
-1
 of leptin expressed greater levels of CD69 than cells cultured 
with 0.5 ng.mL
-1
 (p ˂ 0.05) and 1.5 ng.mL-1 (p ˂ 0.01) or 0.5 ng.mL-1 (p ˂ 0.001), 1.5 
ng.mL
-1
 (p ˂ 0.01) and 5 ng.mL-1 (p ˂ 0.05) of leptin respectively (Figure 6.1).   
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The CD69 Geometric Mean of Fluorescence Intensity (GMFI) of the CD3+, the CD4+ 
and the CD8+ T-cell populations after PMA stimulation and increasing concentrations 
of leptin are presented in the Figure 6.2. 
 
 
 
 
 
 
 
Figure 6.2 CD69 GMFI of all CD3+ (Top), CD4+ (Bottom left) and CD8+ (Bottom right) in function 
of the leptin concentration with or without mitogenic stimuli. Mean values are represented ± SEM. 
Statistical differences from the control condition, 0.25ng.mL
-1
 PMA without leptin is indicated by # 
p ˂ 0.05 and ## p ˂ 0.01. Statistical differences between the different leptin concentrations is 
indicated by * p  ˂ 0.05. 
 
The CD69 GMFI expression was significantly increased in the CD3+, CD4+ and CD8+ 
T-cells by PMA stimulation (p ˂ 0.001).  The CD69 GMFI was significantly higher on 
CD3+ T-cells after stimulation with 25 ng.mL
-1
 and 50 ng.mL
-1
 of leptin stimulation 
when compared with lower concentrations or with an absence of leptin (p ˂ 0.05). 
CD69 GMFI on CD4+ T-cells was greater when the cells were stimulated with 25 
ng.mL
-1
 and 50 ng.mL
-1
 (p ˂ 0.05) of leptin than the CD69 GMFI of control CD4+T-
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cells and CD4+ T-cells expressed more CD69 when cultured with 50 ng.mL
-1
 than 1.5 
ng.mL
-1
 of leptin (p ˂ 0.05). No difference in CD69 GMFI could be observed between 
the control condition containing no leptin and when cells were stimulated with 0.5 
ng.mL
-1
, 1.5 ng.mL
-1
 and 5 ng.mL
-1
 of leptin (p ˃ 0.05). An increased expression of 
CD69 was observed on CD8+ T-cells cultured with 5 ng.mL
-1 (p ˂ 0.05), 25 ng.mL-1 (p 
˂ 0.05), and 50 ng.mL-1 (p ˂ 0.01) when compared to the control conditions. Cells 
stimulated with 0.5 ng.mL
-1 
and 1.5 ng.mL
-1 
of leptin did not have a statistically 
different expression of CD69 GMFI than the cells from the control condition (p ˃ 0.05) 
(Figure 6.2). 
Representative histograms of CD69+ CD4+ and CD8+ T-cells after stimulation with 
increasing concentrations of human recombinant leptin and with or without mitogenic 
co-stimulation are presented in the Figures 6.3 and 6.4. 
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Figure 6.3. Representative flow cytometric histograms showing the proportions of CD69+ CD4+ T-
cells cultured with different concentrations of leptin with or without mitogenic stimulation. The 
positive population is indicated by the marker gate.  The y-axis is the log of the fluorescent intensity  
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Figure 6.4. Representative flow cytometric histograms showing the proportions of CD69+ CD8+ T-
cells cultured with different concentrations of leptin with or without mitogenic stimulation. The 
positive population is indicated by the marker gate.  The y-axis is the log of the fluorescent 
intensity.  
165 
 
6.3.2. OB-Rb expression on T-cells 
 
Increasing concentrations of leptin without simultaneous PMA stimulation did not 
induce T-cell activation, as demonstrated by the lack of CD69 expression on the 
different T-cell subsets. Consequently, we hypothesized that resting T-cells lacked OB-
Rb expression, thus preventing their activation by serum leptin alone. We sought to 
characterise the surface expression of OB-Rb on the different T-cell subsets. The results 
are presented in the Figure 6.5. 
 
 
 
Figure 6.5. Proportions of enriched CD3+, CD4+ and CD8+ T-cell subsets expressing the leptin cell 
surface receptor (OB-Rb) analysed by three-colours flow cytometry. 
 
Very low proportions of enriched CD3+, CD4+ and CD8+ resting T-cells expressed the 
leptin cell surface receptor (in average 2.2%, 1.9% and 2.1% respectively). Although 
those results highlight the limited expression of OB-Rb on the different resting T-cell 
subsets, it does not give information on the capacity of the different T-cell subsets to up-
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regulate OB-Rb. Consequently OB-Rb gene expression was assessed on both resting 
and activated T-cells. 
Total RNA was extracted from resting PBMCs and after PCR-amplification of OB-Rb, 
RNA gel electrophoresis was performed. The resulting gel is presented in Figure 6.6. 
 
 
Figure 6.6. Ethidium-bromide stained agarose gel electrophoresis of OB-Rb cDNA isolated from 
resting PBMCs. The size of the cDNA produced (C) was estimated by comparing the mobility of the 
molecular weight markers (A). OB-Rb negative control (B and D) and positive control (GAPDH) 
(E) were used to validate the gel electrophoresis.  
 
Using the migration of the molecular weight markers, the molecular weight of the 
generated mRNA is comprised between 200 bp and 300 bp, which corresponds to the 
expected molecular weight of OB-Rb mRNA (246 bp) (Sobhani et al. 2000). These 
results highlight the expression of OB-Rb in resting PBMCs at the mRNA level. 
Furthermore, in order to characterise the impact of mitogenic stimulation and leptin 
stimulation on OB-Rb gene expression, Real-Time PCR was performed. The average 
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relative change in OB-Rb expression in PBMCs after being stimulated by various 
concentrations of human leptin are presented in the Figure 6.7.   
 
 
Figure 6.7. Mean fold change in OB-Rb mRNA expression in PMA and/or leptin stimulated 
PBMCs. Real-Time PCR was normalised by using the expression of the housekeeping gene 
GAPDH. Results represent mean ± SEM value of 4 subjects (in duplicate) compared with control 
for each stimulation condition. Statistical differences from the unstimulated condition is indicated 
by # p ˂ 0.05 and ## p ˂ 0.01. Statistical differences between the different stimulations 
concentrations is indicated by * p ˂ 0.05 and ** p ˂ 0.01. 
 
The level of OB-Rb mRNA expression was unchanged in unstimulated PBMCs when 
compared to the level of the housekeeping GAPDH mRNA expression, however when 
cells were stimulated with PMA, they up-regulated OB-Rb (p ˂ 0.05). The up-
regulation of OB-Rb mRNA expression was also observed in PBMCs stimulated with 
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PMA and 5 ng.mL
-1
, 25 ng.mL
-1 
and 50 ng.mL
-1 of human leptin (p ˂ 0.05 and p ˂ 0.01 
respectively).  
When cells were stimulated with 25 ng.mL
-1 
and 50 ng.mL
-1
 of leptin, they expressed 
more OB-Rb mRNA than cells stimulated with PMA alone (p ˂ 0.05) or PMA and 5 
ng.mL
-1
 of leptin (p ˂ 0.05). Indeed when cells were stimulated with PMA alone or 
PMA and 5 ng.mL
-1
 of leptin the mean OB-Rb mRNA fold change observed was 
respectively 1.57 and 1.52 times, whereas when cells were stimulated with PMA and 25 
ng.mL
-1
 or 50 ng.mL
-1 of leptin (p ˂ 0.05), the mean OB-Rb mRNA fold change was 
2.13 and 2.12 times (p ˂ 0.05). 
The level of expression of OB-Rb mRNA remained unchanged when compared to the 
level of GAPDH mRNA expression in cells stimulated with 25 ng.mL
-1
 of leptin alone.  
 
6.4. Discussion 
 
The main aim of the study presented in this chapter was to characterise the effect of 
various physiological concentrations of human leptin on the activation of peripheral 
blood T-cells. This study also sought to assess the expression of the leptin receptor (OB-
Rb) on T-cells, both at the protein and genetic level, and the impact of leptin stimulation 
on its regulation. We have shown that although serum leptin alone was not able to 
activate peripheral blood T-cells, leptin increased mitogen-induced T-cell activation in a 
dose-dependent manner. It was also shown that, although only a very small proportion 
of resting T-cells expressed OB-Rb, they constitutively expressed OB-Rb mRNA after 
stimulation. Furthermore, mitogen-induced T-cell activation lead to the up-regulation of 
OB-Rb when cells were costimulated with high physiological doses of leptin typically 
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seen in obese individuals, but not with the low level of leptin typically seen in lean 
subjects. 
The data presented in Chapter 5 highlighted an association between excess body mass 
and increased proportions of late differentiated T-cells, along with reduced proportions 
of early differentiated and naïve T-cells. Furthermore, a similar effect of high 
physiological leptin concentrations was observed on these cell populations. The study 
presented in this chapter showed that high physiological leptin concentrations, such as 
the one seen in obese individuals, enhanced mitogen-induced T-cell activation. 
Although leptin alone was not able to activate resting T-cells, it amplified T-cell 
activation when costimulated with PMA. The immunological effects of leptin have been 
documented in the past. Indeed, considering their three-dimensional structures, leptin 
and its receptor belong to the class I cytokine receptor family (Zhang et al. 1996) and 
consequently will have an impact on the immune system. Several studies have clearly 
shown effects of leptin on the secretion of pro-inflammatory cytokines, such as the 
increase in pro-inflammatory cytokines production in murine peritoneal macrophages, 
such as IL-6 and TNF-α (Gainsford at al. 1996). Increases in TNF-α and IL-6 
production were also seen after human monocyte activation by serum leptin (Santos-
Alvarez et al. 1999). Studies conducted by Fraser et al. (1999), Martin-Romero et al. 
(1999) and more recently by Lord (2006) highlighted the potential for leptin to up-
regulate activation markers such as CD25 and CD69 when present in very high 
concentration in the medium. In the present study, T-cell activation was assessed by the 
proportion of T-cells expressing CD69 which is the earliest inducible cell surface 
glycoprotein acquired during lymphoid activation. This Ca2+ dependent c-type lectin is 
expressed on B and T-cells, following a direct stimulation by exposition to an antigen or 
a mitogen (e.g. phorbol myristate acetate) (Chen et al. 1997). In a recent study Sancho 
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et al. (2005) has proposed a pro-inflammatory role of CD69, by showing that, in 
presence of a mitogen, the expression of CD69 enhances T-cell proliferation, tumour 
necrosis factor-alpha (TNF-α) through the production of IL-2. However, in vivo studies 
on CD69 knock-out mice didn't show any decreases in T-cell activation, challenging the 
hypothesis proposing CD69 to be a regulator of the immune response (Lauzurica et al. 
2000). Consequently, although the exact role of CD69 is still unclear, its involvement in 
lymphocyte proliferation and signal-transmitting receptor in immune cells establishes it 
as a good marker of T-cells early activation (Diaz-Augustin et al. 1999).  
As stated above, leptin alone did not activate the isolated T-cells, independently of the 
concentration used. However, when T-cells were stimulated with a mitogen (PMA), 
high concentrations of leptin (25 ng.mL
-1
 and 50 ng.mL
-1
) enhanced CD4+ T-cell 
activation and medium and high concentrations of leptin (5 ng.mL
-1
, 25 ng.mL
-1
, 50 
ng.mL
-1
) enhanced CD8+ T-cell activation. Interestingly, lower physiological 
concentrations of leptin did not enhance the PMA-induced T-cell activation. Although 
CD8+ T-cells appear to be more responsive to lower doses of leptin than CD4+ T-cells, 
the lowest concentrations of leptin used (0.5 ng.mL
-1 
and 1.5 ng.mL
-1
) correspond to the 
physiological serum leptin concentrations found in lean subjects (Prolo et al. 1998). The 
lack of activation of CD4+ and CD8+ T-cells by increasing concentrations of leptin 
alone might suggest that the leptin signaling pathway is not sufficient to generate T-
cells activation and proliferation on its own, however it will enhance the activation in 
presence of a mitogenic or antigenic stimuli. 
Another potential explanation lies in the low expression of the active form of the leptin 
receptor (OB-Rb) on the resting T-cell surface. Ob-Rb is expressed in the arcuate and 
ventromedial hypothalamic nuclei where it mediates the central effects of leptin (Glaum 
et al. 1996; Mercer et al. 1996; Tartaglia 1997), and has also been shown to be present 
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on the surface of all cell types of innate and adaptive immunity (Caldefie-Chezet et al. 
2001; Zarkesh-Esfahani et al. 2001; Zhao et al. 2003; Lord et al. 1998).  However the 
data presented in this study show that isolated resting CD3+, CD4+ and CD8+ T-cells 
lack cell-surface OB-Rb expression at the protein level, only a non-significant 
proportion of resting T-cells (less than 3%) expressed the long metabolically active 
form of the leptin receptor. 
The lack of OB-Rb expression on resting T-cells has been previously observed 
(Zarkesh-Esfahani et al. 2001), and provides a potential explanation on the inability of 
leptin alone to activate isolated T-cells. Furthermore, it suggests that PMA stimulation 
up-regulates OB-Rb expression on T-cells, thus enhancing T-cells activation.  
Although resting T-cells lacked expression of the cell surface OB-Rb, it was important 
to establish the presence of OB-Rb mRNA in those cells. Indeed because of the short 
exposure to the different stimulation conditions (4 hours), OB-Rb mRNA had to be 
already expressed in resting T-cells to potentially be translated into OB-Rb protein, and 
be stimulated by exogenous leptin. The results presented in this chapter confirmed the 
presence of OB-Rb mRNA in resting T-cells, suggesting even further that, although 
leptin alone did not activate T-cells, prior stimulation with a mitogen such as PMA is 
required to induce OB-Rb mRNA translation and expression on the cell surface, 
allowing serum leptin to exert its activating effect on the T-cells. This was confirmed by 
the RT-PCR’ analysis of OB-Rb mRNA in stimulated T-cells. It was shown that high 
physiological doses of leptin (25 ng.mL
-1
) without simultaneous PMA stimulation did 
not affect the expression of OB-Rb. However, OB-Rb mRNA was up-regulated (1.5 
fold compared to the level of GAPDH housekeeping gene) when T-cells were 
stimulated with PMA alone, and with PMA and low concentrations of leptin (5 ng.mL
-
1
). Interestingly, cells incubated with PMA and higher concentrations of leptin (25 
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ng.mL
-1
 and 50 ng.mL
-1
) as observed in obese patients expressed significantly more 
OB-Rb mRNA than cells stimulated with PMA alone and PMA + 5 ng.mL
-1
 of leptin. 
This novel finding potentially explains why high physiological concentrations of serum 
leptin enhance the PMA-induced T-cell activation. Extending the tunable activation 
threshold (TAT) hypothesis proposed by Gossman et al. (Grossman & Paul 1992; 
Grossman & Singer 1996; Grossman & Paul 2001), stating that T-cells could 
dynamically tune their activation threshold in response to TCR stimulation to allow a 
degree of controlled autoreactivity, to the up-regulation of OB-Rb could explain this 
effect of high concentrations of leptin on OB-Rb mRNA. Indeed, presence in the 
cellular microenvironment of high doses of leptin, may trigger a cascade reaction 
leading to the up-regulation of OB-Rb, to present increased number of available binding 
site. Following this hypothesis, lower leptin concentrations would not be sufficient to 
achieve the T-cell threshold of activation and would not lead to the up-regulation of 
OB-Rb mRNA. 
Although no difference in OB-Rb mRNA expression was seen between T-cells 
stimulated with PMA alone and T-cells stimulated with PMA and 5 ng.mL
-1
 of leptin, it 
is interesting to observe that more CD8+ T-cells expressed the activation marker CD69 
when co-stimulated with PMA and leptin than PMA alone. This can be explained by the 
use of a mixed T-cell population to analyse OB-Rb mRNA expression. T-cells 
enrichments did not allow the extraction of sufficient amount of genetic material to 
perform the different mRNA analysis, and RNA was isolated from isolated PBMCs 
instead of pure T-cell subsets. To limit the impact of this limitation, RNA was only 
extracted from PBMCs samples containing a minimum of 80% of T-cells and samples 
containing an excessive amount of other cell types, such as NK cells or B cells were 
discarded.  
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Certain limitations exist in this study. Only lean subjects were recruited to take part in 
this study, in order to control for potential leptin resistance as observed in obese patients 
(Tschop et al. 2007). Exposure to high physiological doses of serum leptin over a 
prolonged period of time appears to induce alterations in leptin transport across the 
blood brain barrier (Banks & Farrell 2003), and may impair OB-Rb intracellular 
signaling (Munzberg & Myers 2005). Consequently the use of T-cells isolated from lean 
subjects controlled for such impairments. However, studies have shown an inverse 
correlation between body weight and serum OB-Re, the soluble form of the leptin 
receptor (Chan et al. 2002; Ogier et al. 2002; Shimizu et al. 2002). As a consequence of 
its high affinity for leptin, the complex OB-Re-leptin is formed when OB-Re is present 
in high concentrations, such as those observed with lean patients. This complex prevents 
leptin from binding and being internalized by OB-Rb (Yang et al. 2004; Tu et al. 2008), 
and thus preventing its action. The observed effects may consequently be due to the 
unusual exposure of T-cells to high concentrations of unbound leptin, which may have 
amplified the in vivo leptin effect on T-cells in obese individuals. Consequently, further 
research should study the effect of high leptin concentrations on T-cells isolated from 
obese individuals. Furthermore, future studies should also assess the effect of high 
physiological concentrations of leptin on T-cell proliferation. 
An association between leptin concentration and late differentiated or senescent T-cells 
was previously shown in Chapter 5. The results presented in this study highlight a 
potential mechanistic effect of high physiological concentrations of serum leptin on 
human T-cells. Indeed, when T-cells are activated, as seen during latent viral 
reactivation or bacterial infection, they may become susceptible to further activation by 
endogenous leptin. This could further drive T-cell differentiation toward a senescent 
phenotype. In addition, leptin has been shown to increase anti-apoptotic proteins such as 
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Bcl-2, Bcl-XL (Fujita et al. 2002) and T-bet (Lord et al. 2002), protecting thymocytes 
and mature T-cells from undergoing apoptosis. Suggesting further that prolonged 
exposure to high physiological concentrations of leptin could promote the accumulation 
of senescent T-cells, by enhancing their differentiation and preventing clearance of 
senescent T-cells via apoptosis. The leptin signaling pathway is known to be similar to 
cytokine activation via the recruitment of Janus kinases (JAK) and phosphorylation of 
the signal transducers and activators of transcription (STAT) (Baumann et al. 1996; 
Sanchez-Margalet & Martin-Romero 2001; Cheng et al. 2002). It has been suggested 
that the stimulation effect of normal concentrations of leptin on the immune system can 
be beneficial to the host, by enhancing neutrophil bactericidal capacities (Caldefie-
Chezet et al. 2001; Caldefie-Chezet et al. 2003), potentially inducing lymphopoiesis 
(Bennett et al. 1996) and regulating thymocyte maturation (Howard et al. 1999) in mice. 
However similarly to very low concentrations of leptin, as seen during starvation, 
inducing lymphoid atrophy and increased sensitivity to endotoxic shock (Faggioni et al. 
1999; Howard et al. 1999; Faggioni et al. 2000; Faggioni et al. 2001), sustained 
exposure to high physiological doses of leptin as seen in overweight and obese patients, 
can lead to enhanced T-cell activation, and possibly lead to premature replicative 
senescence.  
In conclusion, the study presented in this chapter provides novel findings on the 
mechanistic effect of high physiological concentrations of leptin on T-cell activation. 
These findings support the data presented in Chapter 5 that highlighted an association 
between high physiological leptin concentrations in obese individual and the increased 
proportions of late differentiated T-cells along with the reduction in early differentiated 
and naïve T-cell pool, independently of chronological ageing. In addition to the effect of 
physical activity on the proportions of the different T-cell subsets presented in Chapter 
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4, increased body weight and the consequent increase in circulating serum leptin 
concentration, is further demonstrating the impact of lifestyle factors on 
immunosenescence.  
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CHAPTER 7 
THE IMPACT OF LATENT HERPESVIRUS INFECTIONS 
ON THE MOBILISATION OF VIRAL-SPECIFIC AND 
SENESCENT T-CELLS IN RESPONSE TO ACUTE 
AEROBIC EXERCISE IN MAN 
 
 
  
177 
 
7.1. Introduction 
 
The impact of exercise on the immune system has been extensively investigated over 
the past century (Larrabee 1902; Nieman et al. 1990a; Nieman et al. 1990b). Studies 
have been distinguishing moderate exercise from acute bouts of strenuous exercise due 
to their observed different effects on the immune system. Indeed, while regular 
moderate exercise appears to improve immune function (Kohut et al. 2001; Drela et al. 
2004; Gleeson 2007; Spielmann et al. 2011), acute bouts of strenuous or exhaustive 
exercise have immunosuppressive effects as demonstrated by the suppressed humoral 
immunity (Verde et al. 1992) and the increased upper respiratory tract infection (URTI) 
prevalence in training and competing athletes (Nieman et al. 1990a; Nieman et al. 
1990b; Nieman 1997; Murphy et al. 2008). On a cellular level, acute exercise induces 
important changes in the T-cell subsets such as decreased naïve (CD45RA+) / memory 
(CD45RO+) and CD4/CD8 ratios, primarily due to a reduction in the naïve CD4+ T-cell 
pool (Baum et al. 1994; Weiss et al. 1995; Rebelo et al. 1998; Buyukyazi et al. 2004), 
and a significant reduction in T-cell activation and proliferative responses (Nieman et 
al. 1994; Nieman et al. 1995; Bury et al. 1996; Vider et al. 2001a; Gleeson 2007). 
Furthermore, acute bouts of exercise elicit a preferential mobilization and extravasation 
of effector-memory T-cells that exhibit a highly differentiated cell surface phenotype 
(TEMRA) (Campbell et al. 2009; Turner et al. 2010) or T-cells with shortened 
telomeres exhibiting a terminally differentiated cell surface phenotype (Simpson et al. 
2007a; Simpson et al. 2008) in the peripheral blood compartment along with Natural 
Killer cells and γδ T-cells (Anane et al. 2009). Indeed, acute exercise activates the 
hypothalamic pituitary adrenal axis (HPA), leading to the release of cortisol and 
catecholamines in the peripheral blood compartment, that will in turn regulate the 
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immune response by binding to surface β2-adrenergic-receptors expressed by 
lymphocytes (Sanders 2011). As a result of histone and DNA methylation-induced 
epigenetic regulations, effector-memory, TEMRA and terminally differentiated CD8+ 
T-cells along with NK cells exhibit very high levels of β2-adrenergic-receptors, 
potentially explaining the preferentially elevated response of these cell subsets to acute 
exercise (Kruger et al. 2008). Following this transient exercise-induced lymphocytosis, 
increased lymphocyte trafficking (Simpson et al. 2007b) combined to a lesser extend 
with moderated levels of cellular apoptosis (Mooren et al. 2002; Mooren et al. 2004; 
Kruger et al. 2008) lead to a lymphocytopenia.     
 
Acute exercise has been shown to preferentially mobilize a population of CD8+ T-cells 
that express CD57 and KLRG1, but lack expression of the co-stimulatory molecule 
CD28 (Simpson et al. 2007a; Simpson et al. 2008; Simpson et al. 2010a). This surface 
phenotype is indicative of an exhausted cell population that may be senescent (Ibegbu et 
al. 2005) and present reduced proliferative capacities coupled with a potential resistance 
to apoptosis while still exhibiting effector cells properties (Spaulding et al. 1999). As a 
consequence of their reduced sensitivity to apoptosis, those stress-sensitive terminally 
differentiated cells have been shown to accumulate with ageing and with repeated 
reactivation of the latent herpesviruses Cytomegalovirus (CMV) and Epstein-Barr virus 
(EBV) (Wikby et al. 1998; Spaulding et al. 1999; Wikby A. 2003). Indeed, it was 
demonstrated in Chapter 5 of this thesis that CMV and EBV infection were associated 
with increased proportions of senescent T-cells and a concomitant reduction in naïve T-
cells, at a very young age. The accumulation of exhausted terminally differentiated T-
cells eventually lead to the congestion of the immunological space, limiting the 
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homeostatic production of functional naïve T-cells, and ultimately contributing to poor 
vaccine efficacy and immunodepression. 
 
As total eradication of an herpesvirus infection is never achieved by the host, the 
probability of a seronegative subject to be primarily exposed to CMV and/or EBV 
increases continuously with age, rationalizing the 50% (CMV) (Bate et al. 2010) to 80% 
(EBV) (Markin 1994) prevalence of single infection observed in the Western adult 
population. CMV and EBV reactivation causes naïve T-cells but also CMV-specific and 
EBV-specific memory T-cells to undergo clonal expansion, increasing the frequency of 
highly and terminally differentiated viral-specific T-cells relative to naïve T-cells within 
the host. In turn, the increased proportions of highly differentiated T-cells in 
seropositive subjects at rest should lead to an accentuated preferential exercise-induced 
mobilisation and extravasation of those cell subsets.  
The data presented in Chapter 4 highlighted clear associations between physical fitness 
and regular physical activity and lower proportions of senescent T-cells along with a 
protected naïve T-cell repertoire in middle-aged men. These results suggest that regular 
physical activity can prevent or reduce the age-associated accumulation in senescent T-
cells, implying that the beneficial impact of regular physical activity on the immune 
system could be due to the periodic repetition of acute bouts of exercise performed over 
an extended period of time (Simpson 2011). Indeed it is postulated in the study 
presented in this chapter that a frequent mobilization of these cells with regular exercise 
may lead to their subsequent deletion via apoptosis, freeing up “immunological space” 
for naïve T-cells to reside. A recent study showed that CMV infection status largely 
influenced the mobilization of highly differentiated effector-memory T-cells (CD28-, 
CD27-/+, CD45RA-/+) in the peripheral blood compartment following acute bouts of 
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exercise (Turner et al. 2010). This study failed however to identify the impact of EBV 
infection and the potential interaction between CMV and EBV in cases of co-infection 
on the exercise-induced preferential lymphocytosis of the terminally differentiated T-
cell subset. In addition to CMV- and EBV-specific CD8+ T-cells being preferentially 
mobilised in the blood after an acute psychological stress (Atanackovic et al. 2006). No 
study to our knowledge has considered the impact of latent herpesvirus on the exercise-
induced mobilization of dysfunctional terminally differentiated T-cells. 
 
The aim of the study presented in this chapter is to determine the relative contribution of 
CMV- and EBV-specific cells to the preferential mobilization and subsequent egress of 
highly-differentiated and senescent CD8+ T-cell subsets in response to exercise in 
subjects carrying a latent infection. It is hypothesized that CD8+ T-cells specific to 
epitopes of CMV or EBV will be mobilized by exercise and will largely account for the 
amplified exercise-induced mobilization and egress of differentiated CD8+ T-cells in 
people with CMV.   
 
7.2. Methods 
 
7.2.1. Subjects 
 
Otherwise healthy adult males (n = 19) aged 22-35 years (mean ± SD age:  28.4 ± 5.4 
years; mass: 84.0 ± 14.5 kg; : 38.1 ± 9.2 ml·kg
-1
·min
-1
) participated in this 
study.  All participants were non-smokers, not taking medication affecting the immune 
system or supplements and were free from any infectious illness for 6-weeks prior to 
2maxOV
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testing. Subjects were asked to refrain from exercise 24 hours prior the exercise 
protocol. After receiving oral and written information pertaining to the risks and 
demands of the study, each subject signed an informed consent document. The 
Committee for the Protection of Human Subjects (CPHS) at the University of Houston 
provided ethical approval for the study prior to the beginning of the study. The physical 
characteristics of the participants are presented in Table 7.2. 
 
7.2.2. Blood Sampling and PBMC isolation 
 
Blood samples were drawn at rest before the start of the exercise protocol, immediately 
after and 1 hour following the end of the exercise protocol and Peripheral Blood 
Mononuclear Cells (PBMC) were isolated as described in the general materials and 
methods Chapter 3.3.  
 
7.2.3. Serological Testing for CMV and EBV IgG Antibodies 
 
Anti-CMV and anti-EBV antibody titers were determined as described in the general 
materials and methods Chapter 3.4. 
 
7.2.4. Submaximal Exercise Test to Estimate Maximal Oxygen Uptake and Maximum 
Cycling Power and Cycling exercise protocol 
 
Submaximal estimation of the subject’s maximal oxygen uptake and subsequent 
exercise protocol were conducted as described in the general materials and methods 
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Chapter 3.2.3. The mean  ̇      and maximum power for the subjects was 39.8 ± 10.0 
mL.kg
-1
.min
-1 
and 244.3 ± 58.7 W respectively.  
 
7.2.5. Antigen-specific T-cell staining and monoclonal antibodies labeling 
 
PBMC’s were divided into 1.0 x 106 aliquots and labelled with 5µl of undiluted CMV-
specific Major Histocompatibility Complex (MHC) class I Pentamer or EBV-specific 
MHC class I Pentamer conjugated to APC (A*201 NLVPMVATV and A*201 
GLCTVAML respectively, Proimmune, Sarasota, FL, USA) and incubated at room 
temperature in the dark for 15 mins. Following incubation, cells were labelled with a 
combination of directly conjugated monoclonal antibodies (mAbs) against the cell 
surface antigens KLRG1, CD57, CD28, CD45RA, and CCR7. The monoclonal 
antibodies were freshly diluted in PBS-BSA to their optimal concentration as 
determined by antibody titration before a volume of 50µL was added to the cell 
suspension. The monoclonal antibody panel used and the phenotypes of interest are 
presented in Table 3.2 and Table 7.1.  
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Table 7.1. Phenotypic identification of the blood T-cell subsets 
Phenotypes T-cell subsets References 
KLRG1-/CD28+  
KLRG1-/CD57- Naïve T-cells 
(Koch et al. 2008) 
CD45RA+/CCR7+ (Geginat et al. 2003) 
KLRG1+/CD28- 
Senescent T-cells 
(Voehringer et al. 2002; 
Ibegbu et al. 2005) KLRG1+/CD57+ 
KLRG1+/CD28+ 
Pan-memory T-cells (Ibegbu et al. 2005) 
KLRG1+/CD57- 
CD45RA-/CCR7+ Central-memory T-cells 
(Sallusto et al. 1999; 
Sallusto et al. 2004) 
CD45RA-/CCR7- Effector-memory T-cells 
(Sallusto et al. 1999; 
Sallusto et al. 2004) 
CD45RA+/CCR7- Highly differentiated TEMRA cells (Geginat et al. 2003) 
 
7.2.6. Flow cytometric analysis 
 
PBMC phenotypes were assessed on an Accuri C6 flow cytometer (Accuri, Ann Arbor, 
MI, USA) as described in the general materials and methods Chapter 3.5. 
 
7.2.7. Statistical Analysis 
 
All data were assessed for assumptions of normality using the Shapiro-Wilk test and 
constant error variance prior to formal statistical testing. Skewed cell-surface 
phenotypic data were then normalised by logarithmic transformation prior to statistical 
analysis when possible, and non-parametric tests were used when phenotypic data could 
not be normalised. No statistical outliers were found. Independent t-tests were 
performed to assess the impact of CMV or EBV infection status on the resting T-cell 
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repertoire while the impact of CMV and EBV co-infection on the resting T-cells was 
assessed by conducting factorial ANOVA. The main effect of infection status and 
exercise along with their interactions was detected among the subjects using linear 
mixed models. The effects of infection status on cell mobilization and egress was 
determined using linear mixed models and independent t-test when interactions where 
found. The effect of exercise on the viral-specific T-cells was assessed using Kruskal-
Wallis non parametric test. Statistical significance was set at P < 0.05. All values are 
presented as the mean ± Standard Error of the mean (SEM), unless stated otherwise. All 
statistical analyses were performed using “Statistical Package for the Social Sciences” 
(SPSS v17.0, Chicago, IL, USA).  
 
7.3. Results 
 
All subjects successfully completed the exercise protocols. The physical characteristics 
and exercise performance measures of all subjects are presented in Table 7.2. No 
statistical differences were found between CMV or EBV seropositive and seronegative 
subjects for any of the physical characteristics or exercise performance measures (p > 
0.05). More CMV seropositive subjects were also infected with EBV than CMV 
seronegative subjects (Chi Square; p < 0.05).   
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Table 7.2. Physical characteristics and exercise performance measures of the participants in 
relation to their viral infection status (mean ± SD). No statistical differences in both the physical 
characteristics and exercise measures amongst the groups were observed. 
#
 indicates a significant 
difference due to CMV serostatus (p<0.05).   
 
Physical Characteristics 
 
All participants 
 (n = 19) 
CMV- (n = 11) CMV + (n = 8) 
Age (years) 28.4 ± 5.4 28.2 ± 5.6 28.8 ± 5.4 
Body mass (kg.) 84.0 ± 14.5 83.2 ± 14.0 85.1 ± 16.0 
BMI (kg.m
-2
) 26.6 ± 4.1 26.0 ± 3.4 27.6 ± 5.1 
Body fat (%) 20.0 ± 8.2 18.2 ± 7.7 22.3 ± 8.9 
Physical Activity level (1-7) 4.6 ± 2.0 4.3 ± 1.8 5.0 ± 2.3 
Maximum Power (w.) 238.9 ± 60.6 240.1 ±62.5 237.1 ± 61.7 
 ̇      (mL.kg-1.min-1) 38.1 ± 9.2 39.6 ± 11.5 35.7 ± 3.1 
EBV seropositivity (%) 73.7 63.7 87.5
#
 
Exercise performance measures    
Mean Power (w.) 203.4 ± 60.0 204.3 ± 57.8 202.1 ± 67.2 
Mean Power (% max) 85.2 ± 13.6 85.5 ± 13.5 84.9 ± 14.7 
Mean Heart Rate (beats. min
-1
) 156.5 ± 7.2 155.5 ± 7.6 157.8 ± 6.7 
Mean Heart Rate (% max) 83.2 ± 3.5 82.6 ± 4.0 84.0 ± 2.8 
 
7.3.1. Impact of latent CMV and EBV infections on blood T-cell phenotypes in healthy 
young adult men. 
 
While CMV and EBV infections are known to have a great impact on the proportions of 
resting naïve, memory and senescent T-cells in the elderly, little is known about their 
impact on younger adults. Consequently, the impact of latent virus infections was 
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initially assessed on the resting T-cell repertoire. The cohort could be divided in 4 
groups according to their infection status: CMV+/EBV+ (n=7); CMV+/EBV- (n=1); 
CMV-/EBV+ (n=7) and CMV-/EBV- (n=4). As seen in Figure.7.1, subjects infected 
with CMV had higher proportions of CD4+ and CD8+ T-cells expressing CD57 (p ˂ 
0.05 and p ˂ 0.001 respectively) and lower proportions of CD8+ T-cells expressing the 
co-stimulatory marker CD28 (p ˂ 0.01) compared to CMV seronegative subjects. The 
frequencies of T-cells expressing those markers were not influenced by EBV infection. 
Naïve, memory and senescent T-cells frequencies in subjects with different infection 
status are presented in Figure.7.2, Figure.7.3 and Figure.7.4 respectively. The naïve 
CD8+ T-cells were affected by CMV infection as seronegative subjects had a greater 
proportion of naïve CD45RA+/CCR7+ (p ˂ 0.05) but not by EBV infection 
(Figure.7.2). While non-significant, a similar trend was observed in the proportions of 
naïve KLRG1-/CD28+ CD8+ T-cells (p = 0.090) (Figure.7.2). Proportions of senescent 
KLRG1+/CD57+ CD4+ and CD8+ T-cells (p ˂ 0.05 and p ˂ 0.001 respectively) and 
KLRG1+/CD28- CD8+ T-cells (p ˂ 0.001) were increased in CMV+ subjects in 
comparison to CMV- subjects (Figure.7.4). The proportions of highly differentiated 
effector-memory CD8+ T-cells re-expressing CD45RA (TEMRA) were greater in the 
CMV+ subjects than the CMV- subjects (p ˂ 0.001) (Figure.7.4). It is interesting to 
observe that a similar effect of CMV infection was seen in the CD4+ TEMRA cells, but 
it was not significant (p = 0.075) (Figure.7.4). Finally, memory CD4+ and CD8+ T-cells 
were not significantly influenced by viral infection status (Figure.7.3).  
No interaction effect of CMV and EBV co-infection was observed on the frequencies of 
naïve, memory and senescent T-cells as presented in Figure.7.5. However, the impact of 
CMV single infection (CMV+/EBV-) on the proportions of the different T-cell subsets 
was based on only one subject.  
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Figure 7.1. The impact of latent CMV or EBV serostatus on the proportions of (KLRG1+, CD57+, 
CD28+) cells in the CD3+/CD4+ (Left) and CD3+/CD8+ (Right) T-cell subsets (in %).  Values are 
mean ± SEM. Statistically significant differences due to CMV infection is indicated by * p ˂ 0.05; 
** p ˂ 0.01 and *** p ˂ 0.001. 
 
 
   
Figure 7.2. The impact of latent CMV or EBV serostatus on the proportions of naïve (KLRG1-
/CD57-, KLRG1-/CD28-) and (CD45RA+/CCR7+) cells in the CD3+/CD4+ (Left) and CD3+/CD8+ 
(Right) T-cell subsets (in %). Values are mean ± SEM. Statistically significant differences due to 
CMV infection is indicated by * p ˂ 0.05.  
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Figure 7.3. The impact of latent CMV or EBV serostatus on the proportions of memory 
(KLRG1+/CD57-, KLRG1+/CD28+), central-memory (CD45RA-/CCR7+) and effector-memory 
(CD45RA-/CCR7-) cells in the CD3+/CD4+ (Left) and CD3+/CD8+ (Right) T-cell subsets (in %). 
Values are mean ± SEM. 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4. The impact of latent CMV or EBV serostatus on the proportions of senescent 
(KLRG1+/CD57+, KLRG1+/CD28-) and TEMRA (CD45RA+/CCR7-) cells in the CD3+/CD4+ 
(Left) and CD3+/CD8+ (Right) T-cell subsets (in %). Values are mean ± SEM. Statistically 
significant differences due to CMV infection is indicated by * p ˂ 0.05; ** p ˂ 0.01 and *** p ˂ 
0.001.   
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Figure 7.5. The impact of latent CMV and EBV co-infection on the proportions of the Naïve 
(KLRG1-/CD57-, KLRG1-/CD28+ and CD45RA+/CCR7+) (Top), Memory (KLRG1+/CD57-, 
KLRG1+/CD28+), Central-memory (CD45RA-/CCR7+), Effector-memory (CD45RA-/CCR7-) 
(Middle) and Senescent (KLRG1+/CD57+, KLRG1+/CD28- and CD45RA+/CCR7-) (Bottom) 
CD3+/CD4+ (Left) and CD3+/CD8+ (Right) T-cell subsets (in %). Values are mean ± SEM. 
Statistically significant differences due to CMV single-infection (CMV+/EBV-) is indicated by * p ˂ 
0.05; ** p ˂ 0.01 and statistically significant differences due to EBV single-infection (EBV+/CMV-) 
is indicated by # p ˂ 0.05.   
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7.3.2. The impact of the latent CMV and EBV infection on the exercise-induced changes 
in T-cells concentration in peripheral blood. 
 
Exercise-induced changes in the total number of T-cells, and the different CD4+ and 
CD8+ T-cell subsets are presented in Table 7.3. The acute bout of exercise performed 
by the subjects was associated with significant changes in the T-cell repertoire. A 
significant increase in total T-cell numbers was observed immediately after exercise (p 
˂ 0.001), followed by a significant reduction in T-cells numbers during the recovery 
phase (1H Post exercise) (p ˂ 0.001). While both CD4+ and CD8+ T-cell numbers 
followed this pattern, only the exercise-induced lymphocytosis and lymphocytopenia of 
the CD8+ T-cell subset were statistically significant (p ˂ 0.001) (Table 7.3.). 
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Table 7.3. Total numbers of peripheral blood lymphocytes and T-cell subsets in response to acute 
cycling exercise (cells.µL
-1
) Values are mean ± SEM. Significant differences from pre-exercise (* 
p<0.05, ** p<0.01, *** p<0.001) and post-exercise (# p<0.05, ## p<0.01, ### p<0.01) (n=24). 
Cell Subsets Cell Phenotype 
Before 
Exercise 
After Exercise 
1H after 
exercise 
T-Lymphocytes CD3+ 1428 ± 78 2055 ± 104 *** 1358 ± 84 
###
 
Helper T-cells CD3+/CD4+ 583 ± 37 706 ± 53 580 ± 40 
Cytotoxic T-cells CD3+/CD8+ 316 ± 20 439 ± 27 *** 301 ± 18 
###
 
Naïve CD4+ T-cells CD4+/KLRG1-/CD28+ 483 ± 35 549 ± 47 493 ± 36 
Naïve CD8+ T-cells CD8+/KLRG1-/CD28+ 185 ± 20 209 ± 26 180 ± 18 
Memory CD4+ T-cells CD4+/KLRG1+/CD57- 68 ± 8 111 ± 12 ** 66 ± 8 
##
 
Memory CD8+ T-cells CD8+/KLRG1+/CD57- 75 ± 7 126 ± 11 *** 77 ± 8 
###
 
Effector-memory 
CD4+ T-cells 
CD4+/CD45RA-/CCR7- 126 ± 15 172 ± 19 137 ± 16 
Effector-memory 
CD8+ T-cells 
CD8+/CD45RA-/CCR7- 87 ± 9 138 ± 12 *** 85 ± 10 
###
 
TEMRA CD4+ T-cells CD4+/CD45RA+/CCR7- 48 ± 5 78 ± 10 42 ± 5 
TEMRA CD8+ T-cells CD8+/CD45RA+/CCR7- 82 ± 9 131 ± 14 ** 70 ± 7 
###
 
Senescent CD4+ T-cells 
CD4+/KLRG1+/CD57+ 15 ± 3 29 ± 6 
p=0.059
 13 ± 2 
##
 
CD4+/KLRG1+/CD28- 31 ± 5 62 ± 11 ** 22 ± 4 
###
 
Senescent CD8+ T-cells 
CD8+/KLRG1+/CD57+ 40 ± 5 85 ± 11 *** 35 ± 5 
###
 
CD8+/KLRG1+/CD28- 51 ± 7 108 ± 14 *** 41 ± 5 
###
 
 
Changes in the number of naïve (KLRG1-/CD28+), memory (KLRG1+/CD57-), 
effector-memory (CD45RA-/CCR7-), TEMRA (CD45RA+/CCR7-) and senescent 
(KLRG1+/CD57+; KLRG1+/CD28-) CD8+ and CD4+ T-cell subsets in response to 
exercise are presented in the Table 7.3. The number of naïve KLRG1-/CD28+ CD4+ 
and CD8+ T-cells did not statistically change with exercise, however exercise mobilized 
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the memory  KLRG1+/CD57- CD4+ and CD8+ T-cells (p ˂ 0.01 and p ˂ 0.001 
respectively) along with the effector-memory CD45RA-/CCR7-CD8+ T-cells (p ˂ 
0.001). After 1 hour, naïve and memory T-cell numbers were comparable to their initial 
levels (p ˂ 0.001). While exercise did not  elicit the mobilisation of naïve T-cells, it 
preferentially mobilised KLRG1+/CD57+ senescent CD4+ and CD8+ T-cells in the 
peripheral blood compartment (p ˂ 0.01 and p ˂ 0.001 respectively) along with 
senescent KLRG1+/CD28- and TEMRA CD45RA+/CCR7- CD8+ T-cells (p ˂ 0.001 
and p ˂ 0.01) (Table 7.3).  
The impacts of CMV latent infection on exercise-induced lymphocytosis and 
lymphocytopenia are presented on Figure.7.6. While CMV infection did not statistically 
impact the exercise-induced CD4+ T-cells mobilisation, it was associated with a lower 
CD4+ T-cell count in blood 1 hour following the exercise (Figure.7.6). CMV infection 
did not impact the exercise-induced CD8+ T-cells and total lymphocyte shift.  
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Figure 7.6. The impact of CMV latent infection on the total lymphocyte (top), CD3+/CD4+ (bottom 
left) and CD3+/CD8+ (bottom right) cell counts changes with exercise (cells.µL
-1
). Values are mean 
± SEM.  Statistically significant differences from the CMV positive group is indicated by * p ˂ 0.05.   
 
The effects of CMV latent infection on the naïve, memory and senescent T-cell subsets 
are presented on Figures 7.7., 7.8. and 7.9. respectively. The egress of naïve KLRG1-
/CD57- CD4+ T-cells (p ˂ 0.05) was greater in the CMV+ subjects than in the CMV- 
subjects (Figure.7.7). When other naïve CD4+ T-cells phenotypes were studied, a 
similar pattern was observed, and the egress of KLRG1-/CD28+ (p = 0.077) and 
CD45RA+/CCR7+ (p = 0.101) CD4+ T-cells was greater in CMV seropositive subjects, 
compared to the CMV seronegative subjects. Naïve CD45RA+/CCR7+ CD8+ T-cell 
egress was also greater in CMV+ subjects than in the non-infected subjects (p ˂ 0.05).  
While CMV seronegative subjects did not mobilize more memory KLRG1+/CD28+ 
CD4+ T-cells (p > 0.05) with exercise than the CMV seropositive subjects, they had 
more memory KLRG1+/CD28+ cells in the peripheral blood compartment 1 hour after 
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exercise (p ˂ 0.05). A similar non-significant pattern was seen in the central-memory 
CD45RA-/CCR7+ CD4+ T-cells (p = 0.083) exercise-induced egress in CMV 
seronegative subjects. CMV serostatus did not have a clear effect on the memory 
KLRG1+/CD57-, central-memory CD45RA-/CCR7+ and CD45RA-/CCR7- CD8+ T-
cells exercise-induced mobilisation or egress. However non-significant trend were seen 
in the association between CMV seropositivity and a lower memory KLRG1+/CD57- (p 
= 0.100) and memory KLRG1+/CD28+ CD8+ T-cells (p = 0.079) removal from the 
peripheral blood compartment during the recovery phase (Figure.7.8). The results 
presented in Figure. 7.9. show the impact of CMV latent infection on the exercise-
induced senescent CD8+ T-cells shifts. A main effect for CMV infection was observed. 
In addition to having significantly larger proportions of the senescent KLRG1+/CD57+, 
KLRG1/CD28- and TEMRA CD45RA+/CCR7- CD8+ T-cells than CMV seronegative 
subjects (p ˂ 0.001), CMV seropositive subjects also mobilise a greater number of those 
senescent cells in the blood with exercise (p ˂ 0.001). The senescent cell counts 
remained higher in the hour following the exercise in the CMV positive subjects (p ˂ 
0.001) (Figure.7.9). No impact of CMV infection was seen on the CD4+ senescent T-
cells (p > 0.05). 
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Figure 7.7. The impact of CMV latent infection and exercise on the number of CD3+/CD4+ (left) 
and CD3+/CD8+ (right)  exhibiting a naïve phenotype (KLRG1-/CD57- (top), KLRG1-/CD28+ 
(middle) and CD45RA+/CCR7+ (bottom)) (cells.µL
-1
).  Values are mean ± SEM. Statistically 
significant differences from the CMV negative group is indicated by * p ˂ 0.05.   
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Figure 7.8. The impact of CMV latent infection and exercise on the number of CD3+/CD4+ (left) 
and CD3+/CD8+ (right) T-cells exhibiting a memory (KLRG1+/CD28+ and KLRG1+/CD57-), 
central-memory (CD45RA-/CCR7+) and effector-memory (CD45RA-/CCR7-) phenotype (cells.µL
-
1
). Values are mean ± SEM. Statistically significant differences from the CMV negative group is 
indicated by * p ˂ 0.05.   
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Figure 7.9. The impact of CMV latent infection and exercise on the number of CD3+/CD4+ (left) 
and CD3+/CD8+ (right) exhibiting a senescent phenotype (KLRG1+/CD57+ (top), KLRG1+/CD28- 
(middle)) and highly differentiated memory phenotype (CD45RA+/CCR7- (bottom))(cells.µL
-1
). 
Values are mean ± SEM. Statistically significant differences from the CMV negative group is 
indicated by * p ˂ 0.05, ** p ˂ 0.01 and *** p ˂ 0.001.   
 
The impacts of EBV latent infection on exercise-induced lymphocytosis and 
lymphocyte efflux are presented on Figure.7.10. A main effect for EBV infection was 
observed on the proportions of CD8+ T-cells. Both resting CD8+ T-cell count and the 
exercise-induced CD8+ T-cells mobilization were statistically greater in EBV 
seropositive subjects, when compared to the seronegative group (p ˂ 0.05). However, 
EBV infection did not statistically impact the exercise-induced total lymphocytes and 
CD4+ T-cells (Figure.7.10).   
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Figure 7.10. The impact of EBV latent infection on the total lymphocyte (top), CD3+/CD4+ (bottom 
left) and CD3+/CD8+ (bottom right) cell counts changes with exercise (cells.µL
-1
). Values are mean 
± SEM. Statistically significant differences from the EBV negative group is indicated by *** p ˂ 
0.001.   
 
 
The effects of EBV latent infection on the naïve and senescent T-cell subsets are 
presented on Figures 7.11. and 7.12. respectively. A main effect for EBV infection was 
observed on the proportions of CD8+ T-cells. Latent EBV infection was not associated 
with any changes in the number of naïve KLRG1-/CD57- and KLRG1-/CD28+ CD8+ 
T-cells immediately after or 1 hour after completion of the cycling protocol (p ˃ 0.05) 
(Figure. 7.11). Latent EBV infection had an impact on the central-memory CD45RA-
/CCR7+ and effector-memory CD45RA-/CCR7- CD8+ T-cells initial concentration in 
the blood (p ˂ 0.05), but was also associated with a greater mobilisation and egress (p ˂ 
0.01 and p ˂ 0.05 respectively) of those cells in response to exercise (Figure. 7.12). 
Exercise-induced changes in memory CD4+ T-cell concentrations were not affected by 
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EBV infection (p ˃ 0.05).  EBV infection was associated with a greater mobilisation of 
senescent KLRG1+/CD28- CD8+ T-cells after exercise when compared to uninfected 
subjects (p ˂ 0.05). This effect of EBV infection on the senescent CD8+ T-cell exercise-
induced mobilisation was also seen on the senescent KLRG1+/CD57+ CD8+ T-cells as 
a non-significant trend (p = 0.100). No significant interaction effect was observed 
between EBV infection and the senescent KLRG1+/CD57+, KLRG1+/CD28- and 
TEMRA CD45RA+/CCR7- CD4+ T-cells concentrations at the different time points 
(Figure. 7.13). 
 
 
Figure 7.11. The impact of EBV latent infection and exercise on the number of CD3+/CD4+ (left) 
and CD3+/CD8+ (right) T-cells exhibiting a naïve phenotype (KLRG1-/CD57- (top) and KLRG1-
/CD28+ (bottom)) (cells.µL
-1
). Values are mean ± SEM. Statistically significant differences from the 
EBV negative group isindicated by ** p ˂ 0.01. 
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Figure 7.12. The impact of EBV latent infection on the central-memory CD45RA-/CCR7+ (top) and 
effector-memory CD45RA-/CCR7- (bottom) CD3+/CD4+ (left) and CD3+/CD8+ (right) cell counts 
changes with exercise (cells.µL
-1
). Values are mean ± SEM. Statistically significant differences from 
the EBV negative group is indicated by * p ˂ 0.05, ** p ˂ 0.01.   
 
 
 
 
 
 
 
 
 
 
 
Figure 7.13. The impact of EBV latent infection and exercise on the number of CD3+/CD4+ (left) 
and CD3+/CD8+ (right) cell exhibiting a senescent phenotype (KLRG1+/CD57+ (top) and 
KLRG1+/CD28- (bottom)) (cells.µL
-1
). Values are mean ± SEM. Statistically significant differences 
from the EBV negative group is indicated by ** p ˂ 0.01.  
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In order to accurately represent the cellular shifts occurring between peripheral tissues 
and the blood compartment, cell mobilization and egress are represented in the Figures 
7.14., 7.15., 7.16. and 7.17. Cellular influx corresponds to the number of cells entering 
the blood compartment during the acute bout of exercise and was obtained by 
subtracting the cell numbers present in the blood before the exercise (Pre) to the amount 
of cells present immediately after the exercise (Post). Cellular efflux corresponds to the 
number of cells leaving the blood compartment during the recovery phase and was 
obtain by subtracting the cell numbers present in the blood immediately after exercise 
(Post) to the amount of cells present in the blood after the recovery phase (1HPost).  
Cellular Influx = cell numberpost – cell numberpre 
Cellular Efflux = cell number1Hpost – cell numberpost 
CMV infected subjects presented a lower naïve CD45RA+/CCR7+ and KLRG1-
/CD28+ CD8+ T-cell mobilization (p ˂ 0.05) than their infection free counterparts. 
While the cycling protocol induced a net increase in naïve CD45RA+/CCR7+ CD8+ T-
cells in the peripheral blood of CMV seronegative subjects, it promoted a reduction in 
those naïve cells in CMV seropositive subjects (p ˂ 0.05). Although not significant, a 
similar trend was observed in the reduced exercise-induced mobilisation of the naïve 
KLRG1-/CD28+ (p = 0.094) and CD45RA+/CCR7+ CD4+ T-cells (p = 0.114) in CMV 
seropositive subjects. EBV infection did not have a significant effect on the different 
naïve CD4+ and CD8+ T-cell subsets mobilisation and egress. (Figure. 7.14).  
CMV and EBV latent infection also had an effect on effector-memory CD45RA-
/CCR7-. While CMV and EBV seropositive subjects statistically mobilised a similar 
amount of effector-memory CD8+ T-cells than infection-free subjects, they presented a 
greater extravastion of CD45RA-/CCR7- CD8+ T-cells during the recovery period 
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when compared to CMV (p ˂ 0.05) and EBV (p ˂ 0.01) seronegative subjects. No effect 
of CMV or EBV latent infections on the central-memory CD45RA-/CCR7+  CD4+ and 
CD8+ T-cells exercise-induced changes were observed (p ˃ 0.05) (Figure. 7.15.). The 
senescent KLRG1+/CD57+ (p ˂ 0.05) and KLRG1+/CD28- (p ˂ 0.05) mobilisation 
after exercise and egress (p ˂ 0.01) during recovery phase was more prominent in CMV 
seropositive subjects, however EBV infection did not have an effect on the senescent 
CD4+ and CD8+ T-cells exercise-induced changes (Figure. 7.16.). While CMV 
infection did not have an impact on the TEMRA CD45RA+/CCR7- CD8+ T-cells 
mobilization, it was associated with a greater extravasation of those cells during the 
recovery phase (p ˂ 0.01) (Figure. 7.17). 
203 
 
 
Figure 7.14. The impact of latent CMV (top half) and EBV (bottom half) infection on cellular 
mobilization and egress of naïve KLRG1-/CD28+ (top) and CD45RA+/CCR7+ (bottom) 
CD3+/CD4+ (left) and CD3+/CD8+ (right) cell counts changes with exercise (cells.µL
-1
). Values are 
mean ± SEM. Statistically significant differences from the CMV positive group is indicated by * p ˂ 
0.05 
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Figure 7.15. The impact of latent CMV (top half) and EBV (bottom half) infection on cellular 
mobilization and egress of central-memory CD45RA-/CCR7+ (top) and effector-memory CD45RA-
/CCR7- (bottom) CD3+/CD4+ (left) and CD3+/CD8+ (right) cell counts changes with exercise 
(cells.µL
-1
). Values are mean ± SEM.   
* 
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Figure 7.16. The impact of latent CMV (top half) and EBV (bottom half) infection on cellular 
mobilization and egress of senescent KLRG1+/CD57+ (top) and KLRG1+/CD28- (bottom) 
CD3+/CD4+ (left) and CD3+/CD8+ (right) cell counts changes with exercise (cells.µL
-1
). Values are 
mean ± SEM. Statistically significant differences from the CMV positive group is indicated by * p ˂ 
0.05 
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Figure 7.17. The impact of latent CMV (top) and EBV (bottom) infection on cellular mobilization 
and egress of TEMRA CD45RA+/CCR7- CD3+/CD4+ (left) and CD3+/CD8+ (right) cell counts 
changes with exercise (cells. µL
-1
). Values are mean ± SEM. Statistically significant differences from 
the CMV positive group is indicated by * p ˂ 0.05 
 
7.3.3. The contribution of viral-specific T-cells to the mobilization of memory and 
senescent T-cells with exercise. 
 
The impact of exercise on the total CMV pp65-specific (n=6) and EBV lmp2-specific 
(n=7) CD8+T-cells are presented on Figure 7.18 and 7.19 respectively. The impact of 
exercise on the total CMV pp65-specific and EBV lmp2-specific CD8+T-cells along 
with the different T-cell subsets are presented on Figure 7.20. The cycling protocol 
induced a significant mobilisation of the total CMV-specific and EBV-specific CD8+ T-
cells (p ˂0.05), followed during the recovery phase by the egress of those viral-specific 
cells to attain the initial level observed in the peripheral blood compartment in the Pre 
sample. As hypothesised, senescent KLRG1+/CD57+ CMV-specific CD8+ T-cells were 
preferentially mobilised by the exercise (Figure. 7.20.) (p ˂ 0.05). A similar exercise-
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induced mobilisation was observed on KLRG1-/CD57+ CMV-specific T-cells (p ˂ 
0.05) (Figure. 7.20.). Levels of “naïve” KLRG1-/CD57- and “memory” 
KLRG1+/CD57- CMV-specific CD8+ T-cells did not significantly change with 
exercise. The cycling protocol also elicited a significant mobilisation of the total EBV 
lmp2-specific CD8+ T-cells (p ˂ 0.05). We observed that naïve (KLRG1-/CD57-), 
memory (KLRG1+/CD57-) and senescent (KLRG1+/CD57+) EBV-specific CD8+ T-
cells were significantly mobilised into the circulation by exercise (p ˂ 0.05). This was 
not the case for the KLRG1-/CD57+ EBV-specific CD8+ T-cells (p ˃ 0.05) (Figure. 
7.20.). 
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Figure 7.18. Representative flow cytometry dotplots highlighting the impact of exercise on the 
CMV-specific pp65+ CD8+ T-cells mobilization in a CMV seronegative subjects (top) and a CMV 
seropositive subject (bottom).   
 
Figure 7.19. Representative flow cytometry dotplots highlighting the impact of exercise on the EBV-
specific lmp-2+ CD8+ T-cells mobilization in a EBV seronegative subjects (top) and a EBV 
seropositive subject (bottom).   
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Figure 7.20. Changes in the total number of CMV pp65-specific CD8+ T-cells (top) and EBV lmp-2-
specific CD8+ T-cells (bottom) and the different subsets in response to exercise in HLA/A2* 
subjects (cells. 100µL
-1
). Values are mean ± SEM. Significant differences from pre-exercise is 
indicated by * p ˂ 0.05.   
 
The mobilisation and egress of each viral-specific T-cell subtype is presented in the 
Figures 7.21. and 7.22. Exercise induced a preferential mobilisation of senescent 
KLRG1+/CD57+ pp65 CMV-specific and lmp2 EBV-specific CD8+ T-cells. While 
memory KLRG1+/CD57- lmp-2 EBV-specific CD8+ T-cells were also mobilised by the 
acute bout of exercise, the memory KLRG1+/CD57- pp65 CMV-specific CD8+ T-cells 
had exited the blood stream immediately following exercise (Figure. 7.21). A 
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preferential egress of senescent KLRG1+/CD57+ pp65 CMV-specific and lmp2 EBV-
specific CD8+ T-cells was also observed during the recovery phase. The memory 
KLRG1+/CD57- CD8+ lmp2 EBV-specific CD8+ T-cells were also seen to be 
importantly removed from the peripheral blood compartment during the recovery phase. 
While some antigen-specific KLRG1-/CD57- cells were identified they are not 
considered as naive cells, but very early differentiated cells that are yet to undergo 
further differentiation (Figure. 7.22).  
 
 
 
Figure 7.21. Mobilization (left) and egress (right) of the total number of CMV pp65-specific CD8+ 
T-cells and EBV lmp-2-specific CD8+ T-cells  and the different subsets in response to exercise in 
HLA/A2* subjects (cells. 100µL
-1
). Values are mean ± SEM.  
211 
 
 
Figure 7.22. Changes in the proportions of total CMV pp65-specific (left) and EBV lmp-2-specific 
(right) CD8+ T-cells and their different cell subsets in response to exercise. The different cell 
subsets are characterised depending on KLRG1 and CD57 surface expression. Values are 
expressed as the percentage of all gated CD3+/CD8+ pentamer positive or pentamer negative T-
cells (in %). Values are mean ± SEM. 
 
The effect of exercise on the mobilization and egress of total CD8+ T-cells and viral-
specific CD8+ T-cells exhibiting a senescent phenotype (KLRG1+/CD57+) are 
presented on Figure 7.23. Both latent CMV and EBV infection were associated with a 
greater mobilization and egress of total senescent CD8+ T-cells than their seronegative 
counterpart (Figure. 7.23). However, the number of senescent pp65 CMV-specific 
CD8+ T-cells and lmp2 EBV-specific CD8+ T-cells entering and leaving the peripheral 
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blood compartment in response to exercise accounted for less than 1% of all mobilized 
cells (Figure. 7.23).  
 
Figure 7.23. The impact of latent CMV (top) and EBV (bottom) infection on the mobilisation (left) 
and egress (right) of total and either pp65 CMV-specific or lmp2 EBV-specific CD8+ T-cells 
exhibiting a senescent phenotype (KLRG1+/CD57+).  
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7.4. Discussion 
 
The study presented in this chapter sought to determine the effect of acute aerobic 
exercise on highly differentiated effector-memory and senescent CMV-specific or EBV-
specific T-cells and more generally to characterise the impact of CMV and/or EBV 
latent infection on the exercise-induced immune changes in young adults. The major 
findings in this study were: (1) CMV infected subjects had more senescent T-cells than 
non-infected. Furthermore those senescent T-cells were mobilized and left the 
peripheral blood compartment in greater numbers in response to exercise in CMV 
infected subjects than non-infected. (2) EBV infection did not impact the mobilization 
or egress of senescent T-cells in response to exercise (3) CD8+ T-cells specific to 
epitopes of the CMV and EBV viruses were mobilized into the blood with exercise but 
unlike recent hypothesis  (Turner et al. 2010),  these contributed very little to the 
amplified mobilization of senescent T-cells seen in CMV and EBV infected people. 
 
TEMRA and senescent T-cells are preferentially mobilised in the peripheral blood 
compartment following acute bouts of exercise, in young and older adults (Simpson et 
al. 2007a; Simpson et al. 2008; Turner et al. 2010). As latent herpesvirus infections 
have also been associated, although to a lesser extent, with increased frequencies of 
senescent T-cells in younger individuals; it was hypothesised in this study that young 
adults carrying a latent CMV and/or EBV infection would mobilize greater numbers of 
terminally differentiated T-cells following exercise than non-infected subjects. While a 
recent study had already highlighted the potentiating effects of latent CMV infection on 
the exercise-induced egress of effector-memory and TEMRA T-cells (Turner et al. 
2010), this is the first study to show that CMV infection is associated with a greater 
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exercise-induced preferential mobilisation of senescent T-cells, in the detriment of the 
naïve T-cells mobilisation as seen in CMV seronegative subjects. Although EBV 
infection is often regarded as having less consequential impacts on the immune system 
than CMV infection, we discovered that EBV seropositive subjects were experiencing 
similar increased exercise-induced changes on the proportions of memory, senescent 
and TEMRA CD8+ T-cells. We did not however verify our third hypothesis stating that 
preferential mobilization and egress of highly differentiated effector-memory and 
senescent viral-specific T-cells in CMV and/or EBV infected subjects were the principal 
actors of the enhanced memory and senescent T-cell shifts seen in viral seropositve 
subjects following acute bouts of exercise.  
 
7.4.1. Latent viral infections impact on the immune system of young men 
 
Repeated immune challenges throughout a lifetime lead to the accumulation of highly-
differentiated memory and senescent T-cells in blood (Koch et al. 2008; Simpson et al. 
2008). While increased proportions of memory and dysfunctional senescent T-cells are 
a feature of normal chronological ageing in mammals, the rate by which they 
accumulate in the elderly has been shown to be drastically influenced by latent 
herpesvirus infections (Kern et al. 1999; Wikby et al. 2002; Ouyang et al. 2003a; 
Ouyang et al. 2003b; Thimme et al. 2005). Although the role played by latent 
herpesvirus infection on the precipitation of senescent T-cell accumulation has been 
well documented in the elderly, only very few studies have assessed the impact of 
herpesvirus infections alone by studying young populations (Akbar & Fletcher 2005; 
Vescovini et al. 2007; Turner et al. 2010). Indeed senescent T-cells accumulation in the 
blood with chronological ageing is assumed to follow a linear progression; however 
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herpesvirus infections could modify this dynamics into an inverse exponential 
progression due to initial infection followed by a progressive decline in reactivation 
frequencies. The differences in senescent T-cell proportions seen among elderly 
populations have great clinical implications and are partial predictors of morbidity and 
mortality when grouped under the IRP with other immune markers, including a 
CD4/CD8 ratio inferior to 1, reduced proportions of naïve T-cells and latent infections 
to the herpesvirus CMV and EBV (Wikby et al. 1998; Olsson et al. 2000; Wikby A. 
2003). In the present study, EBV seropositivity alone was associated with a reduced 
CD4/CD8 ratio compared to infection-free subjects, probably linked to an increase in 
memory CD8+ T-cells; however, the CD4/CD8 ratio reduction was not substantial 
enough to be qualified as a feature of the IRP. This could be explained by the potential 
recent EBV contamination of the subjects tested in this study as a direct consequence of 
their young age (mean 28.5 ± 5 years old). Similarly to CMV single-infection, latent 
CMV and EBV co-infection did not have an impact on the CD4/CD8 ratio. It is 
interesting to observe that while some researchers have reported a greater prevalence of 
EBV seropositivity amongst CMV seropositive subjects (Alvarez-Lafuente et al. 2008; 
Wang et al. 2010), in young adults EBV infection appears to be unrelated to CMV 
infection (p ˃ 0.05).  
In order to analyse the impact of herpesvirus infection on the proportions of resting 
naïve, memory and senescent T-cells, different cell populations based on their 
expression of cell surface molecules (Table 7.1). Highly differentiated effector-memory 
T-cells (TEMRA) were isolated based on their expression of CD45RA concurrent with 
their down-regulation of CCR7. While the common perception is that CD45RA+ T-
cells that do not express CCR7 identifies a population of terminally differentiated T-
cells, this is contentious as CD45RA, in addition to being highly expressed on naïve T-
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cells, is also re-expressed on T-cells that have not encountered their specific antigen in a 
certain time span, and is not related to their proliferative capacity (Dunne et al. 2002; 
Carrasco et al. 2006). Consequently a distinction was made between TEMRA and 
senescent T-cells. Classified as such, a correlation between CMV infection and reduced 
frequencies of naïve CD45RA+/CCR7+ CD8+ T-cells was found, and an increase in 
both TEMRA CD8+ T-cells and senescent CD4+ and CD8+ T-cells. While EBV 
infection did not have an impact on the naïve and senescent T-cells frequencies, it was 
associated with a non-significant reduction of TEMRA CD8+ T-cells, potentially due to 
the confounding effect of CMV co-infection, dampening the EBV-associated reduction 
in TEMRA CD8+ T-cells. In accordance with other studies (Pawelec et al. 2005), no 
effect of CMV or EBV infection on the different memory CD4+ and CD8+ T-cell 
populations was identified. Interestingly, contrarily to the hypothesis of the study 
presented in this chapter, no interaction or synergistic effects of CMV and EBV in co-
infected subjects was observed on the resting T-cell repertoire. Although this could be 
explained by the lack of impact of EBV infection on the different T-cell subsets or the 
small amount of EBV+/CMV- subjects, it could also be due to the limited amount of 
time the subjects were infected by both viruses. 
 
7.4.2. Latent viral infections impact exercise-induced immune changes in young men 
  
The rapid mobilization of lymphocytes into the peripheral blood compartment following 
an acute bout of exercise is consistently observed throughout the literature. Senescent 
and highly-differentiated T-cells have been shown to be more sensitive to exercise-
induced lymphocytosis by being mobilized in relatively greater number compared to 
naïve and early differentiated T-cells (Simpson et al. 2007a; Simpson et al. 2008; 
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Simpson et al. 2010b; Turner et al. 2010), however the potential confounding effect of 
herpesvirus infections is still to be determined.  
In accordance with the current literature, a transient mobilization of senescent and 
memory T-cells was seen immediately after exercise, followed by the return of cell 
numbers to baseline restoration (Simpson et al. 2007a; Simpson et al. 2008; Turner et 
al. 2010). CMV infection did not have an impact on the concentration of CD8+ T-cells 
in peripheral blood compartment following exercise or during the recovery period. This 
could be explained by the preferential shift of certain cell subsets. Indeed, while naïve 
CD8+ T-cells (KLRG1-/CD28+ and CD45RA+/CCR7+) in CMV seronegative subjects 
exhibited a classical exercise-induced mobilization followed by a decrease in cell 
number during the recovery phase, naïve CD8+ T-cells in CMV seropositive subjects 
did not appear to respond to the exercise protocol. Contrarily, senescent 
(KLRG1+/CD57+ and KLRG1+/CD28-) and TEMRA (CD45RA+/CCR7-) CD8+ T-
cells from CMV seropositive subjects were mobilized in greater number with exercise 
than the same cell types isolated from CMV seronegative subjects.   
TEMRA and senescent T-cells have increased effector capacities (Ibegbu et al. 2005), 
consequently, their increased exercise-sensitivity could be related to a required 
enhanced immune-surveillance induced by stressors such as physical exercise or 
psychological stressors (Bosch et al. 2009). It is interesting to observe that different cell 
types responded to exercise in EBV seropositive subjects. Indeed while naïve CD4+ and 
CD8+ T-cells had a similar response regardless of EBV infection status, EBV 
seropositive subjects had a greater number of central-memory (CD45RA-/CCR7+) 
CD8+ T-cells prior, immediately after and 1 hour after exercising than EBV 
seronegative subjects who did not elicit a response in central-memory cell counts 
throughout the test. The absolute exercise-induced mobilization and egress of those cell 
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types were however not different in EBV seropositive and EBV seronegative. Effector-
memory (CD45RA-/CCR7-) cells were also mobilized and egressed in greater number 
in EBV-infected subjects in response to exercise. Central-memory cells constitutively 
express the chemokine receptor CCR7, necessary for cell extravasation through high 
endothelial venules and migration to secondary lymphoid organs (Forster et al. 1999), 
making them more available for antigenic stimulation than effector-memory cells. 
These findings are consistent with the study hypothesis that exercise enhances immune 
cells recirculation in a context of immune vigilance in response to stressors. 
Furthermore, highly differentiated T-cells have been shown to express higher level of 
the catecholamine receptor β2-adrenergic receptor (Karaszewski et al. 1991; Dimitrov 
et al. 2009; Dimitrov et al. 2010), and are consequently likely to respond specifically to 
the increased concentrations of catecholamine seen during acute bouts of exercise 
(Christensen & Galbo 1983; Mazzeo 1991). However no interaction effect between 
CMV and EBV co-infection was observed on the exercise-induced T-cell response.  
Latent herpesvirus infection is associated with alteration in the resting T-cell repertoire, 
as described above. In order to assess accurately cell exercise-induced trafficking in 
function of infection status, cell mobilization and egress were analysed independently to 
the number of cells present in the blood prior to the exercise. Interestingly only a non-
significant enhanced mobilization of CD4+ naïve T-cells (KLRG1-/CD28+; 
CD45RA+/CCR7+) (p = 0.094 and p = 0.110 respectively) in CMV seronegative 
subjects was observed when compared to the CMV seropositive subjects and a greater 
senescent and TEMRA CD8+ T-cell withdrawal in CMV seropositive subjects. A recent 
study has shown that effector-memory and highly-differentiated T-cells were more 
mobilized during acute bouts of exercise and exited the peripheral blood compartment 
to a greater extend in CMV seropositive subjects (Turner et al. 2010). This is in partial 
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concordance with the results presented in this chapter, where an impact of CMV on 
highly differentiated TEMRA and senescent CD8+ T-cells egress was seen, but there 
was no difference in mobilization of those cells between CMV positive and negative 
subjects. Besides the phenotypical differences used in the characterization of highly 
differentiated and senescent T-cells, the divergence of results is inferable to the longer 
and more intense exercise protocol presented in Turner et al. (2010). Indeed as the 
preferential mobilization of highly differentiated TEMRA and senescent T-cells in 
response to exercise has been shown to be varying according to the type, intensity and 
duration of the bout of exercise (Simpson et al. 2007a; Simpson et al. 2008; Campbell 
et al. 2009). EBV infection alone, or in combination with CMV, did not appear to 
influence the exercise-induced shifts in the numbers or proportions of naïve, memory or 
senescent CD4+ and CD8+ T-cell.  
The results presented in this chapter show a greater egress of senescent T-cells during 
the recovery phase in CMV seropositive subjects, compared to CMV seronegative 
subjects.  Some researchers have hypothesized that the reduction in highly differentiated 
and senescent T-cells observed after acute bouts of exercise was the result of cell 
clearance via immediate apoptosis in the peripheral blood compartment instead of 
cellular extravasation (Cioca et al. 2000; Mooren et al. 2002; Mooren et al. 2004), but 
recent literature tends to disagree (Peters et al. 2006; Simpson et al. 2007b; Navalta et 
al. 2010). It is indeed more likely that those highly cytotoxic T-cells are being re-
directed towards peripheral tissues to either be eliminated via delayed apoptosis (up to 
24 hours post-exercise) in peripheral organs such as the spleen, lungs or Peyer’s patches 
(Kruger et al. 2009) or to ensure immune integrity of the host by enhanced potential 
antigen contact. Consequently, by periodically recreating acute aerobic exercise, this 
exercise-induced lymphocytosis and delayed cell apoptosis could be a potential 
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mechanism for creating “vacant immune space” and inducing homeostatic production of 
naïve T-cells (Simpson & Guy 2010). Although this could be a mechanistic explanation 
of the beneficial effect of regular physical activity on the naïve T-cell repertoire 
described in Chapter 4 of this thesis; this hypothesis remains to be tested as no study to 
date has assessed the exact tissue destination and fate of those cells after their 
extravasation from the peripheral blood compartment. 
 
7.4.3. Contribution of viral-specific T-cells to the exercise-induced preferential 
mobilization of memory and senescent T-cells. 
 
The study presented in this chapter sought to determine if the greater numbers of 
senescent cells that are mobilized in CMV and EBV seropositive subjects were specific 
to these viruses. Indeed, as complete clearance of the virus is never achieved, CMV and 
EBV will be periodically reactivated in response to physical or psychological stress 
(Almanzar et al. 2005) throughout the lifetime, inducing the clonal expansion of virus-
specific CD8+ T-cell clone and thus contributing to immune exhaustion (Koch et al. 
2006). It was hypothesized that the CMV and EBV associated increase in TEMRA and 
senescent T-cells numbers in response to exercise was due to viral-specific T-cell 
preferential mobilization. Contrarily to this hypothesis, the results presented in this 
chapter showed that the number of viral-specific T-cells exhibiting a senescent 
phenotype mobilized and exiting the peripheral blood compartment in response to 
exercise only accounted for less than 1% of the difference in senescent T-cell 
mobilization between CMV seropositive and CMV seronegative subjects.  
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It was found that although the numbers of resting naïve, memory and senescent pp65 
CMV-specific and lmp2 EBV-specific CD8+ T-cells appear to be similar, the 
proportions of senescent pp65 CMV-specific and lmp2 EBV-specific senescent T-cells 
are greater than the proportions of naïve viral-specific T-cells (CMV-specific: 40.4% vs 
24.9%; EBV-specific: 42.8% vs 25.2%). Consequently, CMV infection and EBV 
infection are associated with increased proportions of memory and senescent viral-
specific T-cells as hypothesized. Furthermore, pp65 CMV-specific senescent T-cells 
were preferentially mobilized with exercise along with memory (KLRG1-/CD57+) T-
cells compared with “naïve” CMV-specific T-cells. Exercise also mobilized lmp2 EBV-
specific “naïve” (or central-memory), memory (KLRG1+/CD57-) and senescent T-cells. 
Total CMV-specific T-cells mobilization is principally resulting from senescent CMV-
specific T-cells and to a small extent memory viral-specific T-cells entry in the blood 
compartment, while total EBV-specific T-cells mobilization is principally resulting 
from “naïve”, memory and senescent EBV-specific T-cells mobilization. Similarly to 
total memory and highly differentiated effector-memory T-cell egress during the 
recovery phase in EBV seropositive subjects, EBV-specific memory T-cells are 
preferentially leaving the blood compartment during the recovery phase. However, as 
stated above, the very small number of viral-specific T-cells exhibiting a senescent 
phenotype mobilized and exiting the peripheral blood compartment in response to 
exercise could not explain the CMV and EBV-associated difference in senescent T-cell 
mobilization.  
Consequently, a direct impact of CMV on T-cell proliferation via a classical adaptive 
immune response does not appear to be the main culprit for the increase of highly 
differentiated and senescent T-cells in seropositive subjects, other CMV-induced 
mechanisms should be considered. One of which could be T-cell bystander activation 
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during latent herpesvirus reactivation. Activated antigen-presenting cells produce 
interferon-α (IFN-α) and interferon-β (IFN-β) during herpesvirus reactivation, leading 
to STAT-1 activation and ultimately to IL-15 release (Tough et al. 1996; Tough et al. 
1997). This production of IL-15 will induce the heterologous proliferation of cells 
expressing high level of the β chain of the IL-2 receptor, such as memory and highly 
differentiated CD8+ T-cells (Zhang et al. 1998), potentially leading to the accumulation 
of heterologous CD8+ T-cells, that are not specifically directed towards CMV or EBV. 
Interestingly, CD4+ T-cell bystander activation has also been proposed in activated 
CD4+ T-cells expressing the complete form of the IL-2 receptor (CD25 and CD122) in 
response to IL-2 produced by antigen-specific activated CD4+ T-cells (Boyman 2010; 
Di Genova et al. 2010). However, this hypothesis remains to be tested in context of 
CMV and EBV infections.      
Regarding the limitations of this study, viral-specific T-cells could not be assessed in all 
CMV and EBV infected subjects due to the viral-specific pentamers used. Indeed the 
pentamere technology requires subjects to express a specific HLA allele (HLA*A201), 
and only 6 of the CMV positive subjects expressed this allele and 7 of the EBV positive 
subjects were HLA*A201 positive. While HLA*A201 is the most prevalent allele in the 
general population, only around 50% of the population are expressing HLA*A201 (Lee 
et al. 1990) and consequently viral-specific T-cells could not be isolated in CMV and 
EBV seopositive subjects that expressed another HLA allele, as their T-cell receptor 
would not recognize the HLA*A201-pentamere complex. Furthermore, another 
limitation in the characterization of viral-specific T-cells may have led to their under-
estimation. Indeed many viral-proteins are recognized by T-cells, and although pp65 
and lmp2 have been shown to be good target proteins to monitor CMV and EBV-
specific T-cells respectively (Gibson et al. 2004; Gibson et al. 2007; Lalonde et al. 
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2007), 20 other peptides have been shown to be immunogenic for T-cells (Sylwester et 
al. 2005). While other techniques have been used in the past to characterize the 
proportions of viral-specific T-cells, such as ELISPOTs, the use of flow cytometry to 
assess the proportions of pentamer-bound viral-specific T-cells is considered to be the 
most accurate determination technique. However the single use of pp65-specific or 
lmp2-specific pentamers may not be representative of the entire population of CMV-
specific and EBV-specific T-cells and the proportions of viral-specific T-cells observed 
may have been under-evaluated. Another limitation of this study is to be found in the 
protocol used to estimate individual subjects’ workload. Subjects cycled for 30 minutes 
at a fixed-intensity corresponding to 85% of their maximum Wattage. However, this 
intensity was estimated based on a submaximal  ̇      test  (Astrand 1960), which 
could have potentially led to inaccuracies and to overestimated workload in certain 
subjects. Finally both the sample size (n=19) and sex (exclusively male) can be seen as 
a limitation. While additional subjects could have been tested, it was decided to exclude 
women from the study, mostly because CMV effect on the immune system is more 
pronounced in men. Indeed T-cell functions are known to be influenced by progesterone 
and oeastradiol (as reviewed by (Beagley & Gockel 2003)) in a menstrual cycle-
dependent manner (White et al. 1997) and could have been a confounding factor in the 
analysis of CMV and EBV infection impact on the exercise-induced cell trafficking. 
Furthermore, the results presented in Chapter 5 of this thesis suggest that women have 
fewer senescent T-cells than men during adolescent. Although no study in this thesis 
analysed the effect of gender on the accumulation of senescent T-cells at an older age, 
the potential delayed onset of immunosenescence could be protecting female subjects 
from enhanced immune-senescence triggered by herpesvirus infections. A future study 
should analyse gender-associated difference in immunosenescence across the lifespan.        
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In conclusion, latent CMV and EBV infections are associated with immune changes and 
following acute bouts of exercise. While the association between CMV infection and 
increased proportions of senescent T-cells in the elderly are well documented (Wikby et 
al. 2002; Wikby A. 2003; Pawelec & Gouttefangeas 2006; Pawelec et al. 2009), the 
results presented in this study showed a similar impact on younger adults. They also 
highlighted that senescent T-cells in CMV infected subjects are mobilized in great 
quantities in blood and preferentially exit the peripheral blood compartment. This could 
be interpreted as an increased stress-sensitivity of senescent cells in subjects infected 
with CMV, leading to an increased immune surveillance by the recirculation of cells 
with high killing capacities. Finally it was demonstrated that the increase of TEMRA 
and dysfunctional senescent T-cells observed in subjects infected by latent 
herpesviruses, is not related to viral-specific T-cells, and consequently cannot be linked 
to oligoclonal T-cell expansion.     
The study presented in this chapter was conducted to assess the impact of herpesvirus 
infections on the proportions of resting naïve, memory and senescent T-cells along with 
their impact on exercise-induced immune changes in young adults. However 
chronological ageing has been reported to greatly impact the proportions of those 
specific cell-types (Wikby et al. 1998; Brzezinska 2005), consequently future studies 
should assess the effect of herpesvirus infections on the age-associated increase in 
senescent T-cells. Such a study could determine if the age-associated accumulation of 
TEMRA and senescent T-cells is indeed due to chronological ageing, or rather CMV 
infection and repeated viral reactivations.  
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CHAPTER 8 
GENERAL DISCUSSION 
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The studies comprising this thesis investigated the effects of lifestyle factors such as 
physical activity or obesity, along with latent viral infections on T-cell differentiation 
indicative of immunosenescence. Data was gathered from human subjects of various 
age, physical activity, body composition and viral infection status and the analysis of 
cell surface phenotypes was conducted using four-colour flow cytometry. When 
mechanisms potentially affecting T-cell phenotypic shifts were identified, in vitro 
stimulation assays followed by cell surface phenotype and gene expression analysis on 
isolated T-cell subsets were performed. Where the effect of acute bouts of exercise on  
T-cells subsets was characterized, differences in peripheral blood composition based on 
cell surface phenotypes among lymphocytes in resting, exercised and recovery blood 
samples were assessed.   
 
8.1. Main findings of the studies presented in this Thesis 
The aim of this thesis, as stated in Chapter 2, was to address the dearth of information 
regarding the impact of different lifestyle factors and viral infection status on the 
accumulation of highly differentiated and senescent T-cells based on the cell surface 
expression of identified markers of senescence. Although chronological ageing has been 
considered as the main culprit of immunosenescence, the studies presented within this 
thesis were conducted to highlight the importance of behaviors and viral infection 
history on both the accumulation of senescent T-cells and the shrinkage of naïve T-cell 
repertoire, independently of ageing. Many novel findings have resulted from the 
different studies comprised within this thesis. In respect to the specific aims of those 
studies, described in Chapter 2, the main findings of the studies described within this 
thesis are: 
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Aim 1: Investigate the association of physical activity and aerobic fitness and the age-
 related increase of effector-memory and senescent T-cells in adult men (Chapter 
 4). 
 
Main Finding: Aerobic fitness is associated with a lower proportion of senescent and a  
higher proportion of naïve T-cells, particularly within the CD8+ T-cell 
 compartment in healthy adult men. The beneficial impact of aerobic 
 fitness, and consequently of regular physical activity, on the 
 ageing immune system is independent of age, latent viral infection status 
 and body composition. 
 
Aim 2: Investigate the relationship between excess body mass and the proportions of the 
different T-cell subsets in an age-controlled population of adolescents (Chapter 
5). 
 
Aim 3:  Investigate the association between serum leptin concentrations and the 
proportions of effector-memory and senescent T-cells in an age-controlled 
population of adolescents (Chapter 5). 
 
Main Findings:  (1) Excess body mass was associated with reduced proportions of naïve 
  T-cells in Mexican-American adolescents. Obese subjects and subjects 
  at risk for overweight had greater frequencies of CD8+ effector- 
  memory T- cells and CD4+ senescent T-cells than subjects with an 
  appropriate weight. 
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 (2) Elevated serum leptin concentrations were associated with reduced  
 frequencies of naïve T-cells. Individuals with the highest serum leptin 
concentrations had greater proportions of effector-memory CD8+ T-
cells than subjects with lower serum leptin concentrations. Elevated 
serum leptin concentrations were also associated with an accumulation 
of senescent CD4+ T-cells. 
 
(3) After adjusting for age, latent viral infection, gender and quality of 
life, excess body mass was still associated with a reduction in naïve T-
cell frequencies and an increase in effector-memory T-cells and 
senescent CD4+ T-cells. Latent viral infections were associated with 
reduced frequencies in naïve T-cells and in increased frequencies in 
memory and senescent T-cells. Unexpectedly, while quality of life did 
not have an impact on the T-cell repertoire, gender had a significant 
impact on the different T-cell subsets frequencies. Indeed, female 
individuals had greater frequencies of naïve T-cells and fewer 
effector-memory and senescent T-cells 
 
Aim 4:  Investigate the impact of high concentrations of serum leptin on T-cell 
activation state (Chapter 6). 
 
Main Findings: (1) Serum leptin alone did not induce peripheral blood T-cell activation, 
     however leptin enhanced the mitogen-induced T-cell activation. 
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 (2) A limited proportion of resting T-cells expressed OB-Rb, however 
 they constitutively expressed OB-Rb mRNA. Mitogen-induced T-cell 
 activation led to the up-regulation of OB-Rb mRNA when cells were 
 costimulated with high physiological doses of leptin typically seen in 
 obese individuals, but not with the low level of leptin typically seen in 
 lean subjects. 
 
Aim 5: Investigate the impact of latent viral infections on blood T-cell phenotypes in 
healthy young adult men (Chapter 7). 
 
Aim 6: Investigate the impact of the latent viral infections on the exercise-induced 
changes in T-cell subsets (Chapter 7). 
 
Aim 7: Investigate the contribution of viral-specific T-cells to the mobilization of 
memory and senescent T-cells with exercise (Chapter 7). 
 
Main Findings:  (1) CMV infected individuals had reduced proportions of naïve CD8+ 
T-cells and greater proportions of highly differentiated effector-
memory and senescent T-cells than non-infected individuals. EBV 
infection was not associated with changes in the T-cell repertoire. 
 
 (2) Senescent T-cells were mobilized and left the peripheral blood 
compartment in response to exercise in greater numbers in CMV 
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seropositive individuals, compared to non-infected individuals. A 
greater number of highly differentiated effector-memory T-cells were 
removed from the blood during the recovery phase  in CMV 
seropositive individuals than in CMV seronegative individuals. EBV 
infection did not impact the mobilization or egress of naïve and 
senescent T-cells, however a greater number of effector-memory 
CD8+ T-cells were mobilized and  left the blood in EBV seropositive 
individuals than in non-infected individuals.  
   
(3) CD8+ T-cells specific to epitopes of the CMV and EBV viruses 
were mobilized into the blood compartment with exercise but unlike 
recent hypothesis  (Turner et al. 2010),  they did not contribute 
significantly to the amplified mobilization of senescent T-cells seen in 
CMV and EBV infected individuals. 
 
8.2. Exercise 
 
Immunosenescence has been linked with many chronic conditions and is believed to 
directly or indirectly contribute to mortality in later life (Cawthon et al. 2003; Valdes et 
al. 2005; Koch et al. 2007; Starr et al. 2007). One striking feature of immunosenescence 
and advancing age is the accumulation of highly differentiated memory and senescent 
T-cells and a concomitant reduction in the numbers and proportions of fully functional 
naïve T-cells within the periphery (Effros et al. 1994a; Pawelec et al. 1996; Effros 
1997; Spaulding et al. 1997; Ouyang et al. 2004). In addition to chronological ageing, 
certain lifestyle factors such as reduced physical activity and excessively sedentarity 
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lifestyles have also been shown to precipitate leukocyte telomere shortening and up-
regulation of p16
INK4a
 mRNA expression (Cherkas et al. 2008; Ludlow et al. 2008; 
Mirabello et al. 2009; LaRocca et al. 2010; Song et al. 2010). However, while those 
measures are considered to be pertinent markers of biological ageing, the direct impact 
of regular physical activity on the T-cell repertoire composition was not known. 
Furthermore, because no physical determinations of fitness level were conducted in 
these studies, nor were used validated self-reported questionnaire for physical activity, 
no conclusion could be drawn on the specific impact of physical activity on T-cell 
senescence. 
It has been demonstrated in this thesis that aerobic fitness has a moderating effect on the 
age-related accumulation of senescent T-cells (Chapter 4). It was established that above 
average scores of aerobic fitness were associated with lower proportions of senescent T-
cells and higher proportions of naïve T-cells. The study presented in Chapter 4 confirms 
suggestions made by other researchers who advocated that regular physical activity 
could have beneficial effects on the immune system (Valdes et al. 2005; LaRocca et al. 
2010; Song et al. 2010). Contrarily to these studies the present experimental design 
allowed an accurate characterization of the impact of aerobic fitness on the proportions 
of the different T-cell subsets. Indeed exercise tests were performed on each participants 
to estimate their aerobic fitness levels, which is likely to yield more accurate estimates 
of aerobic fitness than the self-reported estimation of physical activity that have been 
used previously. Secondly, the cell surface phenotypic techniques used permitted the 
identification of biomarkers of ageing and the influence of chronological age and fitness 
status on blood lymphocyte subtypes (i.e. CD4+ and CD8+ T-cells), allowing for a 
more accurate quantification of the cell types involved. The impact of exercise on T-cell 
differentiation was examined using two methods, a self-reported physical activity level 
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score and an estimation of  ̇      from a laboratory-based exercise test. While the 
questionnaire-based estimation technique is a simple, convenient way to quantify 
physical activity scores, it was not found to have as much of an impact on age-
associated T-cell phenotypic changes compared to the  ̇      scores obtained from the 
exercise test. As expected, the use of self-reported activity scores to determinate 
physical fitness levels presents inaccuracy and lacks sensitivity, possibly due to 
increased intra-group variations, when compared to a laboratory-based exercise test.  
Using estimated  ̇      measurements the results showed that a difference in estimated 
 ̇      of 10mlkg
-1min-1 was associated with a 9.5% difference in the proportion of 
senescent CD8+ T-cells independently of age. Furthermore, the data presented in 
Chapter 4 showed that this increase in aerobic fitness, corresponding to a transition 
from a  ̇      below average to a  ̇      above average, could offset the age-associated 
accumulation of CD8+ senescent T-cells, found to increase by 10% per decade. 
Senescent T-cells are known to accumulate in the immunological space to the detriment 
of naïve T-cells (Effros et al. 1994a; Cossarizza et al. 1996; Spaulding et al. 1997; 
Lazuardi et al. 2005) with chronological ageing, however, the data presented in Chapter 
4 are suggesting that regular physical activity may prevent the accumulation of 
senescent T-cells in middle-aged men, but also prevent the naïve T-cell repertoire 
shrinkage. Indeed the results showed that while every decade of age was associated with 
a reduction of 10% of naïve CD8+ T-cells, an increase in estimated  ̇      of 10mlkg
-
1min-1 was associated with an increase of the same proportion of naïve CD8+ T-cells 
independently of age. Furthermore, after accounting for fitness level, chronological age 
was no longer associated with senescent T-cell proportions. These data suggest that 
regular physical activity exerts direct protective effects on the ageing immune system, 
preventing the early transition to the IRP category in later life. This novel finding ties in 
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with the differences in immune state observed among the elderly population, providing 
another potential explanation on why some elderly are more competent in responding to 
newly evolving pathogens.  
The mechanisms by which regular physical activity dampens the accumulation of 
senescent T-cells is still not known, however as proposed in Chapter 7, it is plausible to 
hypothesize that periodic repetition of acute bouts of exercise over an extended period 
of time may play an important role in this process. Indeed the study presented in 
Chapter 7 investigated the effect of acute bouts of exercise on the preferential 
mobilization of senescent T-cells in the peripheral blood compartment. The data showed 
that TEMRA and senescent T-cells were preferentially mobilized in the blood following 
exercise, and preferentially exited the blood compartment during the recovery phase, 
confirming findings available in the current literature (Simpson et al. 2007a; Simpson et 
al. 2008). Furthermore, numerous studies have shown that acute bouts of exercise 
altered lymphocyte susceptibility to apoptosis. Indeed, acute bouts of exercise appear to 
up-regulate cell surface receptors involved in apoptosis, such as Fas receptor (Mooren et 
al. 2002; Mooren et al. 2004) and TNFα receptors 1 and 2 (Pedersen et al. 1999), but 
also increase the production of ROS contributing to oxidative stress (Vider et al. 2001b) 
and the secretion of salivary and plasma TNF-α (Rahman et al. 2010). Considering that 
senescent T-cells are sought to be more resistant to apoptosis than their less 
differentiated counterparts (Spaulding et al. 1999; Bryl et al. 2001a; Hsu et al. 2001; 
Effros 2004), their preferential mobilization combined with the pro-apoptotic signals in 
the environment and apoptosis-inducing alterations of the cell surface markers may 
enhance their susceptibility to be cleared via delayed apoptosis (up to 24 hours post-
exercise) in peripheral organs such as the spleen, lungs or Peyer’s patches (Kruger et al. 
2009). While it is plausible to hypothesize that periodically recreating acute bouts of 
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exercise could lead to the creation of “vacant immune space” and the subsequent 
homeostatic production of naïve T-cells (Simpson 2011), providing a mechanistic 
explanation of the beneficial effect of regular physical exercise presented in Chapter 4, 
the exact fate of the mobilized T-cells following exercise remains to be investigated. 
Many of the currently available therapeutic interventions (i.e. gene, cytokine, hormone 
and monoclonal antibody therapy) that have been proposed to negate ageing immunity 
(Greenstein et al. 1987; Kendall et al. 1990; Phillips et al. 2004; Rosenberg et al. 2006) 
are risky and bear a large number of undesired side effects and ethical complications, 
consequently physical exercise could be considered a safer alternative strategy to 
combat age-related immunosenescence. 
Although the impact of estimated  ̇      on the T-cell subsets withstood adjustment 
for, BMI, percentage body fat and waist/hip ratio (Chapter 4), and body composition 
was not associated with the different T-cell subsets, the potential effect of an excess 
body mass and adiposity on the accumulation of senescent T-cell could not be refuted. 
Indeed the study presented in Chapter 4 was conducted on a homogeneously lean 
population with less than 7% of obese subjects, in order to control for body mass and 
adiposity. It was consequently necessary to investigate the impact of excess body mass 
and high adiposity on the T-cell repertoire, using an age-controlled population with a 
wide range of body weight and adiposity (Chapter 5). 
 
8.3. Obesity 
 
Chapter 5 investigated the proportions of the different T-cell subsets, characterized by 
their expression of CD28, CD27, CD57, CD45RA and CCR7 in an age-controlled 
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population of Mexican-American adolescents of heterogeneous body mass and body 
composition. Reduced proportions of naïve or early differentiated CD4+ and CD8+ T-
cells were observed in subjects at risk for overweight and in obese subjects when 
compared to the subjects with an appropriate weight. In addition, increased proportions 
of memory or intermediate CD4+ T-cell subsets were observed in obese subjects and 
greater proportions of effector-memory CD8+ T-cell subsets were observed in subjects 
at risk of obesity and in obese subjects when compared to the subjects with an 
appropriate weight. Similarly, greater proportions of senescent or late differentiated 
CD4+ T-cell subsets were found in obese and subjects at risk of obesity than in subjects 
with an appropriate weight. Potential confounding factors may affect the T-cell 
repertoire and accumulation of senescent T-cells, such as age (Spaulding et al. 1997), 
gender, quality of life or latent viral infection (Chapter 7), consequently generalized 
linear models were generated to analyze the data while controlling for all those factors. 
When controlled for all the potential factors significantly affecting the T-cell repertoire, 
age-adjusted body mass was still correlated with a reduction in naïve T-cell proportions, 
and a concomitant increase in effector-memory T-cells and senescent CD4+ T-cells. 
These data suggest an accumulation of differentiated T-cells along with senescent CD4+ 
T-cells in overweight and obese individuals, a new finding providing new insights on 
the state of immunosuppression associated with obesity. Furthermore, these interesting 
results were obtained from young subjects, suggesting that obesity could be associated 
with the premature onset of immunosenescence, independently of age. Studies have 
shown a primordial role of physical activity on weight regulation (Byers 1995; Booth et 
al. 2000), consequently the data also confirms the hypothesis presented in Chapter 4 
stating that lack of physical activity could lead to obesity and subsequently enhance the 
accumulation of senescent T-cells.  
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The accumulation of senescent T cells with obesity may play a role in the increased 
level of immunosuppression and cardiovascular diseases in obese individuals. However, 
the high level of diversity observed among the subjects may reflect the existence of a 
metabolically healthy but obese (MHO) group in the participants of this study. 
Individuals classified as MHO have previously been identified and shown to have a 
metabolically healthy profile including high levels of insulin sensitivity and a clinically 
normal lipid and inflammation profiles (Brochu et al. 2001; Karelis et al. 2005; Stefan 
et al. 2008). These individuals are not subject to the same immunosuppression and 
cardiovascular risk as obese individuals with metabolic disorder (Meigs et al. 2006) and 
could dampen the observed effect size.    
Although the exact mechanisms by which obesity and excess body mass impact on the 
level of T-cell differentiation remain to be tested, two mechanisms are likely to play a 
role in these premature immune changes. Increased levels of oxidative stress associated 
with obesity (Epel et al. 2004; Valdes et al. 2005) may lead to an increased rate of 
telomere attrition (Makarov et al. 1997; von Zglinicki 2002; Epel et al. 2004; Kurz et al. 
2004) and telomere-independent senescence (Dumont et al. 2000; Toussaint et al. 2000; 
Chen et al. 2001; Frippiat et al. 2001). Another direct consequence of obesity and 
excess adiposity is the increased concentration of circulating adipocyte-secreted 
proteins, such as leptin. Indeed supra-physiological concentrations of leptin have been 
shown to enhance T-cell activation in vitro (Lord et al. 1998; Martin-Romero et al. 
2000; Lord et al. 2002) (Chapter 6), suggesting that high concentrations of circulating 
leptin could lead to an increased rate of telomere erosion and senescent T-cell 
accumulation. Indeed while plasma leptin concentrations have been positively 
correlated with telomere shortening (Valdes et al. 2005), the data presented in Chapter 
5 showed a clear positive association between serum leptin concentration and 
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intermediate differentiated or memory T-cells along with late differentiated or senescent 
T-cells. Furthermore, subjects with the highest concentrations of circulating leptin had 
fewer early differentiated or naïve T-cells than subjects with very low serum leptin 
concentrations. 
Chapter 6 investigated the effect of physiological concentrations of human leptin on T-
cell activation in vitro. Furthermore, the constitutional and inducible expression of the 
physiologically active form of the leptin receptor, both at the protein and mRNA level, 
was assessed in T-cells. Previous studies have shown that supra-physiological doses of 
leptin (160 ng.mL
-1
) enhanced mitogen-induced T-cell activation (Martin-Romero et al. 
2000), however it was not known if physiological doses of leptin also had an effect on 
T-cell activation. The data obtained in Chapter 6 showed that lower physiological 
concentrations of leptin (25 ng.mL
-1
 and 50 ng.mL
-1
), as seen in obese patients (Prolo et 
al. 1998), also induce the up-regulation of the early activation marker CD69 in mitogen-
activated T-cells, suggesting a realistic in vivo mechanism leading to the accumulation 
of senescent T-cells in obese individuals. Indeed, during infections and the development 
of a normal immune response, the exposure of antigen-activated T-cells to high 
concentrations of circulating leptin may unnecessarily and uncontrollably enhance their 
activation state, possibly increasing T-cell differentiation and accelerating the rate at 
which telomere shortening occurs, which could eventually lead to premature 
accumulation of senescent T-cells. It was also shown that although OB-Rb mRNA 
appears to be expressed in resting T-cells, it is not expressed at the protein level on the 
surface of resting T-cells (Chapter 6). In addition, T-cell activation by a mitogen up-
regulated OB-Rb mRNA, and when mitogen-activated T-cells were costimulated with 
high concentrations of leptin, OB-Rb mRNA was further up-regulated. This novel 
finding was only observed when concentrations of leptin corresponding to the one found 
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in obese individuals were used to stimulate the T-cells, but not when stimulated with 
leptin concentrations corresponding to the one found in lean individuals. The kinetic of 
the cell surface OB-Rb down-regulation has been investigated (Barr et al. 1999; Uotani 
et al. 1999) and OB-Rb is known to be internalized mediating leptin cellular uptake. It 
could however be hypothesized that leptin-induced OB-Rb up-regulation on activated 
T-cells during normal immune responses may have a period of latency during which T-
cells would still express high amount OB-Rb after resolution of the immune challenge. 
This would lead to prolonged T-cell activation by circulating leptin, increasing the rate 
of telomere shortening, eventually leading to the accumulation of intermediate 
differentiated and senescent T-cells (Chapter 5). 
. 
8.4. Viral Infection status 
 
Chapter 7 investigated the effect of the latent viral infections CMV and EBV on the 
preferential mobilization and subsequent egress of highly differentiated and senescent 
CD8+ T-cell subsets in response to exercise. Similarly to the data shown in Chapter 5, 
subjects infected with CMV had reduced proportions of naïve T-cells and greater 
proportions of highly differentiated effector-memory TEMRA and senescent T-cells 
when compared to their infection free counterparts. As previously shown by Turner et 
al., CMV infection amplified the removal of TEMRA CD8+ T-cells from the peripheral 
blood compartment following exercise (Turner et al. 2010). The study presented in 
Chapter 7 is however the first study to show a similar effect of CMV infection on the 
exercise-induced changes in senescent T-cell numbers. Senescent T-cells were indeed 
more responsive to the acute bout of exercise in CMV seropositive subjects, as they 
were mobilized and removed from the peripheral blood compartment in greater number 
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in response to exercise than non-infected subjects. Another novel finding of this study is 
the observed limited effect of EBV infection on the T-cell repertoire. Naïve and 
senescent T-cells proportions did not differ from EBV seropositive and seronegative 
subjects, however EBV infected individuals had increased proportions of central-
memory T-cells and a greater non-significant elevated proportion of highly 
differentiated effector-memory T-cells in EBV infected subjects was noted. The major 
finding of the study presented in Chapter 7 was that, although CMV-specific and EBV-
specific CD8+ T-cells were mobilized into the peripheral blood compartment with 
exercise, there contribution in the amplified mobilization of senescent T-cells seen in 
CMV and EBV infected individuals did not appear to be substantial. While very 
interesting, this novel finding is contradicting the hypothesis made in the study. It is 
however necessary to highlight an important limitation in the characterization of viral-
specific T-cells. Many viral-proteins are recognized by T-cells, and although pp65 and 
lmp2 have been shown to be good target proteins to monitor CMV and EBV-specific T-
cells respectively (Gibson et al. 2004; Gibson et al. 2007; Lalonde et al. 2007), 20 other 
peptides have been shown to be immunogenic for T-cells (Sylwester et al. 2005). 
Consequently the characterization of viral-specific T-cells by single use of pp65-
specific or lmp2-specific pentamers may not be representative of the entire population 
of CMV-specific and EBV-specific T-cells and the proportions of viral-specific T-cells 
observed may have been under-evaluated. 
Latent viral infections to CMV and EBV induce exacerbated CD8+ T-cell clonal 
expansion, promoting immune exhaustion (Koch et al. 2006), by being periodically 
reactivated in response to physical or psychological stressors (Almanzar et al. 2005). 
The beneficial effect of regular physical activity on immune ageing presented in 
Chapter 4 could be related to the repeated preferential mobilization of highly 
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differentiated and senescent T-cells in response to acute bouts of exercise and their 
subsequent deletion via apoptosis or AICD. Consequently, it was hypothesized that 
frequent highly differentiated and senescent CMV-specific and EBV-specific CD8+ T-
cells preferential mobilization in the peripheral blood compartment in response to 
exercise, would lead to their subsequent deletion via apoptosis, restoring available 
immune space for homeostatic production of naïve T-cells. The data presented in 
Chapter 7 are confirming the preferential mobilization of highly differentiated and 
senescent T-cells, while suggesting that the vast majority of these are not specific to 
CMV or EBV. Highlighting that senescent T-cells mobilized with acute exercise do not 
appear to be specific for CMV or EBV, corroborate the lack of association between the 
beneficial effects of aerobic fitness on immune ageing and latent viral infection status 
(Chapter 4).   
As described above, CMV-specific and EBV-specific may not all recognize pp65 or 
lmp2 respectively, however current literature suggest that the majority of viral-specific 
T-cells should be specific for these antigens (Gibson et al. 2004; Gibson et al. 2007; 
Lalonde et al. 2007). Consequently these new data suggests that other viral-induced 
mechanisms may impact T-cell proliferation and the accumulation of senescent T-cells, 
such as T-cell bystander activation during latent viral reactivation. Herpesvirus 
reactivation have been shown to induce IFN-α and IFN-β production by APC, leading to 
subsequent production of IL-15 (Tough et al. 1996; Tough et al. 1997). The direct 
consequence of IL-15 secretion will be the heterologous proliferation of cells expressing 
high level of IL-2R β chain, such as memory and highly differentiated CD8+ T-cells 
(Zhang et al. 1998). No study to date has however assessed the impact of serum IL-15 
on the accumulation of senescent T-cells in context of CMV and EBV infections. 
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8.5. Limitations of the studies presented in this Thesis 
 
8.5.1. Lymphocytes phenotypic identification limitations 
 
Different T-cell subsets can be identified according to their expression of particular cell 
surface glycoproteins. Four-color flow cytometry was used in the different studies 
comprised within this thesis to characterize the different T-cell subsets of interest. Some 
limitations are however present when using this technique, as accurate characterization 
of certain T-cell subsets require the identification of the expression (or lack of 
expression) of more than 4 glycoproteins simultaneously. Phenotypic identification of 
T-cell subsets to mark their stage of differentiation and functional status is still a 
contentious issue. However current literature tends to identify highly differentiated 
effector-memory T-cell, that encountered antigen and undergone multiple rounds of cell 
division without reaching terminal differentiation,  as CD3+/CD45RA+/CCR7- and 
senescent T-cell, that has reached terminal differentiation, as CD3+/KLRG1+/CD57+ 
(Voehringer et al. 2001; Voehringer et al. 2002; Appay et al. 2008).  
More discrepancies exist in the literature in the identification of memory T-cells based 
on their expression of KLRG1 and CD28.  Cells with a KLRG1+/CD28+ phenotype are 
consistent with effector-memory cells in that they do not express CD45RA or CCR7, 
but may still express CD27 indicating that they are “early” stage differentiated in 
accordance with the classic CD27/CD28 phenotypic identification provided by Appay et 
al. (Appay et al. 2002). Supporting this phenotypic identification, Thimme et al. (2005) 
reported that KLRG1 expression can appear early in the differentiation process, 
although expressed at greater levels proportionally on late/terminal differentiated T-
cells.  
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The different T-cell subsets analyzed in Chapter 5 were identified without using the 
monoclonal antibody anti-KLRG1, due to technical limitations. Although the 
concomitant use of CD28 and CD27 to identify the different T-cell subsets have been 
well documented (Hendriks et al. 2000; Appay et al. 2008; Koch et al. 2008), the 
classification of T-cell subsets into early differentiated, intermediate differentiated and 
late differentiated were preferred to analyze the result accurately. 
 
8.5.2. Experimental design limitations 
 
In Chapter 4 individuals’  ̇      were estimated from a submaximal cycling protocol to 
limit the physical stress to be endured by the older volunteers that participated to the 
study. Although the protocol created by Astrand et al. (196) has been validated and used 
by the scientific community for the past 50 years, and although a validated non-exercise 
questionnaire (Jackson et al. 1990) was also used to compare the estimated  ̇      
value obtained by the cycling protocol (Pearson’s R = 0.88), small inaccuracies could 
have occurred. The subjects that volunteered for the study presented in Chapter 7 
underwent the same  ̇      estimation tests to ensure consistency throughout the thesis. 
Furthermore subjects cycled for 30 minutes at a fixed-intensity corresponding to 85% of 
their maximum Wattage. However, due to ethical institutional review board regulations, 
submaximal  ̇      test (Astrand 1960) was used to estimate this intensity instead of 
more physically demanding maximal  ̇      testing. Consequently, this could have 
potentially led to inaccuracies and to overestimated workload in certain subjects.  
In Chapter 7 viral-specific T-cells could not be assessed in all CMV and EBV infected 
subjects due to the viral-specific pentamers used. Indeed the pentamer technology 
requires subjects to express a specific HLA allele (HLA*A201), and only 6 of the CMV 
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positive subjects expressed this allele and 7 of the EBV positive subjects were 
HLA*A201 positive. While HLA*A201 is the most prevalent allele in the general 
population, only around 50% of the population are expressing HLA*A201 (Lee et al. 
1990) and consequently viral-specific T-cells could not be isolated in CMV and EBV 
seopositive subjects that expressed another HLA allele, as their T-cell receptor would 
not recognize the HLA*A201-pentamer complex. Furthermore, as discussed previously, 
viral-specific T-cells were characterized by their specificity to the most dominant 
epitope of the most dominant antigen of either CMV (pp65) or EBV (lmp2). 
Consequently, viral-specific T-cells specific for other antigens were not detected using 
the pentamer technology, and other techniques should be used to characterize the total 
CMV-specific and EBV-specific T-cells, such as Enzyme-linked ImmunoSorbent Spot 
assays. 
In Chapter 4 and in Chapter 7 it was decided to exclude women from the study, mostly 
because CMV effect on the immune system is more pronounced in men. Indeed T-cell 
functions are known to be influenced by progesterone and oeastradiol (as reviewed by 
(Beagley & Gockel 2003) in a menstrual cycle-dependent manner (White et al. 1997) 
and could have been a confounding factor in the analysis of CMV and EBV infection 
impact on the exercise-induced cell trafficking. Furthermore, the results presented in 
Chapter 5 of this thesis suggest that women have fewer senescent T-cells than men 
during adolescent. Although no study in this thesis or in the current literature analyzed 
the effect of gender on the accumulation of senescent T-cells at an older age, it is 
plausible to hypothesize that the differences in senescent T-cell proportions observed 
between males and females at an early age, will lead to a delayed onset of 
immunosenescence and consequently in lower rate of morbidity and mortality in later 
life.  
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Finally, the greatest limitation of the study presented in Chapter 4 was the use of a 
cross-sectional design. Indeed, while only a longitudinal study could have shown clear 
effect of regular physical activity and aerobic fitness on the ageing immune system, 
such a study would have required to be conducted over an extended period of time and 
would have exceeded all resources available to complete the studies contained within 
this thesis.  
 
8.6. Future Research 
 
As demonstrated by the studies comprised within this thesis, immunosenescence and the 
rate by which alterations in the T-cell repertoire occur are not solely affected by 
chronological ageing. Regular physical activity is negatively associated with the 
accumulation of senescent T-cells (Chapter 4), and highly differentiated and senescent 
T-cells have an increased exercise-sensitivity when compared to less differentiated T-
cells (Chapter 7). In respect with these observations, it is suggested that future studies 
address the following research questions: 
1) Highly differentiated and senescent T-cells have been shown to exit the 
peripheral blood compartment following exercise, however their destination is 
still unknown. Furthermore, what is the fate of these specific cell types? Are 
they eliminated via apoptosis as hypothesized?    
2) If they happen to be deleted by apoptosis after their extravasation, are they being 
replaced by fully functional naïve T-cells, and if so, where are these new T-cells 
coming from? 
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3) Could exercise be used as a clinical intervention to restore normal proportions of 
naïve T-cells, once an individual is already in the IRP? 
4) Can regular physical exercise prevent the early onset of immunosenescence by 
other mechanisms, such as by enhancing telomerase activity? 
 
The data presented in Chapter 5 and in Chapter 6 showed that excess body mass was 
associated with the accumulation of senescent T-cells and the reduction in the naïve T-
cell pool at a very young age, potentially due to un-regulated T-cell activation by 
elevated concentrations of serum leptin. Further research should be conducted in this 
area, in order to address the following research questions: 
1) Does leptin stimulation enhance T-cell proliferation when compared to 
mitogenic stimulation? 
2) What is the mechanism by which leptin up-regulates OB-Rb expression on 
circulating T-cells? 
3) Do other hormones associated with body mass, such as ghrelin, have similar 
effects on T-cells, or would it have an opposite effect on T-cell activation?  
4) Would an exercise-based weight-loss intervention reduce the rate at which 
senescent T-cells accumulate? Furthermore could regular exercise lead to the 
elimination of highly differentiated TEMRA and senescent T-cells, helping to 
restore a biologically “young” immune system? 
 
The data presented in Chapter 7 showed that, although individuals infected with CMV 
and EBV had greater frequencies of highly differentiated and senescent T-cells than 
non-infected subjects, and that those T-cell subsets were more responsive to exercise 
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than less differentiated T-cells, pp65-specific and lmp2-specific T-cells were not 
accounting for the greater exercise-induced changes in highly differentiated and 
senescent T-cells numbers observed in infected individuals. Consequently, future 
research should be conducted in this area, in order to address the following research 
questions: 
1) Although CMV and EBV latent infections have been associated with the IRP, 
many other viruses such as Herpes Simplex Virus 1 and 2 are also known for 
being periodically reactivated. Could the senescent T-cell pool be composed of 
heterogeneous viral-specific T-cells?  
2) By studying the effect of CMV and EBV infection in older men, would the 
longer period of infection affect the observed exercise-induced T-cell changes?  
 
Finally, the data obtained in Chapter 5 highlighted a clear effect of gender on the 
proportions of naïve, memory and senescent T-cells. The effect of immunosenescence 
on female has not been studied extensively, due to the daily hormonal variations and the 
development of menopause in later life. However, future research should include gender 
as a factor in the characterization of immunosenescence.  
 
The findings of this project demonstrate that T-cell senescence is not solely due to 
chronological ageing, but can also be affected by exercise, obesity and latent viral 
infections. Further research is required to fully understand the effects and mechanisms 
affecting immunosenescence. Indeed, with the constant extension of expected lifespan, 
understanding how regular physical activity and weight management could delay the 
onset of immunosenescence or restore a functional immune system, would have great 
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clinical applications in the prevention of infections, ultimately leading to the reduction 
in morbidity and mortality in the elderly.  
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SUBJECT RIGHTS 
 
1. I understand that informed consent is required of all persons participating in this 
project. 
2. All procedures have been explained to me and all my questions answered to my 
satisfaction. 
3. Any risks and/or discomforts have been explained to me. 
4. Any benefits have been explained to me. 
5. I understand that, if I have any questions about this study, I may contact Dr. Richard 
Simpson at (713) 743-9270 or rjsimpson@uh.edu. 
6. I have been told that I may refuse to participate or to stop my participation in this 
project at any time before or during the project.  I may also refuse to answer any 
question. 
7. ANY QUESTIONS REGARDING MY RIGHTS AS A RESEARCH SUBJECT 
MAY BE ADDRESSED TO THE UNIVERSITY OF HOUSTON COMMITTEE 
FOR THE PROTECTION OF HUMAN SUBJECTS (713-743-9204).  ALL 
RESEARCH PROJECTS THAT ARE CARRIED OUT BY INVESTIGATORS AT 
THE UNIVERSITY OF HOUSTON ARE GOVERNED BY REQUIREMENTS OF 
THE UNIVERSITY AND THE FEDERAL GOVERNMENT. 
8. All information that is obtained in connection with this project and that can be 
identified with me will remain confidential as far as possible within legal limits.  
Information gained from this study that can be identified with me may be 
released to no one other than Dr. Richard Simpson (the principal investigator).  
The results may be published in scientific journals, professional publications, 
or educational presentations without identifying me by name. 
9. If you have an injury or emergency while you are in the lab as a subject in this 
study (i.e., bruise, muscle pain, dizziness, etc), you should inform a member of 
the study staff, who will provide you basic first aid care.  This injury will be 
reported to the Human Subjects Committee.  If an injury or emergency arises 
that is unrelated to this study (i.e., personal injury while not in the lab, injury 
at home or work, etc.), you should dial 911. 
 
 
CONFIDENTIALITY 
 
Every effort will be made to maintain the confidentiality of your participation in this 
project.  Each subject’s name will be paired with a code number by the principal 
investigator.  This code number will appear on all written materials.  The list pairing the 
subject’s name to the assigned code number will be kept separate from all research 
materials and will be available only to the principal investigator.  The code list (linking 
subject names and ID numbers) will be destroyed once the project is complete and your 
self-report data has been verified (we anticipate that this will be within 1-month after 
your last visit to the laboratory).  Confidentiality will be maintained within legal limits. 
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RISKS/DISCOMFORTS 
 
1. Blood Collection.  The risks associated with blood sampling are similar to those 
experienced when donating blood.  These include lightheadness, nausea, 
swelling, edema, and/or bruising.  Collection of the blood sample while you are 
in a seated position by a qualified technician will minimize these risks. 
2. Exercise Tests. The exercise tests in this study should not place you under any 
significant cardiovascular risk; however, there is a remote chance of a serious 
cardiovascular event (e.g., heart attack, <0.01% in healthy individuals).  Other 
possible risks include those normally associated with exercise: feeling of fatigue, 
shortness of breath, lightheadedness, sweating, and post-exercise muscle soreness. 
Persons trained in CPR, First Aid, and emergency response will be present during 
all testing.  Proper warm-up and cool-down will be allowed prior to and after the test 
will minimize the risks/discomforts associated with the exercise test. If you feel 
uncomfortable for any reason at all during the study, a researcher will be on hand to 
assist you. If we cannot find an immediate solution to your discomfort, we will abort 
the exercise test. 
3. In the event of injury, we will only provide immediate first aid.  This general first 
aid would include band-aids for a cut, water, ice packs for muscle soreness, and 
CPR.  If it is necessary for you to seek other medical advice (for example, your 
medical doctor or hospital services), you are responsible for paying for those 
services, not the university. 
 
 
ALTERNATIVES 
 
Participation in this study is voluntary and the only alternative is non-participation. 
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PUBLICATION STATEMENT 
 
The results of this study may be published in professional and/or scientific journals.  
The results may also be used for educational purposes or for professional presentations.  
Data will be presented as group means and standard deviations, without mention of your 
name and personal information. 
 
I HAVE READ (OR HAVE HAD READ TO ME) THE CONTENTS OF THIS 
CONSENT FORM AND HAVE BEEN ENCOURAGED TO ASK QUESTIONS.  I 
HAVE RECEIVED ANSWERS TO MY QUESTIONS.  I GIVE MY CONSENT TO 
PARTICIPATE IN THIS STUDY.  I HAVE RECEIVED (OR WILL RECEIVE) A 
COPY OF THIS FORM FOR MY RECORDS AND FUTURE REFERENCE. 
 
Study Subject (print name): ______________________________________________________  
Signature of Study Subject: _______________________________________________________  
Date: ________________________________________________________________________  
 
I HAVE READ THIS FORM TO THE SUBJECT AND/OR THE SUBJECT HAS 
READ THIS FORM.  AN EXPLANATION OF THE RESEARCH WAS GIVEN AND 
QUESTIONS FROM THE SUBJECT WERE SOLICITED AND ANSWERED TO 
THE SUBJECT’S SATISFACTION.  IN MY JUDGMENT, THE SUBJECT HAS 
DEMONSTRATED COMPREHENSION OF THE INFORMATION. 
 
Principal Investigator (print name and title): _________________________________________  
Signature of Principal Investigator: ________________________________________________  
Date: ________________________________________________________________________  
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PHYSICAL ACTIVITY RATING QUESTIONNAIRE  
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APPENDIX 3 
BIOTIN-CONJUGATED MONOCLONAL ANTIBODIES 
COMPRISED IN THE T-CELL ENRICHMENT 
COCKTAILS 
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Enrichment kit Monoclonal Antibodies Clone 
CD3 T-cells 
Anti-human CD11b/Mac-1 ICRF44 
Anti-human CD16 3G8 
Anti-human CD19 H1B19 
Anti-human CD36 CB38 (NL07) 
Anti-human CD41a HIP8 
Anti-human CD56 B159 
Anti-human CD235a GA-R2 (HIR2) 
CD4 T-cells 
Anti- human CD8 SK1 
Anti- human CD11b/Mac-1 ICRF44 
Anti- human CD16 3G8 
Anti- human CD19 H1B19 
Anti- human CD36 CB38 (NL07) 
Anti- human CD56 B159 
Anti- human CD123 9F5 
Anti- human CD235a GA-R2 (HIR2) 
Anti- human γδTCR B1 
CD8 T-cells 
Anti-human CD4 L200 
Anti-human CD11b/Mac-1 ICRF44 
Anti-human CD16 3G8 
Anti-human CD19 H1B19 
Anti-human CD36 CB38 (NL07) 
Anti-human CD41a HIP8 
Anti- human CD56 B159 
Anti- human CD123 9F5 
Anti- human CD235a GA-R2 (HIR2) 
Anti- human γδTCR B1 
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APPENDIX 4 
PUBLISHED PAPERS PRODUCED FROM THE STUDIES 
PRESENTED WITHIN THIS THESIS 
 
  
 
 
 
  
  
  
  
  
 
  
  
  
  
  
 
 
 
  
  
  
  
 
 
  
  
 
 
